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ABBREVIATIONS 
 
ABTS
•+
  2,2’-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt 
FRAP  ferric reducing antioxidant power 
ASE  ‘antioxidant score’ of extract 
ASM  antioxidant scores of mushrooms 
C  cyclohexane 
CC50  cytotoxic concentration of the substance to cause death to 50% of viable 
cells in the host 
CFU  colony forming unit per ml 
CIU  comparative integrated units 
COSY  correlation spectroscopy 
D  dichloromethane 
DMSO  deuterated dimethyl sulfoxide 
DPPH

  2,2-Diphenyl-1-picrylhydrazyl hydrate radical  
EDW  extract dry weight 
EC50  effective concentration 50% 
ESI  electrospray ionisation 
EX  exsheathment 
EY  extract yields 
FCS  fetal calf serum 
FID  flame ionisation detector 
FL  fluorescein 
GAE  gallic acid equivalent 
GLM  general linear model 
HAT  hydrogen atom transfer 
HMBC  heteronuclear multiple-bond correlation spectroscopy 
HPLC  high performance liquid chromatography 
HSQC  heteronuclear single quantum correlation spectroscopy 
IC50  inhibition concentration 50% 
M  methanol 
MIC  minimal inhibitory concentration 
MS  mass spectrometry 
MTT  3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
N.D.  not detected 
N.T.  not tested 
NMR  nuclear magnetic resonance spectroscopy 
ORAC  oxygen radical absorbance capacity  
PBS  phosphate buffered saline 
PDA  photo diode array detector 
Q-TOF  quadrupole time-of-flight 
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R  correlation coefficient 
Rf  retention factor 
RPM  rotation per minute 
RPMI  Roswell Park Memorial Institute 
RSC  radical scavenging capacity 
Rt  retention time 
SD  standard deviation 
SET  single electron transfer 
SI  selectivity index 
SQD  simple quadrupole detector 
TE  Trolox equivalents 
TEAC  Trolox antioxidant activity coefficient 
TLC  thin layer chromatography 
TPC  total phenolic content 
TPTZ  2,4,6-tripyridyl-s-triazine 
U/ml  units per volume 
UPLC  ultra performance liquid chromatography 
UV  ultraviolet 
V/V  volume to volume 
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INTRODUCTION 
Due to the metabolic diversity, ecological variety, significant role in nature 
and complicated web of life cycles, fungi have attracted the attention of various 
scientists, mycologists, chemists, biologists and pharmacists in multiple ways 
(Tkacz, 2004). The level of mushroom consumption has been increasing over recent 
years, and they remain a commercially important sources for the producers of 
speciality foods (Nowacka et al., 2014). Scientific expertise is increasingly being 
applied to help achieve the primary development goals, which include poverty 
alleviation and the sustainable use of natural resources. Real progress has been and 
continues to be made in the roles that mushrooms play in achieving these goals 
(Boa, 2004). 
In the past many new secondary metabolites with diversified chemical 
structures and various interesting bioactivity functions have been isolated from 
higher fungi. These molecules are likely to provide lead compounds for new 
substances that can improve biological body functions or medicinal discoveries, 
such as chemopreventive agents possessing the bioactivity of immunomodulatory, 
anticancer, etc. However, numerous challenges of bioactive molecules from 
mushrooms are encountered including bioseparation, identification, biosynthetic 
metabolism or screening model issues. Researchers have constantly searched for 
new active substances from mushrooms, however, commercial products as yet are 
very limited and mainly from field cultivation, which is obviously a time-consuming 
and labour-intensive process (Zhong and Xiao, 2009). Strategies to enhance new 
secondary metabolites existing as useful natural products in the wild, unknown and 
underinvestigated mushroom species, due to the high prevalence could be an 
extensive source of valuable components for industy. Moreover, among the known 
species the relative amount of well investigated mushrooms is very low. This fact 
together with the information about the great potential of microscopic fungi for the 
production of bioactive metabolites, the experience in ethnomedicinal use of 
mushrooms, the ecologic need for fungi to produce bioactive secondary metabolites 
and the improved opportunities for genetic, pharmacological and chemical analysis 
lead us to believe that mushrooms have a great potential for successful 
bioprospecting (Lindequist, Niedermeyer and Julich, 2005). A large, untapped, and 
chemically diversity resource of bioactive metabolites from wild macrofungi provide 
increasing opportunities for finding new lead structures for medicinal, nutritional, 
functional, therapeutic and phytochemical chemistry, and a new era of higher fungi 
secondary metabolite research has emerged (Quang, Hashimoto and  Asakawa, 
2006). 
According to folk mycologist knowledge the lesser known wild mushrooms 
grown in the Midi-Pyrénées region of France might be a good source of bioactive 
constituents. Investigations into the scarce information on the presence of natural 
secondary metabolites and their properties such as antioxidants, antimicrobials and 
other food protecting and/or health promoting compounds on selected wild 
mushroom species have not been performed until now. On this basis the main 
hypothesis asserts that wild mushroom species may contain valuable natural 
 12 
 
bioactive molecules with multifunctional properties beneficial for various food and 
medicinal applications, such as ingredients of functional foods and nutraceuticals. 
Meanwhile, the hypothesis needs to be investigated to find promising sources of 
natural bioactive molecules, carrying out detail investigations into those showing 
potential and optimising detection techniques in biochemical studies towards the 
safety of newly discovered sources, and the bioavailability of active molecules.  
The aim of the thesis 
The main aim of this study was to investigate antioxidant, antimicrobial and 
other bioactivities of the selected underinvestigated wild mushroom species to 
obtain scientific information, which is required for their valorisation as a source for 
human nutrition and production of functional ingredients.  
The objectives of this study:   
1. To fractionate dried mushroom material using increasing polarity solvents and 
to determine extract yields. 
2. To evaluate antioxidant activity of mushroom fractions by using several in 
vitro assays.  
3. To evaluate antimicrobial activity of mushroom fractions by using various 
microorganisms. 
4. To evaluate cytotoxicity properties of the selected wild mushrooms species. 
5. To isolate and purify secondary metabolites from the selected mushrooms 
species using various chromatographic methods. 
6. To elucidate the structures of purified metabolites using spectroscopic 
techniques such as ESI-MS, ESI-MS/MS, 
1
H NMR, 
13
C NMR, HMBC, 
COSY, HSQC. 
7. To evaluate antioxidant and cytotoxicity activity of the main secondary 
metabolites, isolated from selected mushroom species. 
8. To examine the influence of selected mushroom extracts collected at different 
mushroom harvesting periods and their isolated compounds inhibitory 
activity properties against gastrointestinal nematodes in vitro. 
Scientific novelty 
The scientific novelty of the research performed may be summarised by the 
following main points: 
Systematic and comprehensive evaluation of antioxidant, antimicrobial and 
cytotoxic properties of various mushroom species from the Midi-Pyrénées 
region of France has been performed for the first time; 
Some compounds isolated from the analysed mushroom species have been 
reported for the first time; 
The effects identified in some mushroom species compounds against 
gastrointestinal nematodes, as well as their antioxidant and cytotoxic 
activity, have been evaluated for the first time; 
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The extracts from selected mushroom species have been reported as 
anthelmintic agents for the first time; 
Practical significance 
Wider exploration of underinvestigated bioresources, including various 
mushroom species, requires sound scientific evidence about their composition and 
properties. From this point of view comprehensive and systematic evaluation of 
antioxidant, antimicrobial and other properties of wild Midi-Pyrénées mushroom 
species may be considered as an important step for the practical valorisation of these 
species as a sources of natural functional ingredients to be applied in nutraceuticals, 
functional foods and other applications.  
More specifically, the new knowledge obtained on hispidin, hispolon and 
inonotic acid methyl ester, the compounds that were identified in mushroom 
extracts, and which have been characterised for their cytotoxic and antioxidant 
activity, may be useful for industries searching for new practical structures to be 
incorporated into food, nutraceutical, pharmaceutical and cosmetic products as 
efficient bioactive natural ingredients. 
Finally, the in vitro assay results confirmed the potential activity of selected 
mushroom species and the isolated compounds that inhibit gastrointestinal 
nematodes. This knowledge may be applied to develop new effective preparations 
possessing anthelmintic activities for increasing resistance to worm populations in 
ruminants. For instance, mushroom extracts might be a promising natural candidate 
as an alternative to synthetic drugs causing residues in animal raw materials, which 
is an important characteristic in the production of organic livestock.  
The key points of the thesis 
1. Selected wild mushroom species contain valuable bioactive 
constituents, such as antioxidants, antimicrobial and cytotoxic agents, 
while the proper selection of solvents enables the extracts to be obtained 
with the highest concentration of bioactive compounds that might be a 
valuable source of natural products for various applications. 
2. The selected mushroom genus P. schweinitzii and I. hispidus have the 
potential in vitro activity against gastrointestinal nematodes; however, 
depending on the mushroom harvesting period, anthelmintic activity may 
change in terms of active constituent concentrations accumulated in the 
selected genus. 
Structure and content of the dissertation 
The dissertation is written in English. It consists of acknowledgements, a list 
of abbreviations, introduction, literature review, materials and methods, results and 
discussion, conclusions, a list of references, annexes, and a list of publications 
relevant to the results of thesis. The dissertation has 138 pages in total, results 
presented in 9 tables and 41 figures. The list of references includes 244 
bibliographic sources. 
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1. LITERATURE REVIEW 
1.1. HISTORY, DIVERSITY AND IMPORTANCE OF MUSHROOMS 
1.1.1. General characterisation and definition of mushrooms  
Historically, mushrooms were classified as lower plants due to the relatively 
simple anatomical structural attributes such as lack of true roots, true stems, true 
leaves, true flowers and true seeds. The existence of a cell wall linked them to plants 
rather than to animals. Improved technology and science found that mushroom biota 
have their own characteristics, together with other fungi, which are sufficiently and 
significantly particular. The chitin cell wall is different in composition from plants 
(cellulose or hemicellulose) and a mode of nutrition is heterotrophic but, unlike 
animals, is absorptive (osmotrophic) rather than digestive (Miles and Chang, 2004). 
Therefore, mushrooms have been placed in a kingdom called Myceteae, separate 
from pants and the animal kingdom. Mushrooms can produce a wide range of 
enzymes that degrade complex substrates (agricultural, industrial and forest waste 
products) and form their own nutrition with soluble substances. Mushrooms can be 
classified into three ecological groups: saprophytic (grows on complex organic 
material, found in dead or living tissues), parasitic (deriving their food substances 
from living plants) and mycorrhizal or mutualistic symbiotic (living in association 
with roots of vascular plants) (Stamets, 1993).  
The word mushroom has been used in a variety of ways at different times and 
may mean different things to different people or countries. In a broad sense the term 
mushroom includes all the larger fungi, or all fungi with stems and caps, which are 
edible and/or have medicinal value (Miles and Chang, 2004). More than twenty 
years ago scientist (Miles and Chang, 1997) correctly described mushrooms as 
“macrofungus with a distinctive fruiting body, which can be either hypogeous 
(underground) or epigeous (above ground), large enough to be seen with the naked 
eye and to be picked by hand”. From a taxonomic point of view, mainly 
basidiomycetes but also some species of ascomycetes belong to mushrooms. 
Basidiomycota mostly contain macrofungi, including mushrooms and toadstools, 
bracket fungi and puffballs, although 30% of its species are microscopic. Some 
“larger fungi” cup-fungi, morels and truffles belong to Ascomycota (Senn-Irlet et al., 
2007). 
1.1.2. History, traditions and importance of mushrooms 
Mushrooms have been a part of the fungal variety for about 300 million years. 
The first records of fungi have been found as fossils in the Silurian period, 408 to 
438 million years ago during the Palaeozoic era. Fungal diversity, included 
Basidiomycetes and Ascomycetes with some fruiting bodies, had increased by the 
Pennsylvanian period, from 286 to 320 million years ago. Prehistoric native people 
probably collected wild mushrooms as food and perhaps for medicinal purpose 
(Miles and Chang, 2004). As evidence, mushrooms have been represented in images 
in the caves at Tassili, dating back 5,000 years B.C. Approximately 1,700 years later 
the first primates used Birch Polypore (Piptoporus betulinus), tinder fungus (Fomes 
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fomentarius) and mushroom that may have magical-spiritual significances. Polypore 
can be used as tinder for starting fires and medicine for treating injuries. Also, tea 
prepared by boiling these mushrooms may contain antibacterial and tonic attributes. 
These data were recovered from the well-preserved remains of a man known as 
“Iceman” or “Otzi” found in 1991 (Stamets, 1993). Other archaeological records 
reveal edible mushroom species associated with people living 13,000 years ago in 
Chile. Although it is in China where the eating of wild fungi is first reliably noted, 
with a long history of use for their health promoting benefits, reach several hundred 
years before the birth of Christ. Edible fungi were collected from woodlands in 
ancient Greek and Roman times and highly valued as a delicacy, although more by 
high-ranking people than by farmers. Caesar's mushroom (Amanita caesarea) is a 
good example of an ancient tradition and memorable history that still exists in many 
parts of Italy, embracing a diversity of edible species consumed today as truffles 
(Tuber spp.) and porcini (Boletus edulis) (Boa, 2004). The early civilisations of the 
Greeks, Egyptians, Romans, Chinese and Mexicans appreciated mushrooms as a 
delicacy, knew something about their medical properties, and also used them in 
religious ceremonies for devious purposes. Claudius II and Pope Clement VII were 
both killed by enemies who poisoned them with deadly Amanita. Also, according to 
legend, Buddha died from mushrooms that grew underground. Less powerful, 
psychoactive mushrooms have been used in religious ceremonies and humans 
believed in their spiritual changes, until Gordon Wasson, Albert Hofmann and Carl 
Ruck discovered the shamanic use of psilocybin-containing mushrooms (Stamets, 
1993). This strong emphasis on hallucinogenic mushrooms has unlocked academic 
interest of wild edible fungi. During the last twenty to thirty years researchers have 
substantially increased our knowledge of the mushroom world (Boa, 2004). In 
recent years reports on the chemical, nutritional and functional properties of 
mushroom have been overwhelming. More than 300 articles related to mushrooms 
have been published in the last two decades (Rathee et al., 2012) and the interest is 
still growing.  
For centuries the Chinese have valued many species, not only for food and the 
highly desirable taste, but also for their stimulating and medicinal properties. These 
values and traditions are as strong today as they were centuries ago. The huge 
assortment of mushrooms collected from forests and fields is marketed widely. In 
600-1,000 A.D. in China the first mushrooms, Auricularia auricula-judae,  
Flammulina velutipes and Lentinula edodes were cultivated on wood logs, today this 
country a is leading exporter of cultured mushrooms (Boa, 2004, Miles and Chang, 
2004). In some regions of China the rate of mushroom consumption has reached 20-
24 kg of fresh product per capita annually, which is relatively higher than in Europe 
(Sweden 1 kg, Czech Republic 7-10 kg) (Zhang et al., 2010). Yunnan province of 
China has an area of 390,000 km
2
, and is a specific region abundant in wild-grown 
mushrooms with over 880 species identified as edible. This region accounts for 
about 80% of the edible species identified in China and around 40% in the world 
(Wang et al., 2014a). China also exports wild edible mushrooms, the export rate of 
Yunnan was 105,000 and 135,000 tonnes per year in 2010 and 2011 respectively. 
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One of the most valuable mushrooms, Tricholoma matsutake covers more than 80% 
of the total export from Yunnan Province, China (Wang et al., 2014a).  
There are approximately 100 mushroom species in Lithuanian forests, 
however, only 15-25 of them are collected as edible mushrooms. The annual 
exploitable mushroom yield is 15 to 30 kg per hectare, and it is believed that only 
30-40% of the exploitable harvest is collected. Edible wild mushroom production in 
Lithuanian forests amounts to 24,000 tonnes and industrial production to about 
8,000 tonnes (Olmos, 1999).  
The biggest advance in mushroom cultivation came in France in the early 16
th
 
century when Agaricus bisporus was cultivated on composted substrate. A. bisporus, 
commonly known as champignon or the button mushroom, increased rapidly in 
popularity from its early beginnings and today is produced large quantities (Miles 
and Chang, 2004). Mushroom cultivation fluctuates from year to year, depending on 
demand, but the production of forest mushrooms is not predictable. Picking them is 
a popular pastime and a recreational activity for many people in a substantial 
number of countries.  
1.1.3. Diversity, composition and characteristics of mushrooms  
Today mushrooms are one of the richest and most diverse groups of organisms 
on Earth. Fungi constitute a significant part of the terrestrial environment, forming a 
large share of the species and are key-players in ecosystem processes. The kingdom 
of fungi was long considered an unfamiliar group of organisms, poorly understood 
and difficult to study due to their largely hidden nature and frequently sporadic and 
short-lived fruiting body. However, through the research of scientist and the 
contribution of mycologists over the last few decades our knowledge of fungi has 
significantly increased. 
According to Miles and Chang, (2004) mushrooms can be roughly divided into 
four categories: freshly and edible mushrooms (e.g. A. bisporus); medicinal 
mushrooms – that have medicinal applications (e.g. Ganoderma lucidum), poisonous 
mushrooms – those that are proved or suspected to be poisonous (e.g. Amanita 
phalloides), diverse category – which includes a large number of mushrooms whose 
properties remain less well defined. These may tentatively be grouped together as 
“other mushrooms”. Some mushrooms fall into more than one category; such as 
mushrooms that are not only edible, but also have stimulating and medicinal 
properties. 
There are estimated to be at least 1.5 million fungal species worldwide, but 
only 74,000-140,000 of these have been described. The number of mushrooms, 
according to the definition given by Miles and Chang, (1997), that are known about 
is 14,000, which would account for 10% of the described species (Garibay-Orijel et 
al., 2009). Fig. 1.1 describes the distribution of the known wild edible and medicinal 
mushroom species from more than 200 different sources and 110 countries (Boa, 
2004). 
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Fig. 1.1 Diversity of wild edible and medicinal mushrooms species. (Note: varieties 
and subspecies are counted separately. The categories ‘food’ and ‘edible’ are mutually 
exclusive. To distinguish clearly between use and properties of a species: substantial 
numbers of edible species lack confirmed use as food). 
Furthermore, only 200 species are experimentally grown, 100 economically 
cultivated, approximately 60 commercially cultivated, and about 10 have reached an 
industrial scale of production in many countries. The number of poisonous 
mushrooms is usually reported as approximately 1%, but mushrooms with 
poisonous symptoms are estimated to be approximately 10% (Miles and Chang, 
2004). The proportion of described mushrooms among the undiscovered and 
unexamined mushrooms is only 5%, which implies the 7,000 species that are 
unknown may be of possible benefit to humankind and the environment (Lindequist 
et al., 2005). 
Obviously, mushrooms have been widely used as human food for centuries 
and have been appreciated for their texture and flavour as well as various medicinal 
and stimulating properties, and have even been used as a textile dye (Velíšek and 
Cejpek, 2011). Mushrooms are considered a healthy food due to the high content of 
proteins, usually 12-40% dry matter. The highest contents of 48.8% and 51.2% dry 
matter were observed in Calocybe gambosa and Macrolepiota mastoidea 
respectively. Mushroom protein contains the nine essential amino acids required by 
humans (threonine, valine etc.). Mushrooms also contain relatively large amounts of 
carbohydrates, 13-70% dry matter, (oligosaccharides, chitin, mannitol, glucose, 
glycogen etc.) and fibre, which is a group of indigestible carbohydrates, 4-30% dry 
matter (Barros et al., 2008, Manzi et al., 2004). In addition, they contain significant 
amounts of vitamins, namely thiamine, riboflavin, niacin, ascorbic acid, tocopherol 
and vitamin D, as well as minerals (K, Ca Mg, Fe) (Kalač, 2009). They are also 
valuable foods due to their low-calorie and low-fat content, 2-8%. The differences 
between polyunsaturated fatty acids and saturated fatty acids is quite high, 
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constituting more than 75% of total fatty acids, of which oleic and linoleic acids are 
the most significant, while palmitic acid is the main saturated fatty acid (Ribeiro et 
al., 2009).  
In addition to their nutritional value, taste and aroma, edible mushrooms 
usually contain various bioactive molecules. These naturally occurring chemical 
compounds or complex substances identified in mushrooms have multifunctional 
properties. 
1.2. THE MUSHROOM AS A SOURCE OF NATURAL BIOACTIVE 
MOLECULES 
Unlike the primary products participating in nutrition and essential metabolic 
processes inside the plant or fungi, secondary products play a major role in the 
adaptation to their environment. Higher fungi have formed a special mechanism of 
metabolism that could produce diversified functional secondary metabolites 
containing various properties of a complex chemical structure and bioactivity during 
their long-term evolution. An attempt to resist unfavourable survivable 
environments and finish cell proliferation, differentiation and the entire life cycle to 
reach the purpose of self-defence and survival, mushrooms simultaneously provide a 
rich and fascinating resource for new bioactive molecules (Keller, Turner and 
Bennett, 2005). 
Most bioactive molecules are derived from natural sources and named 
phytochemicals or pharmacologically active compounds. They play an important 
role in the human health during each person’s lifetime and development, besides 
reducing the risk of disease. Many companies are actively engaged in finding new 
bioactive substances that can influence health or diseased status and that can be 
incorporated in food products. Research in the food industry resembles the approach 
used in the pharmaceutical world, starting with molecular targets that are frequently 
derived from drug targets (Georgiou, Garssen and Witkamp, 2011).  
Higher fungi bioactive substances include a wide range of chemical 
components and can be divided into: secondary metabolites, proteins and high 
molecular mass polysaccharides, including polysaccharopeptides and proteoglycans 
(Fig. 1.2). Polysaccharide -glucan are the most widely investigated bioactive 
molecules from mushrooms, possessing antitumor and immunomodulatory 
properties and are already used in clinical treatment. New proteins (include 
lignocellulose degrading enzymes, lectins, proteases and protease inhibitors, 
ribosome-inactivating proteins and hydrophobins) with biological activities can be 
used in biotechnological processes and for the development of new drugs. 
Secondary metabolites from mushrooms combine various structures, such as 
polyketides, terpenes, steroids and phenolic compounds (Barros, Baptista and 
Ferreira, 2007), with diverse and multifunctional biological activities. Studies on 
biologically active substances in mushrooms are not only theoretical but also 
applied. Based on the updated research, five main aspects may be summarised: 
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Fig. 1.2 Higher fungi bioactive components 
An incredible diversity of natural bioactive molecules disclosing anti-
inflammatory, antitumor, antidiabetic, antibacterial, antiviral and antioxidant 
activity, also have cardiovascular and liver protective properties (Lindequist 
et al., 2005, Ferreira et al., 2010, Poucheret, Fons and Rapior, 2006); 
Moreover, their antiallergic, antiatherogenic, hypoglycemic and 
haematological properties have been demonstrated (Palacios et al., 2011). 
Mushroom’s bioactive compounds are involved in immunomodulation 
therapies as components that stimulate or inhibit the immune system. 
Polysaccharides such as lentinan, schizophyllan, polysaccharide K (Kerstin), 
and polysaccharide peptide (PSP) are now available on the medicine market. 
For example, lentinan is applied as a contributor in cancer immuno-therapy 
or in parallel to radio- and chemo-thermotherapy (El Enshasy and Hatti-
Kaul, 2013). 
Different mushrooms species can be considered as functional food due to the 
bioactive molecules. According to the International Life Science Institute 
(ILSI Europe) the definition that states “a food can be regarded as 
functional” if it is satisfactory demonstrated to beneficially affect one or 
more target functions in the body, beyond adequate nutritional effects, to 
improve the state of health and reduce the risk of disease. Extensive studies 
have proved that mushrooms are of value in the prevention and treatment of 
a number of human diseases (Guillamón et al., 2010). 
People worldwide rely on plant-based medicines or dietary supplements for 
their primary health care that can improve biological functions and thereby 
make people fitter and healthier. These products with one or more active 
ingredients are variously known as: vitamins, dietary supplements, 
phytochemicals, nutraceuticals and nutraceuticals. In 2002, mushroom 
products (mushroom derivatives from medicinal, edible and wild 
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mushrooms) used mainly for dietary supplements (mushroom 
nutraceuticals) were assessed to have generated about US$ 11 billion. Since 
then medicinal mushrooms and derived products have increased by 20-40% 
annually depending upon the species (Chang and Buswell,1996). 
Mushrooms pigments were used as textile dye before the invention of synthetic 
dyes (Velíšek and Cejpek, 2011), however, extracting natural colours from 
mushrooms has recently been increased (King, 2002). Pigments, that also 
have bioactive properties might be considered as eco-friendly and produce a 
vast range of vivid coloration agents. 
1.2.1. Brief review on the investigated wild mushrooms bioactive molecules 
It is evident that mushrooms accumulate a great variety of biologically active 
organic compounds, and secondary metabolites that are not directly involved in 
primary metabolic processes of growth and development. Recently, researchers have 
been gradually interested in the chemical composition of mushrooms, although 
curiosity begun in 20
th
 century. The most important discovery of a natural active 
metabolite and antibiotic in medicine was penicillin in 1929, and first used during 
World War II. Alexander Fleming published his observation on the inhibition of 
growth of Staphylococcus aureus on an agar plate contaminated with micro fungi 
Penicillium notatum, which describes an important path for the development of 
modern antibiotics (Rishton, 2008). However, the first fungal bioactive metabolite is 
mycophenolic acid from P. glaucoma that was initially discovered by Bartolomeo 
Gosio in 1893 as an antibiotic agent (Regueira et al., 2011). These antibiotic 
discoveries laid the foundation of bioactive secondary metabolite research of 
mushrooms. An increasing attention worldwide for active molecules has continued 
unabated and thousands of compounds with various properties (antioxidant, 
antibacterial, antifungal, antitumor etc.) have been investigated and identified in 
fungi (Pelaez, 2004). In the present literature survey of macrofungal metabolite over 
38% (approximately 8,600 compounds) from more than 22,000 microbial fungi 
species were described as bioactive substances and these numbers are doubling 
every 10 years. In addition, around 25,000 microbial secondary metabolites, over 
half of which were derived from higher fungi, need further assay and investigations 
about bioactive molecule availability. The most frequent producers of bioactive 
secondary metabolites among macrofungi species belong to the genera Ganoderma, 
Polyporus and Lactarius (Zhong and Xiao, 2009). Chemical constitutes of 
mushrooms have received a lot of attention in the past decades. Numerous further 
studies have proven the effectiveness of bioactive molecules of investigated 
mushrooms and resulted in the various applications that are summarised in Table 
1.1. 
Many other mushroom species have been extensively studied with respect to 
their biological activity. Pleurotus, Lentinula, Grifola, Sparassis, Hericium, 
Coriolus, Cordyceps, Trametes genus also possess active substances, which are 
mainly polysaccharides and proteins representing anti-tumour and 
immunomodulation effects (Roupas et al., 2012). 
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Table 1.1 Bioactive molecule and bioactivity and of mushroom genus  
Genus name Compound Bioactivity Ref. 
Agaricus sp. Agaritine derivatives, 
agaricole, ergosterol, blazein, 
phenolic compounds; 
Tumour growth 
reduction, antiviral, 
antioxidant; 
(Itoh, Ito and Hibasami, 
2008); 
(Wisitrassameewong et 
al., 2012) ; 
(Ferreira, Barros and 
Abreu, 2009). 
 
Suillus sp. Suillusin, suillumide, 
pulvinone derivatives, 
grevilline derivatives, flazin; 
Cytotoxic against the 
human melanoma, 
antioxidant, anti-
inflammatory, anti-
fever, anti-ageing, 
anti-HIV; 
 
(Zhong and Xiao, 2009); 
(Leon et al., 2008, Yun 
et al., 2001, 
Klostermeyer et al., 
2000)  
Phellinus sp. phelligridin (A- J), 
phelligridimer, hispidin, 
davallialactone; 
Antioxidant, 
antibacterial, 
anticancer; 
(Mo et al., 2004); 
(Reis et al., 2014, Lee et 
al., 2008a). 
 
Paxillus sp. Paxillamide, curtisians 
derivatives, ergosterol 
derivatives; 
Antioxidant, 
anticancer; 
(Gao et al., 2001a, Gao 
et al., 2004) 
 
 
Russula sp. Aristolane, nardosinane, 
russulanobilines, nigricanice 
and derivatives; 
 
Anticancer, 
antimicrobial; 
(Vidari, Che and 
Garlaschelli, 1998, 
Malagòn et al., 2014, 
Tan et al., 2004);  
Lactarius sp. Rufuslactone, lactarane 
derivatives, mitissimol 
derivatives, phenolic 
compounds; 
 
Antifungal activity, 
against tumour-
causing cells, 
antioxidant; 
(Luo et al., 2005);(Kim 
et al., 2010, Luo et al., 
2006); (Ferreira et al., 
2009, Gao et al., 2001b). 
 
Tuber sp. Tuberoside, cerevisterol 
ergosterol derivatives. 
 
Antiviral; (Gao et al., 2001b). 
Leucopaxillus 
sp. 
 
Cucurbitacins, leucopaxillone 
(A,B) triterpene; 
  
Anticancer;  (Clericuzio et al., 2004, 
Clericuzio et al., 2006) 
  
Ganoderma sp. Ganomycin, lucidenic acid N, 
methyl lucidenate F, 
lucialdehyde (A-C) 
prenylated phenols, 
hesperetin, formometin, 
biochanin, triterpenoids; 
Antibacterial, 
antioxidant, as agents 
against cancer, 
hepatitis, chronic 
bronchitis, asthma, 
haemorrhoids, fatigue 
symptoms; 
 
(Wu, Shi and Kuo, 
2001, Mothana et al., 
2000); 
(Gao et al., 2002) ; 
(Peng et al., 2015) 
(Ferreira et al., 2009, 
Zjawiony, 2004)  
Cortinarius sp. Unsymmetrical disulphide 
cortamidine oxide, 
symmetrical disulphide 
cortamidine oxide, quinolone, 
isocarbostyryl alkaloid, 
polyketide derivatives;  
Antimicrobial, 
anticancer, antifungal, 
antioxidant; 
(Nicholas, Blunt and 
Munro, 2001, Teichert 
et al., 2008) 
(Bai et al., 2013) 
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Genus name Compound Bioactivity Ref. 
 
Polyporus sp. Biformin, polyporusterones 
A-G, ergosterol derivatives, 
hispolon, hispidin. 
Antimicrobial, 
cytotoxic activity 
against leukaemia, 
antiviral; 
(Zjawiony, 2004, 
Awadh Ali et al., 2003) 
 
 
Most biologically active metabolites from mushrooms possess the drug-like 
characteristics of a chemical structure, which can act as major natural compound 
factories for new drug discovery. The drug-likeness of secondary metabolites from 
higher fungi mainly have a molecular weight in the range of 150–1,000 Da and 
metabolites usually contain C, H, O, and N, even S, P and chlorine group atoms such 
as Cl, Br, and F. Also, the chemical structure commonly contains some important 
functional groups, such as hydroxyl, carboxyl, carbonyl, amino, etc., which can 
provide multi-pharmacophore points, and the number of hydrogen-bonding donors 
and receptors conform to the rules of drug-likeness. According to Zhong and Xiao 
(Zhong and Xiao, 2009) secondary bioactive metabolites of fungi can be grouped 
into heterocyclics, polyketides, sterols, terpenes, and miscellaneous. 
1.2.1.1. Heterocyclic compounds in mushrooms 
Heterocyclic compounds are defined as constituting cyclic structures with at 
least two different atoms as members of the ring. Heterocyclics freely emerge and 
compose almost one-third of the total number of known natural organic products, 
such as antibiotics, vitamins, dyes, alkaloids, pharmaceuticals, etc. The major types 
of bioactive molecules represented in mushrooms are nitrogen heterocyclics, oxygen 
heterocyclics, sulphur-heterocyclics, etc., (Zhong and Xiao, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
The shiitake mushroom (Lentinus edodes) is traditionally consumed in East 
Asia, is edible and well established as a medicinal mushroom because it contains 
several substances that promote health and have antioxidant activity properties 
(Zhang et al., 2013). The heterocyclic agent responsible for the plasma cholesterol-
reducing effect of shiitake is a secondary metabolite designated eritadenine, (Fig. 
Fig. 1.3 Structural formula of eritadenine Fig. 1.4 Structural formula of flazin 
 24 
 
1.3) (2R, 3R)-4-(6-Amino-9H-purin-9-yl)-2,3-dihydroxybutanoic acid (Enman et al., 
2008). 
Other nitrogen-containing heterocycle compounds exhibiting a weak anti-HIV-
1 activity, namely flazin (Fig. 1.4), 1-[5-(Hydroxymethyl)-2-furyl]-9H-β-carboline-
3-carboxylic acid, belonging to β –carboline derivatives, from the fruiting body of 
Suillus granulatus (Zhong and Xiao, 2009). Two quinoline active secondary 
metabolites, (6-Hydroxyquinoline-8-carboxylic acid (1R), 4-Amino-6-hydroxy-
quinoline-8-carboxylic acid (2R); Fig. 1.5) and isocarbostyryl alkaloid (7-Hydroxy-
1-oxo-1,2-dihydroisoquinoline-5-carboxylic acid; Fig. 1.5), products of Cortinarius 
subtortus, exhibited antioxidant and antifungal effect (Teichert et al., 2008). 4-
hydroxymethyl quinoline (Fig. 1.6) was isolated from the wood-rotting fungi 
Trametes versicolor and Pycnoporus sanguineus. This was the first detection in 
fungi of an unoxidised quinoline nucleus, and it is active against malaria (Abraham 
and Spassov, 1991), and may have role in plant growth regulation and antifungal 
activity (Vinale et al., 2010). 
 
 
 
 
 
1.2.1.2. Polyketides in mushrooms 
Polyketides are secondary metabolites formed from a polyketone and/or the 
polyketide chain and containing as a minimum one acetate group, and comprises a 
huge class of bioactive molecules with a broad of structural variety. In general, the 
polyketide chain is formed by the subsequent addition of simple carboxylic acids 
like acetate. Polyketides of higher fungi are the richest natural organic complexes 
that have been shown to display a wide range of potentially valuable therapeutics 
due to their antibiotic, anticancer, antifungal, antimicrobial, antioxidant, 
hypolipidemic and immunosuppressive properties among natural products.  
Phellinus igniarius, basidiomycete belonging to the family Polyporaceae has 
been long used in traditional Chinese medicine for the treatment of wounds, 
bellyache, and bloody gonorrhoea since ancient times. In recent years’ scientists 
have obtained over 20 secondary metabolites with interesting chemical structures 
and significant bioactivities from P. igniarius. Several active polyketides, 
phelligridin C (8,9-dihydroxy-3-[(E)-2-(4-hydroxyphenyl)vinyl]-1H,6H-pyrano[4,3-
c]isochromene -1,6-dione; Fig. 1.7) and phelligridin B (methyl 6-[(E)-2-(3,4-
dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-carboxylate; Fig. 1.8) had 
significant selective cytotoxicity against human lung cancer. Phelligridin G, 
Fig. 1.5 Structural formula of two 
quinoline (1R, 2R) and isocarbostyryl 
alkaloid 
Fig. 1.6 Structural formula of 4-
hydroxymethyl quinoline 
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containing an unprecedented carbon skeleton, was a unique pyrano derivative that 
showed not only moderate cytotoxic activity against human cancer cells but also 
antioxidant activity inhibiting rat liver microsomal lipid peroxidation (Zhong and 
Xiao, 2009). 
 
 
 
 
 
 
 
  
 
Recently, chemical studies of the ethyl acetate fruiting bodies of Cortinarius 
purpurascens led to the isolation of nine, polyketide-derived, anthraquinone 
Fig. 1.7 Structure of phelligridin C Fig. 1.8 Structure of phelligridin B 
Fig. 1.10 Structure of rufoolivacin D, leucorufoolivacin 
Fig. 1.9 Structure of rufoolivacin, rufoolivacin C 
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pigments among four tested natural compounds, rufoolivacin, rufoolivacin C, 
rufoolivacin D and leucorufoolivacin (Fig. 1.9 and 1.10), exhibited potent DPPH 
radical-scavenging activity (Bai et al., 2013, Brondz et al., 2007). 
1.2.1.3. Sterols in wild mushrooms 
Sterols are group of steroids with a multiple-ring structure and hydroxyl group 
at the third position of the A ring. They naturally occur in live organisms’ 
membranes and are an important class of organic molecules. The most abundant 
sterol in mushrooms is ergosterol ((3β,22E)-Ergosta-5,7,22-trien-3-ol; Fig. 1.11) 
containing 28 carbon atoms (Teichmann et al., 2007), differing from the major plant 
phytosterols in having two double bonds in the sterol ring structure instead of one. 
Various minor sterols present in fungi have been isolated, including fungisterol 
((3β,5α,22E)-ergosta-6,8,22-trien-3-ol; Fig. 1.11), ergosta-5, 7-dienol, 24-methyl 
cholesterol and methylene cholesterol. The fungal sterols provide characteristic 
functions that are necessary for vegetative growth. (Mattila et al., 2002). 
 
 
 
Another known sterol represented in mushrooms is ergocalciferol or Vitamin 
D2. This essential compound is the synthetic form of vitamin D2 that can be formed 
from the mushroom steroid, ergosterol, by UV irradiation and it is assumed to have 
the same biological activity as cholecalciferol (vitamin D3). It plays a vital role in 
calcium metabolism and bone mineralisation especially for children (Jasinghe and 
Perera, 2005). 
 
In the course of searching for new bioactive products with developed 
properties, sterol (5α,8α-epidioxy-(22E,24R)-ergosta-6,22-dien-3β-ol; Fig. 1.12) 
Fig. 1.11 Structure of ergosterol, fungisterol 
Fig. 1.12 Structure of 5α,8α-epidioxy (22E,24R)-ergosta-6,22-dien-3β-ol, cerevisterol 
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isolated from Paxillus panuoides (Gao et al, 2002) and Agrocybe aegerita (Zhang, 
Mills and Nair, 2003) possessed potent anticancer and antioxidant activity. The 
ectomycorrhizal Tuber species and related fungi also some Volvariella species 
contain cerevisterol (22E,24R)-ergosta-7,22-dien-3β,5α,6β-triol; Fig. 1.12), which 
have cytotoxic activity against malaria (Li et al., 2007, Jinming, Lin and Jikai, 2001, 
Mallavadhani et al., 2006). 
1.2.1.4. Terpene compounds in mushrooms 
Terpenes are constituted from multiple isoprene units, which has the molecular 
formula (C5H8)n. Terpenes are known as an important diversity of naturally 
occurring bioactive molecules produced by many higher fungi. Diterpenoid, 
triterpenoid, and sesquiterpenoid are the typical representatives of terpenes with 
interesting biological activities of mushrooms.  
Ganoderma lucidum, a well-known traditional Chinese medicine in eastern Asia, is 
used as a folk panacea for the treatment of cancer, hepatitis, chronic bronchitis, 
asthma, haemorrhoids, and fatigue symptoms, and has contributed over 130 highly 
oxygenated and pharmacological active lanostane-type triterpenoids from its fruiting 
bodies, mycelia, and spores, many of which exhibited cytotoxic activity against 
various tumour cell lines (Paterson, 2006). Three triterpenes lanostane-type 
aldehydes lucialdehydes B and C ((24E)-3,7-dioxo-5alpha-lanosta-8,24-dien-26-al; 
(24E)-3beta-hydroxy-7-oxo-5alpha-lanosta-8,24-dien-26-al; Fig. 1.13) and lucidenic 
acid N ((3β,5α,7β)-3,7-dihydroxy-4,4,14-trimethyl-11,15-dioxochol-8-en-24-oic 
acid; Fig. 1.14), were successively isolated from G. lucidum and showed significant 
cytotoxic effects against cancer cells (Wu et al., 2001, Gao et al., 2002). Therefore, 
the mushroom G. lucidum is considered as a rich mine of triterpenoids bioresource. 
 
 
Fig.1.13 Structure of lucialdehydes B, C 
 
 
Fig 1.14 Structure of lucidenic acid N 
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Most members of the genus Lactarius contain an abundance of milky juice, 
which appears when the fruiting bodies are injured. Sesquiterpenes represent an 
important biological role in the great majority of Lactarius species, essential for the 
pungency and bitterness of the milky juice and the change in colour of the latex on 
exposure to air, and constituting a chemical defence system against various invaders 
such as bacteria, fungi, animals and insects. In the process of bioactive metabolite 
investigation for Lactarius species sesquiterpene, known as rufuslactone was 
isolated, from the mushroom L. rufus. Rufuslactone ((9S,13R)-8,11,11-Trimethyl-
4,14-dioxatetracyclo[6.5.1.0
2,6
.0
9,13
]tetradec-2(6)-en-5-one; Fig. 1.15) is an isomer 
of a previously described lactarane (3,8-oxa-13-hydroxylactar-6-en-5-oic acid γ-
lactone) from L. necatar and possessed potent antifungal activity (Luo et al., 2005).  
 
 
 
 
Subvellerolactones B and D (Fig. 1.15) structurally unusual lactarane 
sesquiterpenoids, were isolated from the fruiting bodies of Lactarius subvellereus. 
Subvellerolactones B exhibited cytotoxicity against lung carcinoma, skin melanoma 
and human lung cancer, and subvellerolactones B and E showed cytotoxicity against 
skin melanoma and human tumour cells (Kim et al., 2010). 
1.2.1.5. Miscellaneous compounds in mushrooms 
Naturally occurring small diversified molecules are recognised as an important 
source of bioactive substances. Miscellaneous group have wide range compounds 
including phenolics, acids, polyphenols and others. The Paxillaceae family is a 
typical representative, possessing the rich secondary metabolites p-terphenyls. 
Approximately 20 p-terphenyls, known as curtisians A–Q (Fig. 1.16), were 
successively isolated from P. curtissii growing widely in East Asia and Southern 
Europe on decayed pine trees. Most of the p-terphenyl compounds exhibit attractive 
antioxidant activities against lipid peroxidation or radical-scavenging activity 
against DPPH (Quang et al., 2003a; Quang et al., 2003b). 
Ellagic acid and its derivatives are widely distributed in plants, but are rare in 
fungi. The basidiomycete Russula nigricans whose fruiting bodies have been found 
to show antitumor activity was identified as a phenolic compound based on the 
ellagic acid skeleton. Nigricanin (3,8-dihydroxy-10-methoxy[1]benzopyrano[5,4,3-
cde][1]benzopyran-5(10H)-one; Fig. 1.17) is considered as the first ellagic acid like 
compound found in higher fungi. 
 
 
Fig. 1.15 Structure of subvellerolactones B, D and rufuslacton 
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Another unique benzofuran, known as suillusin, was isolated from the fruiting 
body of the mushroom Suillus granulatus. Suillusin (1H-cyclopenta[b]benzofuran; 
Fig. 1.17), which is biogenerated from polyporic acid, indicates potential antioxidant 
activity and specific cytotoxic effects against human cancer and melanoma (Yun et 
al., 2001). 
1.3. BRIEF REVIEW OF COLLECTED MUSHROOM SPECIES AND 
THEIR SECONDARY METABOLITES  
This research focuses on wild growing mushroom species from the Midi-
Pyrénées region in France (Table 2.2). Literature surveys on the collected coastal 
and forest mushrooms species with potential activity or biological compounds are 
rather scarce or not described at all.  
Agaricus are well known mushroom genus with possibility over 200 species 
all over the world (Kerrigan, Challen and Burton, 2013). Agaricus pseudopratensis 
possess an unpleasant odour provided by a phenolic compound composition as well 
as fatty acids and their esters (Petrova et al., 2007). Another species, Agaricus 
devoniensis, was extracted with increased polarity of solvents to obtain microbial 
and antioxidant activity (Al-Fatimi et al., 2005). Agaricus fissuratus, with its 
phenolic compound and almond odour has shown potential antitumor activity 
(Didukh and Mahajna, 2005). 
Boletus is a genus of mushrooms, consisting of over 100 species. Of all the 
forest species gathered worldwide, the edible mushrooms from the Boletus genus are 
Fig. 1.16 Structure of curtisian B and C 
Fig. 1.17 Structure of nigricanin and suillusin 
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the most popular and frequently harvested in European countries, due to their 
particular aroma, taste and texture (Heleno et al., 2011). There are few studies 
available in literature reporting nutrients analysis, chemical composition and 
antioxidant activity of Boletus impolitus collected in Northeast Portugal (Pereira et 
al., 2012). Also, the antimicrobial potential of methanol fraction extract 
(Nikolovska-Nedelkoska et al., 2013) and monoterpenic volatile compounds of fresh 
Boletus lupines were determined (Breheret et al., 1997). Several carotenoids were 
identified in edible species of Boletus luridus (Czeczuga, 1978); however, studies on 
the antioxidant properties of selected Boletus species are scarce. 
Gilled genus Tricholoma generally grow in woodlands or sandy dunes. 
Tricholoma caligatum forms a small fuscous to blackish fruit body and grows in the 
Mediterranean region (Murata et al., 2013). Various aromatic derivatives were 
identified in T. caligatum (Fons et al., 2006). The pine forest or seaside sand dune 
mushroom Tricholoma auratum has an active anti-osteoporosis ergosterol derivative 
(Hata et al., 2002) and has microbial activity (Yamaç and Bilgili, 2006). Tricholoma 
columbetta is edible and can be consumed fresh, dry or pickled. A cyclopentene 
derivative, columbetdione (Vadalà et al., 2003), and endopeptidase (Lamaison, 
Pourrat and Pourratt, 1980) were found in its fruiting bodies, while ethyl acetate 
extracts of T. columbetta were shown to possess nematicidal activity against 
Caenorhabditis elegans and antibacterial activity against Bacillus brevis (Stadler 
and Sterner, 1998). Unfortunately, an antioxidant activity of bioactive components 
on selected species is not detected. 
Clitocybe odora, known as the anise odour mushroom, rich in -anisaldehyde, 
benzaldehyde and other volatile compounds (Malheiro et al., 2013), has a valued 
chemical composition, also exhibiting potential antioxidant and antimicrobial 
properties (Vaz et al., 2011, Suay et al., 2000). 
The most species-rich mushroom genus known today is Cortinarius. Some 
species of Cortinarius possess chemical compounds that have significant biological 
properties, such as the alkaloid activity against Alzheimer´s disease of the species 
Cortinarius infractus (Brondz et al., 2007, Geissler et al., 2010, Stefani, Jones and 
May, 2014). 
Phaeolus schweinitzii (Fr.) is a common root and butt pathogen of conifers in 
North America and Eurasia producing a strong, water-soluble pigments possessing 
five intensive colours: olive-brown, olive-grey, dark-brown, brownish-grey and 
linoleum-brown (Cedano, Villaseñor and Guzmán-Dávalos, 2001). This mushroom, 
also known as Polyporus schweinitzii, has a wide host range infecting species of 
Cupressaceae (Thuja), Pinaceae (Abies, Larix, Picea, Pinus, Pseudotsuga, Tsuga) 
and Taxaceae (Taxus) in natural forests. The sessile mushroom has a velvety, brown 
to olive spongy cap when mature, and a yellowish brown or orange with dark brown 
pore surface and margin when young. The pores are angular and fairly large, and the 
fairly thin, flexible flesh is brown to reddish brown, its small stipe is solid and 
fibrous with a tomentose surface (Simpson and May, 2002). In medicine P. 
schweinitzii has been recorded to possess bioactivity against tumour cells in vivo and 
showed antimicrobial activity. Only one active metabolite, hispidin, was isolated 
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from acetone extraction of P. schweinitzii (Ueno et al., 1964). There were no reports 
describing secondary metabolites and their activity of P. schweinitzii. During our 
ongoing efforts to discover active substances researchers in China have described a 
potent radical scavenging capacity of five new hispidin derivatives, phaeolschidin 
A−E, together with the known compounds pinillidine and hispidin from ethanol 
extraction (Cedano et al., 2001, Han et al., 2013).  
Inonotus hispidus is a parasitic fungus preferably living on deciduous trees 
such as Fraxinus, Quercus, Sorbus and Malus. It has been used as a traditional 
medicine for treating dyspepsia, cancer, diabetes and stomach problems in the 
northeast region and Xinjiang province of China (Awadh Ali et al., 2003). I. 
hispidus contains polyphenol pigments with a styrylpyrone skeleton, which were 
reported to exhibit antimicrobial, antioxidant, antiviral and anti-inflammatory 
activities. Two natural antioxidants, named inonotusin and hispidin were isolated 
from the methanolic extract of the fruit bodies and showed antioxidant and cytotoxic 
activity against human breast carcinoma cells (Zan et al., 2011). 
Xerocomus chrysenteron is an edible mushroom occasionally harvested in 
autumn. The lectin was identified in X. chrysenteron (Birck et al., 2004), while its 
methanolic extract was reported to possess antioxidant activity (Sarikurkcu, Tepe 
and Yamac, 2008, Heleno et al., 2012). 
Hydnellum ferrugineum has a red spore deposit and is easily recognised. 
Hydenellum spp. are regarded as “nitrogen sensitive” organisms (Ainsworth et al., 
2010, Van der Linde, Alexander and Anderson, 2008) and have become a concern of 
European conservation. 
Biologically active compounds interact differently with microorganisms 
indicating that different components may have different modes of action or that the 
metabolism of some microorganisms are better able to overcome the effect of the 
compound or adapt to it. Although it is important to mention that a single compound 
may not be responsible for the observed activity but rather of compounds interacting 
in an additive or synergistic manner (Paiva et al., 2010). 
Considering that there are about 7,000 poorly studied wild mushrooms species, 
it may be concluded that mushrooms have a good potential in searching for valuable 
bioactive substances for developing natural preparations for multipurpose goals. To 
increase practical exploration of mushroom diversity in various regions they should 
be more comprehensively and systematically studied, e.g. by using various activity 
guided assays. Regardless of the above-cited articles, the reports on the properties 
and the presence of bioactive compounds in the mushroom species selected for this 
study are rather scarce. Therefore, the primary aim of the present work was to 
evaluate antioxidant, antimicrobial cytotoxic properties and biological active 
compounds of the 30 underinvestigated wild mushroom species by applying a more 
systematic approach in order to obtain scientific information, which is required for 
their preliminary valorisation as a source for human nutrition, production of 
functional ingredients and medicinal applications as biologically active substances.  
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1.4. THE POTENTIAL ACTIVITY OF MUSHROOM SUBSTANCES AND 
THEIR RECOVERY  
Historical traditions and the extensive research prove the preventive and 
therapeutic properties of many mushroom species. The natural compounds of 
mushrooms are potentially important not only in medicine, with their specific health 
effects and cures for diseases associated with oxidative damage. But it is also 
important for the food industry because they obstruct oxidative degradation of lipids 
and thereby improve the quality and nutritive value of food products, including 
dietary supplements and products sometimes referred to as functional foods. 
Therefore, the search for effective and non-toxic natural antioxidants and other 
bioactive molecules has become a regularly increasing topic. Synthetic antioxidants, 
such as butylated hydroxyanisole, tert-butylated hydroxyquinone and butylated 
hydroxytoluene, are radical scavengers but are usually associated with negative side 
effects (Woldegiorgis et al., 2014). Affecting free radical damage by naturally 
occurring antioxidants from several sources, either the plant or fungi kingdom is 
becoming one of the most appreciate models of modern therapy. Antioxidants with a 
source of healthy compounds are present in all biological systems and mushrooms 
are no exception. In the literature antioxidative active components can be ranked as 
primary or long-term antioxidants and as secondary or processing antioxidants. 
Primary antioxidants contain hindered phenols and secondary aryl amines, while 
secondary antioxidants contain organophosphates and thioesters; thus the primary 
antioxidants are active radical scavengers, hydrogen donors or chain reaction 
breakers while the secondary ones are peroxide decomposers (André et al., 2010). 
Since the antioxidant capacity of complex biological extracts is usually 
determined by a mixture of various antioxidative active constituents, which may act 
by different mechanisms and sometimes possess synergistic effects, the reliability of 
the evaluation of overall antioxidant potential of any plant material increases by 
applying several assays (Frankel and Meyer, 2000, Laguerre, Lecomte and 
Villeneuve, 2007). ABTS
•+
 and DPPH
•
 scavenging, FRAP, ORAC and TPC assays 
are the most common methods for determining in vitro antioxidant capacity of plant 
origin substances. ORAC and TPC measured with Folin-Ciocalteu reagent and one 
of the single electron/hydrogen atom transfer assays (SET or HAT) should be 
recommended for the representative evaluation of antioxidant properties (Huang, Ou 
and Prior, 2005). The DPPH
•
 scavenging method is mainly attributed to the SET 
assays; however, quenching of DPPH
•
 to form DPPH-H is also possible. Other SET 
based methods include ABTS
•+
 decolourisation assay, ferric ion reducing antioxidant 
power (FRAP) assay and the TPC assessment using Folin-Ciocalteu reagent. The 
ORAC assay evaluates radical chain breaking antioxidant activity via HAT and 
measures antioxidant inhibition induced by peroxyl radical oxidation. 
Frequently, solvent extraction techniques are used for bioactive compound 
recovery. Depending on the extracted compound or class of compound, important 
factors in the process are solvent type, extraction time and temperature. The polarity 
of the solvent should be a similar class to the desired bioactive molecule. Efficient 
extraction of antioxidants, antimicrobials and other biologically active molecules 
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requires the use of solvents with different polarities: hydrophilic compounds are 
better soluble in polar solvents such as methanol and water, whereas cyclohexane or 
dichloromethane are preferable for isolating lipophilic molecules. Two main 
techniques may be applied for exhausting isolation of various biologically active 
compounds from material, namely parallel extraction of the initial material with 
different solvents or sequential fractionation with increasing polarity and dielectric 
constant solvents.  
1.4.1. Antioxidants in mushrooms and their mode of action 
Free radicals are produced in the normal natural metabolism of aerobic cells as 
oxygen reactive species (ROS). The essential conditions for normal organism 
functioning and maintaining of equilibrium free radicals are neutralised by cellular 
antioxidant defences (enzymes and non-enzymatic molecules). However, the 
overproduction of ROS or the loss of the cell antioxidant defences is known as 
oxidative stress and in this case, the excess ROS may oxidise and damage cellular 
lipids, proteins and DNA, leading to their modification and inhibiting their normal 
function. This disequilibrium of radicals has been related to more than one hundred 
diseases including several kinds of cancer, diabetes, cirrhosis, cardiovascular 
diseases, neurological disorders, aging process and others (Ferreira et al., 2009). 
Free radicals derived from molecular Oxygen (O2) are usually known as reactive 
oxygen species (ROS) and generally described as unstable and the most important 
class of radical species generated in living systems. Superoxide anion (O2
-
) is the 
“primary” ROS radical and mostly produced in mitochondria, due to a small but 
continuous “leak” of the electrons in the mitochondrial electron transport system 
(ETS). This anion can also be formed by different endogenous enzymatic systems 
present in the cell, such as NADPH oxidases and xanthine oxidase. However, O2
-
 
possibly interacts with other bioactive molecules and generate “secondary” ROS, 
such as hydrogen peroxide (H2O2) and hydroxyl radical (OH
•
). Hydroxyl radical is 
described as the most toxic among all radicals, being responsible for the effect on 
DNA molecules, although it has a very short existence period (Halliwell and 
Gutteridge, 1990). The hydroxyl radical is the neutral form of the hydroxide ion and 
it is formed by an electron transfer from transition metals to H2O2, and interacts with 
biomolecules enzymes immediately after generation (Valko et al., 2007). Free ROS 
radicals are susceptible to attacking membrane lipids, where lipid peroxidation 
usually begins with the extraction of a hydrogen atom from a polyunsaturated lipid 
(LH) chain, through the action of reactive species such as HO•. This generates a 
highly reactive lipid radical (L•) that can interact with oxygen to form a peroxyl 
radical (LOO•), which is not influenced by antioxidants, will react with other 
neighbouring lipids producing hydroperoxide lipids (LOOH) and can easily be 
decomposed to form new L• radicals, initiating a process that is known as chain 
propagation reactions (McCord, 2000, Abreu, Santos and Moreno, 2000). 
Other important radicals are reactive nitrogen species (RNS), were nitric oxide 
(NO•) is generated in biological tissues by specific nitric oxide synthases (NOS), 
which metabolise arginine to citrulline. Nitric oxide is an important oxidative 
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biological molecule with a different type of physiological processes, including 
neurotransmission, blood pressure regulation, defence mechanisms, and regulation 
of immune response. The RNS abundance is called nitrosative stress and may lead to 
nitrosylation of proteins and affect their normal function. Nitric oxide jointly with 
superoxide anion oxidation in the cell immune system may influence inflammatory 
processes. Whereas NO• can react with O2 and produce a potent oxidising agent 
peroxynitrite anion (ONOO
-
), which can cause DNA fragmentation and lipid 
oxidation (Ferreira et al., 2009, Carr, McCall and Frei, 2000). 
Exposure to free radicals from a variety of sources has led organisms to 
develop a series of different endogenous enzymatic antioxidant defences in the 
organism which include superoxide dismutase (SOD), catalase (CAT), glutathione 
peroxidases (GPx), glutathione reductase (Gred), glutathione (GSH), -tocopherol 
(vitamin E), ascorbic acid (vitamin C), lipoic acid and other antioxidants (Valko et 
al., 2007, Fang, Yang and Wu, 2002). Besides endogenous defences, antioxidant 
supplements or antioxidant-containing foods may be used to help the organism to 
reduce oxidative damage or to protect food quality by preventing oxidative stress. A 
multitude of natural antioxidants have already been isolated from different kinds of 
biological materials and mushroom bioactive substances are identified as one 
possibility. The benefit of using mushrooms over plants as sources of bioactive 
compounds are that often the fruiting body can be produced in a short time, the 
mycelium may also be rapidly produced in liquid culture and the culture medium 
can be manipulated to produce optimal quantities of biologically active substances 
(Ferreira et al., 2009).  
The antioxidants found in mushrooms are mainly represented as phenolic 
compounds (phenolic acids and flavonoids), followed by tocopherols, ascorbic acid 
and carotenoids. Phenolic compounds are secondary metabolites, constituted from 
aromatic hydroxylated compounds, possessing one or more aromatic rings with one 
or more hydroxyl groups, usually found in vegetables, fruits and many food sources. 
Natural bioactive molecules are accumulated from biological sources as end-
products and can range from relatively simple molecules (phenolic acids, 
phenylpropanoids and flavonoids) to highly polymerised compounds (lignins, 
melanins and tannins), such as flavonoids and phenolic acids representing the most 
common group in mushrooms. Phenolic acids can be divided into two groups (Fig. 
1.18): one of hydroxybenzoic acids derived from non-phenolic molecules benzoic 
acid, usually occurring in the bound form and are typical component of a complex 
structure like lignins and hydrolysable tannins, also linked with sugars or organic 
acids in plants. 
 
Fig. 1.18 Benzoic and cinnamic acid derivatives 
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The other group is hydroxycinnamic acids, a derivative of cinnamic acid, 
commonly present in the bound form and connected to cell-wall structure 
components, such as cellulose, lignin and proteins, also to tartaric or quinonic acids 
(Liu, 2004; Ferreira et al., 2009).  
There are important factors that determine the antioxidant effectiveness and 
potential of natural phenolic compounds: stability of natural antioxidant formed 
during radical reaction, involvement of the phenolic hydrogen in radical reaction and 
chemical substitutions present on the structure. The substitutions on the structure are 
one of most important aspects with the ability of the active phenolic molecule to 
participate in the control of radical reactions and form resonance-stabilised 
antioxidants radicals from natural origin as follows: 
 
 
 
Antioxidant activity of phenolic acids depends on phenolic hydrogens and 
hydroxyl substitutions at ortho and para positions. The stability of the phenoxy 
radical increases if intermolecular hydrogen bonds are formed in the ortho position, 
also the second hydroxyl group possess stronger antioxidant activity than 
compounds containing a methoxy (OCH3) group (Ferreira et al., 2009). 
Flavonoids represent a large group of phenolic compounds (Fig. 1.19), which 
consist of two aromatic rings (A and B rings) linked by a three carbon chain that is 
usually in an oxygenated heterocyclic ring (C). These compounds naturally occur in 
plants, fruits, vegetables, grains, bark and roots and have been linked in reducing the 
risk of major chronic diseases (Liu, 2004). 
 
 
 
Several classes of flavonoids identified in wild mushrooms are described on 
the basis of the differences in the generic structure of the heterocycle C ring and can 
be classified as flavonols, flavones, flavan-3-ols, flavanones and isoflavones (Fig. 
1.20) (Ferreira et al., 2009). 
 
Fig.1.19 The generic structure of flavonoids. 
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Fig.1.20 Flavonoids classes identified in wild mushrooms 
 
Flavonoids are characterised as health-promoting molecule, including 
antioxidant, anti-inflammatory and anti-proliferative activities, within inhibition 
mechanisms of bioactivating enzymes, or the induction of detoxifying enzymes 
(Le Marchand, 2002). The protective effect against cardiovascular diseases was the 
first mechanism of the action of flavonoids as antioxidants to be studied. 
Flavonoids’ multifunctional properties have been shown to be highly effective 
radical scavengers mostly of oxidising molecules, including singlet oxygen and 
various free radicals, which are possibly responsible for DNA damage and tumour 
promotion (Wright, Johnson and DiLabio, 2001). Phenolic compounds from wild 
mushrooms represent one of the most effective antioxidants with a reduced risk of 
chronic diseases due to their ability to reduce agents by donating hydrogen and 
quenching singlet oxygen.  
Tocopherols (-,-, -, -tocopherols) found in mushrooms also have the 
antioxidant properties and play a vital role in cancer and cardiovascular disease. 
Vitamin E is one of the tocopherol forms that react with peroxyl radicals produced 
from polyunsaturated fatty acids in membrane phospholipids or lipoproteins to yield 
a stable lipid hydroperoxide. Whereas, they act as antioxidants by donating a 
hydrogen atom to peroxyl radicals of unsaturated lipid compounds, forming a 
hydroperoxide and tocopheroxyl radical. This active radical reacts with other 
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peroxyl or tocopheroxyl radicals forming better stability of foods, as well as in the 
antioxidative defence mechanisms of biological systems (Lampi et al., 1999) 
Ascorbic acid, also known as vitamin C, associates with various oxidative 
stress related health problems such as heart disease, stroke, cancer, several 
neurodegenerative diseases and cataractogenesis. Vitamin C is effective against 
superoxide, hydroxyl radical, hydrogen peroxide, peroxyl radical and singlet oxygen 
as well as protecting biomembranes against lipid peroxidation damage. This 
antioxidant eliminates peroxyl radicals in the aqueous phase before the latter can 
initiate lipid peroxidation. Vitamin C and vitamin E interact synergistically at the 
membrane cytosol interface to regenerate membrane-bound oxidised vitamin E 
(Sies, Stahl and Sundquist, 1992). 
Overall, phenolic compounds, tocopherols and ascorbic acid, defined as 
antioxidative active compounds, which could be found in wild mushrooms, are used 
as functional ingredients or health promoters against chronic diseases related to 
oxidative stress.  
1.4.2. Antimicrobials in mushrooms and their mode of action  
Mushrooms are forced to accumulate antibacterial and antifungal compounds 
in their fruiting body to survive in their natural environment. It is not surprising that 
antimicrobial compounds with potential activities isolated from many mushroom 
species could be a benefit for humans, as a rich source of natural antibiotics with the 
ability to combat bacteria and viruses (Lindequist et al., 2005). During the 
antimicrobial mechanism of action biologically active molecules penetrate and 
interfere with cell membrane lipids, and affect normal barrier functions. This may 
cause membrane fusion and leakage of intermembranous material aggregation, 
which may damage and confuse normal functions, determining cell death (Ikigai et 
al., 1993, Sato et al., 1996). Bioactive molecules terpenes are described as 
membrane disruption promoters, coumarins cause reduction in cell respiration and 
tannins act on microorganism membranes as well as bind to polysaccharides or play 
as cell enzymes promoting inactivators (Paiva et al., 2010). Less hydrophilic 
molecules, for instance flavonoids lacking the hydroxyl groups on their B ring, are 
more active inhibitors against microorganisms than those molecules with OH 
groups. (Chabot et al., 1992). Either methyl group number on the C ring of the 
flavonoids increases antimicrobial activity (Ibewuike et al., 1997). The aliphatic side 
on the A ring defined as group of flavones with better polarity and enlarged potential 
antibacterial activity (Cowan, 1999). However, antimicrobial activity of compounds 
vary dependant on the microorganism strain and membrane structure. 
Several biologically active molecules (polyketides, terpenes, steroids and 
phenolic compounds) extracted from mushrooms revealed antifungal and 
antibacterial activity, namely against Staphylococcus aureus, Bacillus subtilis and 
Escherichia coli. Sesquiterpenoid hydroquinones, isolated from the well know 
Gandoderma species Ganoderma pfeifferi, inhibited the growth of methicillin-
resistant S. aureus, also, the same mushroom extract prevent the growth of 
microorganisms responsible for skin problems (Mothana et al., 2000). Applanoxidic 
acid A belongs to the triterpens class bioactive molecules and was isolated from 
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Ganoderma annulare, it possesses potential antifungal activity against Trichophyton 
mentagrophytes. Several steroids (5α-ergosta-7, 22-dien-3β-ol and 5,8-epidioxy-
5α,8α-ergosta-6,22-dien-3β-ol) isolated from Ganoderma applanatum, proved to be 
moderately active against a number of Gram positive and Gram negative 
microorganisms (Smania et al., 1999). Oxalic acid has an inhibitory effect for 
microbials isolated from the Lentinula edodes mushroom against S. aureus and other 
bacteria (Lindequist et al., 2005). 
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2. MATERIALS AND METHODS 
2.1. MATERIALS 
2.1.1. Research objects 
Twenty-four coastal-dune mushroom species were collected in a mature 
condition in the South-western region of France in autumn 2011 (Table 2.1; Table 
2.2). Six forest mushroom species (Phaeolus schweinitzii, Inonotus hispidus, 
Tricholoma columbetta, Tricholoma caligatum, Xerocomus chrysenteron and 
Hydnellum ferrugineum) were harvested in the Midi-Pyrénées region of France in 
autumn 2009. Additionally, mature Phaeolus schweinitzii mushrooms were collected 
in 2011 and 2012. Taxonomic identification was carried out by the “Mycology and 
Food Safety” Research Unit at the INRA Research Centre of Bordeaux-Aquitaine 
and the Mycologist Association of the Faculty of Pharmacy of Toulouse University. 
All freeze-dried (Lyophilisateur pilote LPCCPLS15, Cryotec, Saint-Gély-du-Fesc, 
France) mushrooms were stored in paper bags in a desiccator at ambient temperature 
(<30 
0
C) for further analysis. All experiments were performed over a one-year 
period. 
 
Table 2.1 List of studied mushroom families 
Family Number of species 
 Forest species Coastal-dune species 
Agaricaceae 9  
Tricholomataceae 4 2 
Boletaceae 4 1 
Russulaceae 2  
Cortinariaceae 2  
Polyporaceae  2 
Amanitaceae 1  
Gyroporaceae 1  
Bankeraceae  1 
Strophariaceae 1  
2.1.2. Reagents 
Stable 2,2-di-phenyl-1-picrylhydrazyl hydrate radical (DPPH•, 95%), gallic 
acid, anhydrous sodium carbonate, 6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid (Trolox, 97%), 2,2,-azinobis(3-ethylbenzothiazoline-6-sulphonic 
acid) diammonium salt (ABTS), fluorescein (FL), [2,2’-azobis(2-amidino propane) 
dihydrochloride (AAPH)], cyclohexane, dichloromethane acetonitrile, ethanol, 
methanol, vanillin, 2-aminoethyl diphenylborinate, polyethylene glycole, macragol 
4000, Sephadex LH-20, amphotericin B, 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT), dimethyl sulfoxide (DMSO), isopropanol, 
sodium dodecyl sulphate, methanol, chloroform, TLC plates (silica gel G60 F254)  
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and medium (RPMI 1640) mouse macrophage cell line (J774A.1 cell line) were from 
Sigma-Aldrich (Steinheim, Germany); 2.0 M Folin-Ciocalteu phenol reagent, KCl, 
NaCl, Na2HPO4, Na2CO3 and K2S2O8 and PBS (0.1 M phosphate containing 0.05 M 
NaCl, pH-7.2) were from Merck (Darmstadt, Germany); KH2PO4 from Jansen 
Chimica (Beerse, Belgium); 98% acetic acid from Lachema (Brno, Czech Republic) 
and agricultural origin ethanol (96.6%) from Stumbras (Kaunas, Lithuania); 2,4,6-
tripyridyl-s-triazine (TPTZ) was from Fluka Chemicals (Steinheim, Switzerland). 
Sulfuric acid, bismuth nitrate, glacial acetic acid and potassium iodide were from 
Jansen Chimica (Beerse, Belgium); Nutrient agar (Bit Phar. acc EN 12780:2002) 
was from Scharlau (Barcelona, Spain). Bacillus cereus (330) was from Microbial 
Strain Collection of Latvia (MSCL); Pseudomonas aeruginosa (27853), 
Staphylococcus aureus (25923) and Escherichia coli (25922) were from American 
Type Culture Collection (ATCC). Leishmania infantum MHOM/MA/67/ITMAP-263 
(CNR Leishmania, Montpellier, France). Milton sterilising fluid (2%, w/v and the 
16.5% w/v sodium chloride solution) was from Louzy, France. Steady Glow reagent 
was from Promega (California, USA). Leishmania infantum MHOM/MA/67/ITMAP-
263 (CNR Leishmania, Montpellier, France). Haemonchus contortus (stored at 4 C 
for 2 months before use) and Trichostrongylus colubriformis (stored at 4 C for 1.5 
months before use) the L3 (third stage larvae) were obtained from a donor sheep 
with a monospecific infection (INRA, France).  
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Table 2.2 List of studied mushroom species 
Botanical name Ecology Family  Characterisation Habitat Edibility References 
Agaricus  
menieri 
Saprotrophic Agaricaceae 
 
 
Strong phenolic odour, cap 
chalk whited, yellow 
discolouring by handling or 
cutting; belongs to 
Xanthodermatei;  
 
Internal side of high 
dunes, close to 
plants of 
Ammophiletum spp.; 
Inedible (Lacheva, 2013)  
(Kerrigan et al., 
2005) 
 
Agaricus 
pseudopratensis 
Saprotrophic Agaricaceae Strong phenolic odour, 
brown cap squamous and 
frequently rufous flesh; 
belongs to Xanthodermatei; 
 
Grassed rear dunes, 
anthropic or grassy 
areas; 
Inedible (Petrova et al., 2007, 
Callac and 
Guinberteau, 2005) 
 
Agaricus  
freirei 
Saprotrophic Agaricaceae Strong phenolic odour, faint 
yellowish discolouring flesh 
of the stipe quickly 
followed by a red vinaceous 
discolouring; cap colour 
varying from mahogany 
brown to chocolate brown; 
section Xanthodermatei; 
 
Wooden dunes, 
sandy calcareous 
soil either in the 
Pino-Quercetum 
ilicis or under 
Cupressus 
macrocarpa; 
 
Inedible (Kerrigan et al., 
2005) 
Agaricus 
devoniensis 
Saprotrophic Agaricaceae Colour: whitish with 
irregular brownish areas; 
odour mushroomy; 
unchanging when cut, latter 
becoming brownish; section 
Bivelares (Duploannulati); 
 
Fixed dunes close to 
Phleo Tortuletum, 
in fairly level areas 
of dark dunes; 
Edible (Kerrigan, Callac 
and Parra, 2008) 
Agaricus 
fissuratus  
Saprotrophic Agaricaceae Phenolic and almond odour; 
Cap white and smooth 
hemispherical shape;  
 
Wooden dunes close 
to Pino-Quercetum 
ilicis and thickets of 
dunes; 
Edible (Guinberteau) 
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Botanical name Ecology Family  Characterisation Habitat Edibility References 
Agaricus 
coniferarum 
Saprotrophic Agaricaceae Cap blushing; Thrives on humus; 
 
  
 
 
Leucoagaricus 
litoralis 
Saprotrophic Agaricaceae Cap first convex, latter 
spread out; pink colour with 
bleaching shade; 
Semi fixed dunes at 
sagebrush carpet or 
Cupressus 
macrocarpa; 
 
Inedible (Guinberteau) 
Leucoagaricus 
subolivaceus 
Saprotrophic Agaricaceae Cap green bronze with 
bleaching shade; sensitive 
to sunlight, becomes lighter; 
Semi fixed dunes at 
sagebrush carpet or  
Cupressus 
macrocarpa; 
 
Inedible (Guinberteau) 
Sericeomyces 
subvolvatus 
Saprotrophic Agaricaceae Cap silky smooth, whitish 
and creamy in the middle; 
Semi fixed dunes, 
grassy areas or 
degraded dunes; 
 
Inedible (Guinberteau) 
Gyroporus 
ammophilus 
Mycorrhizal Gyroporaceae Cap often shapeless, wavy 
and velvety surface; similar 
to blond boletus; 
Beside wooden 
dunes close to 
Cistus salvifolius or 
Pino-Quercetum 
ilicis; 
 
Inedible (Guinberteau) 
Leccinum 
(Boletus)  
lepidus 
Mycorrhizal Boletacea Cap broad, reddish-brown; 
stem white and becomes 
darker at the base; 
Wooden dunes or 
close to Pino- 
Quercetum ilicis;  
 
Edible  (De Dominicis and 
Barluzzi, 1983) 
Boletus  
impolitus 
Mycorrhizal Boletacea Robust stature and floccose 
stem; smell of iodine at the 
stipe base when cut; 
truncated stipe becomes 
yellow; 
 
Wooden dunes or 
close to Pino-
Quercetum ilicis; 
Inedible (Hills, 2008) 
Boletus  Mycorrhizal Boletacea Cap convex velvety or Wooden dunes, Edible (LI, WU and XU, 
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Botanical name Ecology Family  Characterisation Habitat Edibility References 
luridus nearly bald; Stem yellowish 
above and reddish below; 
sandy calcareous 
soil either in the 
Pino-Quercetum 
ilicis; 
 
2009) 
Boletus  
lupinus 
Mycorrhizal Boletacea Cap dry, smooth, pale grey 
to very pink pale; stem 
bright yellow, discolouring; 
tinted orange red or reddish 
in places; 
Warm broadleaf 
dune forests close to 
oaks Quercus or 
sweet chestnut 
Castanea; 
 
Inedible  (Guinberteau) 
 
Xerocomus 
chrysenteron 
 
 
 
Mycorrhizal Boletacea Cap velvety brown to 
cracked brown or olive 
brown; stem yellow to 
reddish  
Hardwoods; 
especially oak; 
North America and 
northern Europe 
Edible (Hills, 2008) 
Stropharia 
halophila 
Saprotrophic Strophariaceae Yellow cap colour, dark 
spore print, ring on the 
stem; Stipe whitish to pale 
yellowish, dry; 
Foreshore dunes or 
outer related dunes, 
close to Ammophila 
arenaria; 
 
Inedible (Guinberteau, 
Jahnke, Hoffmann 
and Pacioni, 1988) 
Tricholoma  
focale 
Mycorrhizal Tricholomataceae Cap sticky at first, later dry; 
covered with long fibrils; 
brown to yellow brown, 
orange-brown; Odour 
mealy; 
 
Wooden dunes or 
close to Pino- 
Quercetum ilicis; 
Inedible (Kalamees, 1821) 
Tricholoma 
auratum 
Mycorrhizal Tricholomataceae Cap bright to olive brown or 
brownish centre; Stem pale 
yellow or whitish; odour 
mealy;  
Pine forests (Pinus 
pinaster) of seaside 
sand dunes; 
 
Inedible (Moukha et al., 
2013) 
 
Tricholoma 
caligatum 
 
Mycorrhizal 
 
 
Tricholomataceae 
 
 
Small and fuscous to 
blackish fruit body, taste 
bitter;  
Sand dunes, close to 
Pinus nigra; 
 
Inedible 
 
 
(Murata et al., 2013) 
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Botanical name Ecology Family  Characterisation Habitat Edibility References 
 
 
Tricholoma 
columbetta 
 
 
 
Mycorrhizal 
 
 
Tricholomataceae 
 
 
White to creamy or bluish 
fruit body; odourless; 
 
 
Deciduous and 
coniferous woods 
 
 
 
Edible 
 
 
(Vadalà et al., 2003) 
 
Melanoleuca 
cinereifolia 
Saprotrophic Tricholomataceae With a dark cap covering 
pallid gills; Cap, gills and 
stem all become ingrained 
with sand; 
 
White dunes close 
to Ammophila 
arenaria; 
Inedible  (Guinberteau, 
Vizzini et al., 2012) 
 
 
Clitocybe  
odora 
Saprotrophic Tricholomataceae Pale greyish blue to greyish 
green, convex later 
expanded; strong anise 
odour  
Soil, litter in 
deciduous and 
coniferous forests 
close to Pino- 
Quercetum ilicis;  
 
Edible (Heinze, 2012) 
Amanita  
avoidea 
Mycorrhizal Amanitaceae Cap convex to shield 
shaped; colour White to 
creamy;  
Wooden dunes, 
sandy calcareous 
soil or close to 
Quercus pubescens; 
 
Edible (Guinberteau) 
Cortinarius 
suberetorum 
Mycorrhizal Cortinariaceae Lemon yellow cap; body 
red to lightly brown; 
Mediterranean, 
close to oaks or 
Pino-Quercetum 
ilicis; 
 
Inedible (Guinberteau) 
Cortinarius 
infractus 
Mycorrhizal Cortinariaceae Brown spore mushroom; 
odour and taste may be 
explained of the indole 
alkaloids infraction; 
Deciduous forests 
with oak, beech, or 
chestnut, from 
Mediterranean area; 
 
Inedible (Brondz et al., 2007) 
Russula 
badia 
Mycorrhizal Russulaceae  Cap red or black-purple-red 
colour, stem white, or 
reddish; 
Coastal pine forests 
on sand dunes; 
Inedible  (Burlingham, 1944) 
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Botanical name Ecology Family  Characterisation Habitat Edibility References 
  
Lactarius  
vinosus 
 
 
 
 
Phaeolus 
schweinitzii 
Mycorrhizal 
 
 
 
 
 
Saprotrophic 
parasitic 
 
Russulaceae 
 
 
 
 
 
Polyporaceae 
Cap surface smooth, 
slightly viscous; vinaceous 
red with more orange and 
darker zones; smell faintly 
fruity; 
 
Caps are velvety to hairy 
when young; from bright 
yellow to brown with age; 
Calcareous soils 
close to Pinus;  
Distribution mainly 
Mediterranean; 
 
 
Roots and 
heartwood of living 
conifers; dead or 
decaying woods; 
 
Edible 
 
 
 
 
 
Inedible 
(Nuytinck and 
Verbeken, 2003) 
 
 
 
 
(Cedano et al., 2001) 
 
Inonotus 
hispidus 
Saprotrophic 
parasitic 
 
Polyporaceae Surface felty/hairy varying 
from yellowish to tobacco-
brown, finally blackish and 
bristly 
Usually on 
deciduous trees; 
distributed in North 
America, Central 
and Southern 
Europe 
 
Inedible (Pegler, 1964) 
Hydnellum 
ferrugineum 
Mycorrhizal Bankeraceae Body surface velvety or 
prickly whitish with exuded 
reddish droplets; old 
specimens dark brown  
Pine trees and other 
confers. 
Inedible (Ainsworth et al., 
2010) 
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2.2. PREPARATION OF EXTRACTS 
Mushrooms were ground in a Microfine mill (MF-10, IKA, Staufen, Germany) 
through a 1.5 mm sieve and extracted with four solvents. HPLC grade cyclohexane 
(C), dichloromethane (D), methanol (M) and deionized water (W) were used to 
fractionate soluble compounds from the mushrooms in ascending polarity by 
sequentially extracting 2-100 g (depending on material availability) of mushroom 
powder in a Soxhlet extractor for 5 hours (Fig. 2.1). The samples were air dried after 
each solvent extraction and finally the residues were extracted with boiling water 
over 5 hours constantly mixing in the Ikamag “RTC basic” magnetic stirrer (IKA 
Labortechnik, Staufen, Germany). Organic solvents were removed in a vacuum 
rotary evaporator RV 10 (IKA, Staufen, Germany), while water extracts were 
freeze-dried. The organic solvents residues were removed with nitrogen. All extracts 
were kept in a refrigerator until further analysis.  
 
Fig. 2.1 Mushroom extraction scheme 
Residue 1 
Residue 2 
Cyclohexane 
extract 
Dichloromethane 
extract 
Residue 3 
Methanol extract 
Residue 4 Water extract 
Soxhlet extraction 
 with cyclohexane, 5h 
Soxhlet extraction 
 with dichloromethane, 5h 
Soxhlet extraction 
 with methanol, 5h 
Magnetic stirrer extraction 
 with water, 5h 
Mushroom sample 
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2.2.1. Isolation of active compounds from P. schweinitzii extract 
The crude extract of P. schweinitzii (2 g) was dissolved in methanol (50 ml), 
and added to silica gel Si 60 (2 g, 230–400 mesh) by constant stirring. The methanol 
was evaporated in a rotary evaporator under vacuum at 45 °C. The fraction 
impregnated silica gel was cooled down to 25 C and kept in a desiccator until 
required. 
The silica gel chromatography column was packed as follows: the bottom of 
the chromatography column was plugged with glass wool to retain solids. Silica gel 
Si 60 (100 g, 200–300 mesh, 40-63 µm particle size) was suspended in 
dichloromethane (500 ml), and then transferred to the column (600 mm length × 30 
mm i.d.) with no trapped air. The column was rinsed with 500 ml of 
dichloromethane, three times. As soon as the silica gel settled to the bottom of the 
column, the sample impregnated silica gel was added to the top of the column, and 
elution was performed with a dichloromethane/methanol gradient (98:2, 95:5, 90:10, 
85:15, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, 10:90, 0:10%, 300 ml each) at a 
constant flow rate of 8 ml/min. Fractions of 15 ml each were analysed by thin layer 
chromatography. TLC analyses were performed on silica gel F254 plates using 
chloroform/methanol/water (65:45:10) as developing reagent. Spots were detected at 
254 and 366 nm. The eluates containing target compounds were pooled and 
concentrated under reduced pressure. Fractions were purified on Sephadex LH-20 
column (100 mm length × 10 mm i.d.) eluted with methanol. The concentrate was 
stored at -10 °C for further HPLC-preparative separation. 
2.3. RESEARCH METHODS  
Different methods were used for the analysis of mushroom extracts (Fig. 2.2) 
and bioactive compounds isolated from P. schweinitzii (Fig 2.3). All the methods 
are presented in schemes and further described in detail. 
 
 
Fig 2.2 Scheme of analysis used for mushroom extracts 
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Fig 2.3 Schemes of analysis used for selected extract and isolated compounds from P. 
Schweinitzii 
2.3.1. ANTIOXIDANT ANALYSIS 
2.3.1.1. DPPH
•
-scavenging capacity 
This method is based on scavenging DPPH
•
 by the antioxidant colorimetric 
changes (from deep violet to light yellow), when DPPH
•
 is reduced (Brand-
Williams, Cuvelier and Berset, 1995). The assay was performed in a 96-well 
microtiter plate using a UV spectrophotometer EL808 Microplate Reader (BioTex 
Instruments, Vermont, USA). The reaction mixture in each of the 96-wells consisted 
of 7.5 µl of different concentration mushroom extracts (0.5%; 0.25%; 0.125%) and 
300 µl of methanol solution of DPPH
•
 (6×10
-5
 M). The mixture was left to stand for 
40 min in the dark and the reduction of DPPH
•
 was determined by measuring the 
absorption at 515 nm. All measurements were performed in triplicate. Radical 
scavenging capacity (RSC) was determined from the calibration curve, which was 
drawn by using 50, 100, 125, 250, 500, 1,000 µM/l concentration solutions of 
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Trolox and expressed in µM of Trolox equivalents (TE) per g dry extract weight 
(µM TE/g EDW). 
2.3.1.2 ABTS
•+
 decolourisation assay 
The Trolox equivalent antioxidant capacity (TEAC) assay is based on the 
scavenging of ABTS
•+
 by the antioxidant that may be measured 
spectrophotometrically (Re et al., 1999). A stock solution of 2 mM ABTS was 
prepared by dissolving the reagent in 50 ml of phosphate buffered saline (PBS) 
obtained by dissolving 8.18 g NaCl, 0.27 g KH2PO4, 1.42 g Na2HPO4 and 0.15 g 
KCl in 1 l of Milli-Q water. If pH was lower than 7.4, it was adjusted with NaOH. 
ABTS
•+
 was produced by reacting 50 ml of ABTS stock solution with 200 µl of 70 
mM K2S2O8 solution in purified water and allowing the mixture to stand in the dark 
at room temperature for 15–16 hours before use. The radical was stable in this form 
for more than 2 days when stored in the dark at room temperature. For the 
assessment of extracts, the ABTS
•+
 solution was diluted with PBS to obtain the 
absorbance of 0.800±0.030 at 734 nm. 1 ml of ABTS
•+
 solution was mixed with 10 
µl extract solution in 96-well microtiter plates. The absorbance was read at ambient 
temperature every minute over 40 min. PBS solution was used as a blank; all 
measurements were performed in triplicate. The TEAC was determined from the 
calibration curve, which was drawn using 50, 100, 125, 250, 500, 1,000 µM/l 
concentration solutions of Trolox and calculated in µM TE/g EDW as follows: 
, TEs – antioxidant activity of sample expressed in TE 
(µM), Vs – sample volume (ml), ms – sample mass (g). 
2.3.1.3. Ferric-reducing antioxidant power assay  
Ferric-reducing antioxidant power (FRAP) assay is based on the reduction of 
Fe
3+
 in its tripyridyltriazine complex to the blue Fe
2+
 form (Benzie and Strain, 1999). 
The final results were expressed in µM TE/g EDW. The FRAP reagent was prepared 
from acetate buffer (pH 3.6), 10 mM TPTZ solution in 40 mM HCl and 20 mM iron 
(III) chloride solution in proportions of 10:1:1 (v/v), respectively. The FRAP reagent 
was prepared fresh daily and was warmed to 37 °C in a water bath prior to use. Ten 
µl of sample were added to 300 µl of the FRAP reagent and 30 µl water. The 
absorbance of the reaction mixture was then recorded at 593 nm after 4 min. All 
measurements were performed in triplicate. The TEAC values were determined as 
indicated in previous sections. 
2.3.1.4. Oxygen radical absorbance capacity  
The oxygen radical absorbance capacity (ORAC) method was performed as 
described by Prior, Wu and Schaich, (2005) and Dávalos, Gómez-Cordovés and 
Bartolomé, (2004) by using fluorescein as a fluorescent probe. The reaction was 
carried out in a 75 mM phosphate buffer (pH 7.4); stock solution of fluorescein was 
prepared according to Prior et al (2005). Mushroom extracts were diluted 1:1000 
(w/v); 25 μl of extract and 150 μl of fluorescein (14 μM) solutions were placed in 
96-well transparent flat-bottom microplates, the mixture was pre-incubated for 15 
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min at 37 ºC and 26 μl of AAPH solution (240 mM) as a peroxyl radical generator 
added with a multichannel pipette. The microplate was immediately placed in the 
FLUORstar Omega reader (BMG LABTECH, Ortenberg, Germany), automatically 
shaken prior to each reading and the fluorescence was recorded every cycle (66s), a 
total of 150 cycles. The 485-P excitation and 520-P emission filters were used. At 
least 4 independent measurements were performed for each sample. Raw data were 
exported from the Mars software to an Excel 2003 (Microsoft, Roselle, IL) sheet for 
further calculations. Antioxidant curves (fluorescence versus time) were first 
normalised and from the normalised curves the area under the fluorescence decay 
curve (AUC) was calculated as 



80
1 0
1
i
i
i
f
f
AUC , where f0 is the initial 
fluorescence reading at 0 min and fi is the fluorescence reading at time i. The final 
ORAC values were calculated by using a regression equation between the Trolox 
concentration and the net area under the curve (AUC). The TEAC values were 
determined as described in previous sections. 
2.3.1.5. Determination of total phenolic content  
The total phenolic content (TPC) was measured with Folin-Ciocalteu reagent 
as originally described by Singleton, Orthofer and Lamuela-Raventós, (1999). 
Briefly, 30 μl (0.1%) of sample were mixed with 150 μl of 10-fold diluted (v/v) 
Folin-Ciocalteu reagent, and 120 μl of 7.5% Na2CO3. After mixing of all reagents, 
the microplate was placed in the reader and shaken for 30 s. After incubation for 30 
min at room temperature the absorbance of the mixtures was measured at 765 nm. 
All measurements were performed in triplicate. A series of gallic acid solutions in 
the concentration range of 0.025-0.35 mg/ml was used for the calibration curve. The 
results were expressed in mg of gallic acid equivalents per g of dry extract weight 
(mg GAE/g EDW) and calculated by the following formula , were  the 
total content of phenolic compounds in mg/g mushroom extract, in GAE;  – the 
concentration of gallic acid established from the calibration curve in mg/ml; V – the 
volume of extract in ml; m – the weight of plant extract in g.  
2.3.2. MICROBIAL ANALYSIS 
2.3.2.1. Disc diffusion assay 
The antimicrobial activity was assessed by the disk-diffusion method (Bauer et 
al., 1966). The bacterial cell suspension was prepared from 24 hours culture and 
adjusted to an injection of 1x10
8
 colony forming units per ml (cfu/ml). Sterile 
nutrient agar was inoculated with bacterial cells (50 l of bacterial cell suspension in 
25 ml medium) and poured into petri dishes to obtain a solid plate. 20 mg of test 
material dissolved in the same solvent of the extraction were applied on sterile 5 mm 
diameter paper discs, which were deposited on the surface of the inoculated agar 
plates. The plates with bacteria were incubated for 24 hours at 37 °C. Inhibition zone 
diameters around each of the disc (diameter of inhibition zone plus diameter of the 
disc) were measured and recorded at the end of the incubation time. An average 
 51 
 
zone of inhibition was calculated from 3 replicates. Paper discs with solvents were 
used as controls. 
Minimal inhibitory concentrations (MIC) showing the lowest concentration of 
extract able to inhibit any visible microbial growth was determined by the agar 
diffusion technique (Rajbhandari and Schöpke, 1999). The highest concentration of 
extract tested during the experiment was 20 mg/ml. The extracts were prepared at 
the series of concentrations (5; 10; 20 mg/ml). 10 µl of each concentration solution 
was transferred in the disk. Then the disks were transferred in the Petri dishes 
containing the microorganism culture. The plates were incubated for 24 hours at 37 
°C for bacteria. After incubation, the size of active zones of each concentration was 
measured. Each assay was replicated three times. Paper discs with solvents were 
used as control. 
2.3.2.2. Agar-overlay assay (TLC bioautography) 
Thin-layer chromatography, combined with both biological and chemical 
detection methods, is an effective and inexpensive technique for the study of natural 
products. It can thus be performed both in sophisticated laboratories and in small 
laboratories that only have access to a minimum of equipment (Marston, 2011). 
When TLC is combined with a biological detection method, it is known as TLC 
bioautography. Historically, the technique of TLC bioautography has been known 
since 1946 (Goodall and Levi, 1946). This elegant, simple and rapid method is 
highly sensitive and permits immediate detection of biologically active compounds 
in the fractions, coupled with an accurate localisation of active substances. 
Bioautography are compact and simple tests that can be performed with a minimum 
of samples in a short time. The major applications of TLC bioautography are to be 
found in the fast screening of a large number of samples for bioactivity and in the 
target-directed isolation of bioactivity guided fractionations (Müller et al., 2004, 
Choma and Grzelak, 2011). 
Bioautography assay was carried out for the mushrooms methanol fractions 
according to method described by Sawaya et al., (2004) and Mendonça-Filho, 
(2006). In the first step, 20 µl of mushroom extracts (concentration 10 mg/ml in 
methanol) were applied to TLC plates as a spot at a distance of 1.5 cm from the 
lower edge of the plate. The mobile phase was chloroform/methanol/water 
(65:45:10, v/v). Bioautography was carried out after airing the TLC plates for over 8 
hours. The plates were covered with 20 ml of sterile nutrient agar at 45 ºC, 
inoculated with the microorganisms and then incubated for 24 hours at 37ºC. After 
this period each plate was covered with 7 ml of a 0.08% aqueous solution of (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT) and incubated for up 
to 24 hours at 37 ºC (Fig.2.4). Inhibition zones were visualised and recorded as clear 
areas against a violet coloured background. Each fraction was replicated three times. 
TLC pates with solvent were used as control. 
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2.3.3. BIOLOGICAL ANALYSIS 
2.3.3.1. Antileishmanial activity on amastigotes of wild mushrooms species 
For assessing the biological activity of mushroom fractions against the 
amastigote stage of the parasite, Leishmania infantum was used. Amastigotes were 
incubated at average density 10
6 
parasites/ml in a sterile 96-well plate with various 
concentrations of fractions dissolved in DMSO serially from 100, 10, 1, and 0.1 
µg/ml. Appropriate controls treated with DMSO and amphotericin B reference drug 
were added to each set of experiments. After 72 hours of incubation, 10 μl of MTT 
(10
-3 
ml/l) was added to each well and the plates were further incubated for 4 hours. 
After the enzymatic reaction was stopped with 100 μl of a 50% isopropanol and 
10% sodium dodecyl sulphate solution and the plates were incubated for an 
additional 30 min under agitation at 25 C temperature. The absorbance was 
measured at 595 nm with a microplate Bio-Rad FTS-7 spectrophotometer 
(California, USA). Inhibitory concentration 50% (IC50) was defined as the 
concentration of drug required to inhibit the metabolic activity of Leishmania infantum 
amastigotes by 50% compared to the control. IC50 were calculated by non-linear 
Dipping of TLC 
plate in mobile 
phase  
TLC plates airing 
8 hours  
Overlaying TLC pates with 
inoculated agar  
Incubation at 
37ºC for 24 h. 
Spraying with 
MTT, incubation 
at 37ºC for 24 h.  
  
Zones of inhibition identify antimic-
robial leads 
Fig. 2.4 Bioautography assay technique with microorganisms 
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regression analysis processed on dose-response curves, using Excel 2010 software. IC50 
values represent the mean value calculated from three independent experiments. 
2.3.3.2. Antileishmanial activity on promastigotes of isolated compounds 
The effects of the tested compounds on the growth of Leishmania infantum 
promastigotes were assessed by Luciferase Assay. Briefly, promastigotes in log-
phase in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS), 2 mM 
L-glutamine and antibiotics (100 U/ml penicillin, 100 μg/ml streptomycin and 50 
μg/ml geneticin), were incubated at an average density of 106 parasites/ml in sterile 
96-well plates with various concentrations of compounds dissolved in DMSO (final 
concentration less than 0.5%, v/v), in duplicate. Appropriate controls treated by 
DMSO and amphotericin B were added to each set of experiments. After a 72-hour 
incubation period at 24 °C, each plate-well was examined by microscope to detect 
any possible precipitate formation. To estimate the luciferase activities of 
promastigotes, 80 μl of each well are transferred in white 96-well plates, Steady 
Glow reagent was added according to the manufacturer’s instructions, and plates 
were incubated for 2 min. The luminescence was measured in a Microbeta 
Luminescence Counter (PerkinElmer, Connecticut, USA). Inhibitory concentration 
50% (IC50) was defined as the concentration of drug required to inhibit the 
metabolic activity of Leishmania infantum promastigotes by 50% compared to the 
control. IC50 was calculated by non-linear regression analysis processed on dose–
response curves, using Table Curve 2D V5 software. IC50 values represent the mean 
value calculated from three independent experiments. 
2.3.3.3. Cytotoxicity assay 
The evaluation of the tested molecules cytotoxicity by MTT assay on the 
J774A.1 mouse macrophage cell line was done according to Mosmann, (1983) with 
slight modifications. Briefly, cells (5,104 cells/ml) in 100 μl of complete medium, 
[RPMI 1640 supplemented with 10% fetal calf serum (FCS), 2 mM/l-glutamine and 
antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin)] were seeded into each 
well of 96-well plates and incubated at 37 °C in humidified 6% CO2 with 95% air 
supplemented by CO2. After 24 hours incubation, 100 μl of medium with various 
product concentrations and appropriate controls were added and the plates were 
incubated for 72 hours at 37 °C. Each plate-well was then examined by microscope 
to detect possible precipitate formation before the medium was aspirated from the 
wells. 100 μl of MTT solution (0.5 mg/ml in RPMI) were then added to each well. 
Cells were incubated for 2 hours sat 37 °C. After this time, the MTT solution 
was removed and DMSO (100 μl) was added to dissolve the resulting formazan 
crystals. Plates were shaken vigorously (300 rpm) for 5 min. The absorbance was 
measured at 570 nm with a microplate spectrophotometer (PerkinElmer, 
Connecticut, USA). DMSO was used as a blank and doxorubicin as a positive 
control. The cytotoxic effect was expressed as 50% lethal dose (CC50), i.e., as the 
concentration of a fraction which reduced 50% of cell viability compared to cells in 
a culture medium alone. CC50 was calculated by non-linear regression analysis 
processed on dose–response curves, using Excel 2010 software. CC50 values represent 
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the mean value calculated from three independent experiments. The selectivity index 
(SI) for each compound was calculated as a ratio between cytotoxicity (CC50) and 
activity (IC50), against Leishmania infantum amastigotes and promastigotes. 
2.3.3.4. Larval exsheathment assay  
This test uses ruminant gastrointestinal nematodes (infective third stage) in a 
two-stage process aimed at examining the effect of the test product on larval 
exsheathment induced by a diluted sodium hypochlorite solution. This is an 
adaptation process and the aim is to obtain a progressive exsheathment of the larvae, 
making microscopic observation of the process feasible. For a control, a 100% 
exsheathment after 60 min is observed; negative controls (PBS) and tested 
substances are incorporated into the assay (Jackson and Hoste, 2010). 1,300 L3/ml 
ensheathed H. contortus L3 were incubated with each compound at a concentration 
of 300, 150, 75, 37.5 µg/ml in PBS for 3 hours at 21 C, with control larvae 
incubated in PBS. After incubation, the larvae were washed and centrifuged (1,000 
rpm) three times in PBS (pH 7.2). Larvae were then subjected to an artificial 
exsheathment process by contact with a solution of sodium hypochlorite (2%, w/v 
and the 16.5% w/v sodium chloride) solution diluted 1:300 in PBS (pH 7.2). The 
kinetics of the larval exsheathment process in each experimental treatment was 
monitored by microscopic observation (x200 magnification). Exsheathed larvae 
were counted at 0, 20, 40, 60 min. At each time the larvae were killed and examined 
immediately. Four replicates were run for each compound to look for possible 
changes in the proportion of exsheathed larvae over time. A general linear model 
(GLM) test was used to determine the difference in the mean percentage of 
exsheathment rates between the control and the treatment groups over time: 
; Ex–Exsheathment (%); Nex–exsheathed larvae; N–total larvae. 
2.3.3.5. Detailed biological activity assays of hispidin 
2.3.3.5.1. Cell culture and cytogenetic procedures 
Lymphocyte cultures from three healthy donors were set up according to 
conventional techniques within 2-4 hours after blood collection. In brief, 
phytohemagglutinin (PHA, 7.8 g/ml) stimulated cultures were incubated at 37 C 
for 72 hours in RPMI 1640 medium supplemented with 12 heat-inactivated new-
born calf serum and 40 g/ml gentamycin. All reagents were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Treatment with hispidin was carried out 24 hours 
after culture initiation and lasted for the period of 48 hours. Hispidin was dissolved 
in ethanol and then diluted with RPMI 1640 medium to the desired concentration. 
Ethanol in a final concentration of  7.5 µl/ml was used as a solvent control. Ethanol 
concentration in the experimental series did not exceed this concentration. Working 
solutions were made just before treatment. Two parallel cultures were used for each 
concentration of the compound tested. 
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2.3.3.5.2. Cytokinesis-block micronucleus assay 
Lymphocytes from two donors (donor F1-female, 22 years-old, and donor M1-
male, 27 years-old) were used in this part of the study. In the cultures assigned to 
micronucleus analysis cytochalasin B at a final concentration of 6 g/ml (Sigma-
Aldrich, St. Louis, MO, USA) was added to the cultures 44 hours after PHA 
stimulation to arrest cytokinesis and induce binuclear cell formation. At 72 hours the 
cells were treated hypotonically with 0.075 M KCl, fixed with methanol:acetic acid 
(5:1, v/v), air-dried and stained with Giemsa (5% in Sorensen’s buffer). All slides 
were coded and analyses were performed on coded slides by a single scorer at 
1,000 magnification on a light microscope (Nikon Eclipse 80i, Japan). The 
presence of micronuclei (MN) was evaluated by scoring a total of 1,000 binucleated 
(BN) cells for each donor following the scoring criteria of Fenech (Fenech, 2007). 
The nuclear division index (NDI) was used for measuring cell proliferation kinetics 
and was calculated from 500 cells according to the formula: 
NDI(M1+2M2+3M3+4M4)/N, where M1, M2, M3 and M4 represent the number of 
cells with one, two, three and four nuclei and N is the total number of cells scored. 
2.3.3.5.3. Chromosome aberration and sister chromatid exchange assay 
 A blood sample obtained from one donor (donor F2-female, 22 years-old) was 
used for this experiment. Cultures were treated with 10 µg/ml 5-bromo-2’-
deoxyuridine (BrdU) for the entire culture period and colchicine (0.6 µg/ml) for the 
last 3 hours of incubation. The cells were harvested, hypotonically swollen in 0.075 
M KCl (25 min) and fixed in methanol:acetic acid (3:1) fixative with three changes. 
Air-dried slides were differentially stained by fluorescence plus Giemsa technique. 
Briefly, the slides were stained for 10 min with 10 µg/ml of Hoechst 33258 dye 
(dissolved in 0.07 M Sorensen’s buffer, pH 6.8). Then the slides were rinsed, 
mounted with citrate buffer (pH 8.5), covered with cover slips and exposed to UV 
light (400 W mercury lamp at a distance of 15 cm) for 6-7 min. Slides were then 
rinsed and stained for 3-4 min with 5 Giemsa. Sister chromatid exchange (SCEs) 
were scored by a single scorer in no less than 50 second-division metaphases per 
treatment. Two hundred cells were scored for the cell replicative kinetics determined 
by means of replication index RI (RI = [M1+2M2+3M3]/N, where M1, M2 and M3 
are the numbers of cells that had undergone one, two or three cycles of replication, 
and N is the total number of cells scored). No less than 200 first-division metaphases 
per concentration were analysed for chromosome aberrations. The CA were 
recorded according to An International System for Human Cytogenetic 
Nomenclature (Shaffer and Tommerup, 2005). Aberrations were scored as 
individual types (chromatid and chromosome type breaks and exchanges), but for 
statistical analysis only total CA per 100 cells was used.  
2.3.3.5.4. Comet assay 
The comet assay was conducted under alkaline conditions according to Singh 
et al. (Singh et al., 1988) with minor modifications. Peripheral blood was obtained 
immediately before conducting the test from two healthy donors (donor F1 and 
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donor F3-female, 22 years-old) into heparinized vacutainer tubes (Becton-
Dickinson, USA) by venipuncture. Lymphocytes were isolated by Lymphoprep 
density gradient centrifugation according to the manufacturer’s instructions (Axis-
Shield, Norway). Following isolation, the cells were resuspended in RPMI 1640 
medium and incubated with increasing concentrations (dose range from 25 to 1,000 
M) of hispidin for 1 hour at 37 C in 5% CO2. Hispidin solutions were prepared 
just before treatment. Negative (ethanol, 3% v/v), blank and positive (20 µM H2O2) 
controls were also included at the same temperature and exposure time. Following 
incubation, the lymphocytes were centrifuged at 400 x g for 10 min, the supernatant 
was then drawn and the cells were resuspended in RPMI 1640 medium. Then 40 l 
of cell suspension was mixed with 40 l of 1% low melting point agarose (LMP), 
pipetted onto the slides recoated with 1% normal melting point agarose (NMA) and 
covered with a coverslip. The agarose was allowed to solidify for 10 min at 4 C. 
The coverslip was then removed, and the next layer of 0.5% LMP agarose was 
added, covered with a coverslip and left to solidify for an additional 10 min at 4 C. 
After the coverslips were taken off, the slides were immersed in cold freshly 
prepared lysis solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris, with 1% 
Triton X-100 and 10% DMSO added just before use, pH 10) in the dark for 1.5 
hours at 4 C. Then the slides were removed from the lysis solution, and placed in a 
horizontal gel electrophoresis tank filled with ice-cold fresh electrophoresis buffer (1 
mM Na2EDTA and 300 mM NaOH, pH 13). The slides were left in the solution for 
20 min to facilitate DNA unwinding, and then electrophoresis was carried out at 17 
V and 300 mA for 30 min. After electrophoresis, the slides were neutralised with 
Tris buffer (0.4 M Tris, pH 7.5), and stained with 80 µl ethidium bromide (20 
µg/ml). All the above steps were conducted under dimmed light to prevent 
additional DNA damage. Low melting point agarose, Na2EDTA, Tris and Triton X-
100 was from Carl Roth GmbH (Germany). All other chemicals were from Sigma-
Aldrich (St. Louis, MO, USA). The slides were examined by a single scorer using a 
fluorescence microscope (Nikon Eclipse 80i, Japan) at 400x magnification. Image 
capture and analysis were performed using Lucia Comet Assay Software. In all cases 
100 comets were scored and percentage of DNA in the comet tail (% TDNA) was 
used as the DNA damage parameter.  
2.3.3.5.5. Salmonella/microsome test 
The plate incorporation method using histidine-dependent S. typhimurium 
TA98 and TA100 strains in the presence and absence of metabolic activation system 
(S9 liver fraction) was used for assessing the mutagenicity (Mortelmans and Zeiger, 
2000). Moltox (Trinova Biochem, Germany) products for the Ames test were used 
in the present study. Hispidin was tested at four concentrations (dose range from 50 
to 250 μg/ml). 100 l of extract solution was added to 2 ml top agar mixed with 100 
l of bacterial culture and then poured on to a plate containing minimal glucose 
agar. These plates were incubated at 37 C for 48 hours and revertant colonies were 
counted using automatic Sorcerer colony counter (Perceptive Instruments, UK). The 
influence of metabolic activation was tested by adding 500 l of S9 mixture. The 
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experiments were analysed in triplicate and the results are presented as the mean of 
the three plates with standard deviation. The criteria employed to interpret the results 
of the Ames test as positive were similar to those used in regulatory guidelines 
(OECD,1997). The number of induced mutations should be at least twice the activity 
observed in negative control and there must be a reproducible dose response curve. 
Concurrent positive and negative (ethanol, 3% v/v) controls were used in the study. 
The standard mutagens used as positive controls were daunomycin for TA98 strain 
and sodium azide for TA100 strain without metabolic activation and 2-
aminoanthracene for both TA98 and TA100 strains with metabolic activation. 
2.3.4. CHROMATOGRAPHIC ANALYSIS 
2.3.4.1. Thin layer chromatography on selected mushroom extracts 
The 5µl methanol solution of P. schweinitzii (10 mg/ml) was directly 
deposited on three silica gel G60 F254 plates. Chloroform/methanol/water (65:45:10) 
were used as the mobile phase to develop thin layer chromatography (TLC) plates. 
The TLC plates were placed in solvent chambers until the developing reagents reach 
1 cm from the top of the plate. The developed TLC plates were removed from the 
solvents and allowed to air-dry. UV active absorbing spots were detected at 254 and 
366 nm and exposing with adequate TLC reagents vapour: Vanillin/sulfuric (100 
ml:1 g vanillin, 10 ml sulfuric acid, 90 ml ethanol, 95%) reacts universally with 
many compounds such as terpeniods, sterols and alkaloids, and in general with 
lipophilic compounds forming dark-coloured zones; Neu (100 ml:1 g 2-aminoethyl 
diphenylborinate, 5 g polyethylene glycol, macrogol 4000, 100 ml ethanol 95%) 
reacts with phenolic compounds showing hydroxyl groups such as flavonoids, 
sugars, anthocyanins or hydroxyl acids; Dragendorff’s reagents (Solution A: 0.8g 
bismuth nitrate, 10 ml glacial acetic acid, 50 ml water; Solution B: 20 g potassium 
iodide, 50 ml water; Solution C: 5 ml solution A and 5 ml solution B, 50 ml distilled 
water) identify nitrogen-containing compounds such as alkaloids class compounds; 
These reagents identified the category of active secondary metabolite-
phytoconstituents of P. schweinitzii extract. 
2.3.4.2. Bioautography using DPPH
• 
as the detection reagent  
P. schweinitzii methanol extract was tested for their antioxidant activities 
based on DPPH
•
 scavenging capacity, using a TLC bioautography method (Marston, 
2011, Cieśla et al., 2012). The 5 µl methanol solution of P. schweinitzii (10 mg/ml) 
was directly deposited on silica gel G60 F254 plates. Chloroform/methanol/water 
(65:45:10) mixture was used as the mobile phase to develop TLC plates. The TLC 
plates were placed in solvent chambers until the developing reagents reach 1 cm 
from the top of the plate. The developed TLC plates were removed from the 
solvents, and allowed to air-dry for 30 min, followed by spraying with 0.1% w/v 
DPPH
•
 methanol solution for activity identification. Bands with the DPPH
•
 
scavenging activity were observed as white yellow bands on a purple background. 
The experiment was replicated three times. 
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2.3.4.3. HPLC-preparative chromatography 
The HPLC (High performance liquid chromatography) autopurification system 
used consisted of a Waters 2767 sample manager (Waters, Milford, MA, USA) 
equipped with a Waters 2489 UV/Vis detector, 2545 binary gradient module, system 
fluidics organiser and MassLynx Software with the FractionLynx application 
manager. The chromatographic separation was carried out using analytical and 
preparative XBridge 5µm (in 4.6 i.d.×150 mm and 19 i.d.×150 mm respectively) 
columns at 25 °C. The mobile phase consisted of 0.02% (v/v) formic acid solution in 
water (solvent A) and acetonitrile (solvent B). The optimised linear gradient elution 
program was determined to be 0–40% solvent B at 0–0.5 min, 40-100% solvent B at 
0.5-12.50 min, 100% solvent B at 12.5-14.50 min, 100-40% solvent B at 14.50-15 
min. The ﬂow rate was set at 20 ml/min and the injection volume of sample was 250 
μl.  
2.3.4.4. UHPLC- analytical chromatography 
The UHPLC (Ultra high performance liquid chromatography) Acquity system 
combined with PDA (photo diode array detector) type eLambda 800 nm and 
equipped with SQD 4271 (simple quadrupole detector), (Waters, Milford, MA, 
USA). UPCL have a binary solvent delivery system and autosampler with a 2.0 μl 
sample loop. An Acquity (Waters) CSH C18 column (1.7 µm, 50 × 2.1 mm, i.d.) 
was used for the separation of compounds. The mobile phase was initially composed 
of 98% eluent A (0.02% v/v formic acid solution in ultra-pure water) and 2% B 
(0.02% v/v formic acid with acetonitrile), followed by a linear gradient: 2% solvent 
B at 0–2.4 min, 98% solvent B at 2.4-3.0 min, 2% solvent B at 3.0-3.50 min, 
temperature 35 °C. The ﬂow rate was set at 0.6 ml/min and the injection volume of 
the sample was 1.0 μl and the effluent was monitored at 377 nm. The effluent from 
the PDA detector was introduced directly into the SQD mass spectrometer and data 
acquisition were observed with Empower 2 Build 2154 software. MS experiments 
were performed in a positive ionisation mode.  
2.3.5. STRUCTURE ELUCIDATION OF ISOLATED COMPOUNDS 
The structures of the purified compounds were elucidated by various 
spectroscopic methods: UPLC-PDA-SQD, UV, ESI-MS, ESI-MS/MS, 2D NMR,
 1
H 
and 
13
C NMR. Acquity UPLC equipped with PDA (photo diode array detector) – 
SQD (simple quadrupole detector), type eLambda 800 nm (Waters, Milford, MA, 
USA). 
1
H NMR spectra were recorded on a Bruker Avance 500 (Bruker, 
Rheinstetten, Germany). 
13
C and 2D spectra (HMBC, COSY and HSQC) were 
recorded on a Bruker DPX 400. Mass spectra were recorded on a UPLC Xevo G2 Q 
TOF or UPLC/ESI-QTOF-MS (Waters, Milford, MA, USA).  
2.4. STATISTICAL ANALYSIS 
Mean values and standard deviations (SD) of antioxidant, antimicrobial and 
cytotoxic activity from all experiments were performed on at least three replications 
(n=3). RSC, FRAP, ORAC, and TPC values were calculated with n=4 replicate 
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measurements as indicated in each section. Statistical analysis of the obtained results 
was performed by using one-way analysis of the variance (ANOVA), the differences 
between samples showed significant variation (P<0.05). Correlation coefficients (R) 
to determine the relationship between two variables, RSC, FRAP, ORAC and TEAC 
tests were calculated using MS Excel 2010 software (CORREL statistical function).  
The antioxidant indicators of extracts were summed-up by using integrated 
values, an ‘antioxidant score’ of extract (ASE), which is the sum of values for the 
fraction obtained with the same solvent in all assays. ASE is expressed in the so-
called ‘comparative integrated units’ in 1 g of dry extract weight (ciu/g EDW) and 
for the whole mushroom dry material, expressed in 1 g of dry mushroom weight 
(ciu/g mdw). The latter values, reflecting ‘antioxidant scores of mushrooms’ (ASM) 
take into the account ASE and extract yields (EY); they were calculated as follows: 
ASEcEYc/100 + ASEdEYd/100 + ASEmEYm/100 + ASEwEYw/100. These 
integrated values to some extent reflect the total antioxidant potential of the tested 
mushroom species, which consider extract yields, as well as the effectiveness of 
different polarity solvents used for the extraction. The concept of antioxidant scores 
may assist in assessing a large number of antioxidant activity data obtained in this 
study. 
Statistical analysis for detailed biological assays of hispidin was performed 
using the SPSS (Version 19) package (SPSS, Inc., Chicago, IL, USA). Statistical 
tests were chosen according to the nature of the data analysed. The Student’s two 
sided t-test was applied for MB, CA, SCE and comet assay results, comparing the 
different treatment groups, and z test for NDI and RI analysis (Lazutka, 1991). 
Dose–response relationships were determined by Pearson’s correlation. P value 
<0.05 was regarded as statistically significant.  
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3. RESULTS AND DISCUSSION 
3.1. YIELDS AND ANTIOXIDANT PROPERTIES OF WILD MUSHROOM 
EXTRACTS 
Antioxidants with the source of healthy compounds are present in all 
biological systems and mushrooms are no exception. A large number of assays have 
been developed for evaluating antioxidant capacities of botanical extracts. Following 
the scientific recommendations (Huang et al., 2005) all these methods were applied 
for the comprehensive assessment of antioxidant potential for different mushroom 
species. To obtain comparable values the results of ABTS
•+
, DPPH
•
, FRAP and 
ORAC assays were expressed in Trolox (a hydrosoluble analogue of vitamin E) 
equivalents, i.e. in the amount of Trolox µM possessing similar antioxidant capacity 
as 1 g EDW, while TPC was expressed in mg of gallic acid equivalents per g of 
EDW (Table 3.2). A remarkable diversity of yields and antioxidant capacity, 
depending on mushroom species, extraction solvent and assay method, may be 
clearly observed. Therefore, it is convenient to consistently discuss the effect of 
these factors in separate sections. For easier assessment of antioxidant potential of 
different mushroom species, as well as the effects of different solvents and applied 
antioxidant activity assays (Table 3.2). The antioxidant characteristics were also 
summarised by using ‘antioxidant scores’ of extracts (ASE) and dry mushroom 
material (ASM) and expressed in the so-called ‘comparative integrated units’ (ciu), 
which are explained in 2.4 section.  
To the best of our knowledge such approach is applied for the selected 
mushroom species for the first time. Moreover, there are no available literature 
sources about tested species, except the rough reports on antioxidant properties of A. 
devoniensis, B. impolitus and C. odora. 
3.1.1. Yield of mushroom extracts fractionated with different solvents  
Efficient extraction of antioxidants and other biologically active molecules 
requires the use of solvents with different polarities: certain antioxidants are better 
soluble in polar solvents such as methanol and water, while cyclohexane or 
dichloromethane are preferable for isolating lipophilic compounds. Two main 
approaches may be applied for exhausting isolation of various components from 
biological material, namely parallel extraction of initial material with different 
solvents or sequential fractionation with increasing polarity and dielectric constant 
solvents. The latter approach was applied in our study: non-polar cyclohexane was 
followed by polar aprotic solvent dichloromethane; the residues were further 
extracted with polar protic solvent methanol and the process for several species was 
finalised with boiling water possessing the highest dielectric constant. It is obvious 
(Table 3.1) that selected mushrooms are composed of very different classes of 
substances from the point of view of their solubility in the applied solvents. The 
yields of total mushroom species sorted by families represented in Fig. 3.1. 
Dominant families, which possessed significant total yields, were Agaricaceae, 
Tricholomataceae and Boletaceae. The yield of non-polar cyclohexane-soluble 
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fraction depending on mushroom species was from 0.61% (S. halophila) to 5.14% 
(R. badia), aprotic solvent dichloromethane yielded from 0.52% (G. ammophilus) to 
3.42% (T. caligatum), protic methanol from 6.77% (S. halophila) to 41.29% (A. 
pseudopratensis), more hydrogen bonding components. While boiling water from 6 
species additionally extracted from 2.94% (H. ferrugineum) to 25.29% (T. 
columbetta) of hydrosoluble components. Thus, the highest total yield of all 
fractions was obtained from T. caligatum (63.15%), while the lowest from S. 
halophila (8.54%). Protic solvents possessing high dielectric constant gave 
remarkably higher extract yields compared with non-polar and aprotic solvents. It 
proves that all tested mushroom species contain low amounts of lipophilic 
constituents. The yields obtained by different solvents are very important 
characteristics in applying the biorefinery concept to biomaterials for their effective, 
preferably no-waste conversion into the fractions for different applications. For 
comparison, previously a reported yield of methanol extracts of B. lupinus was 
37.67% (Nikolovska-Nedelkoska et al., 2013); thus, it is similar to the sum of 
extracts (36.01%) obtained in our study for this species; however, in reported studies 
the initial material was extracted. Sequential extraction of A. devoniensis with 
dichloromethane, methanol and water extracted at room temperature was also 
applied previously and the yields were 5.3, 11.5, and 18.3% respectively (Al-Fatimi 
et al., 2005) In our study dichloromethane yield was lower (1.37%) while methanol 
yield (33.01%) was remarkably higher. The yields of ethanolic and water soluble 
polysaccharide fractions of C. odora under agitation extractions were reported 1.26 
and 18.68% (Vaz et al., 2011); thus the sum of extracts obtained in their study 
(19.94%) was lower than the sum of yields (35.43%) obtained in our work for this 
species. The yield of phenolic and polysaccharide fractions of X. chrysenteron from 
Portugal were reported as 12.28 and 27.40% (Heleno et al., 2012); thus, the sum of 
extracts (39.68%) is similar to the sum of yields (39.93%) obtained in our study for 
this species. More than half the tested species have a higher sum of yields than the 
well-known edible species “Paris mushroom” (A. bisporus) sequentially extracted 
with hexane, ethyl acetate and aqueous methanol (7.17%) or “oyster mushroom” 
(Pleurotus ostreatus) methanol (16.9%) or ethanol (12.01%) fractions (Öztürk et al., 
2011, Yang, Lin and Mau, 2002, Arbaayah and Kalsom, 2013). 
 
Table 3.1 The yields of mushroom extracts isolated by different solvents, % (w/w) 
Botanical name C D M W Total 
A. menieri 2.40 0.67 27.08  30.15 
A. pseudopratensis 3.00 1.72 41.29  46.01 
A. freirei 1.47 0.90 34.50  36.87 
A. devoniensis 2.28 1.37 33.01  36.67 
A. fissuratus  3.43 0.89 26.37  30.69 
A. coniferarum 1.22 1.06 9.90  12.18 
L. litoralis 2.61 0.87 29.70  33.19 
L. subolivaceus 1.66 0.75 26.49  28.90 
S. subvolvatus 2.15 0.89 34.63  37.76 
G. ammophilus 1.20 0.52 17.77  19.50 
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Botanical name C D M W Total 
B. Lepidus 3.57 1.16 22.78  27.45 
B. impolitus 1.87 1.04 15.55  18.46 
B. luridus 1.56 0.54 21.01  23.11 
B. lupines 1.18 1.45 33.39  36.01 
X. chrysenteron 2.64±0.25 1.90±0.20 14.16±0.12 21.23±0.17 39.93 
S. halophile 0.61 1.16 6.77  8.54 
T. focale 2.63 0.75 24.54  27.91 
T. auratum 4.39 0.75 31.44  36.58 
T. caligatum 4.00±0.13 2.79±0.10 36.69±0.25 19.67±0.30 63.15 
T. columbetta 1.55±0.05 1.57±0.30 18.74±0.30 25.29±0.25 47.15 
M. cinereifolia 3.17 0.86 19.57  23.60 
C. odora 2.95 1.03 31.45  35.43 
A. avoidea 3.52 1.61 35.58  40.71 
C. suberetorum 3.69 1.58 27.37  32.64 
C. infractus 3.03 1.24 29.98  34.25 
R. badia 5.15 1.05 33.23  39.42 
L. vinosus 4.99 1.06 25.59  31.64 
P. schweinitzii 3.75±0.30 2.07±0.16 13.91±0.20 4.82±0.20 24.55 
I. hispidus 0.40±0.15 0.43±0.25 4.55±0.10 11.10±0.15 16.48 
H. ferrugineum 1.42±0.12 1.33±0.12 11.67±0.16 2.94±0.23 17.36 
C, cyclohexane; D, dichloromethane; M, methanol; W, water; Results expressed: mean±SD (n=3) 
Standard deviation not calculated, replication are not possible, deficiency of samples;  sample not 
tested. 
 
 
 
Fig.3.1 The total yields of mushroom extracts sorted by families 
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Table 3.2 Antioxidant activity of extracts isolated from tested mushroom species by different solvents.  
Botanical name Extract μM TE/g EDW TPC, mg 
GAE/g EDW 
  ABTS+ DPPH
• FRAP ORAC 
Agaricus menieri C 80.6±2.8 10.5±4.8 119.0±6.0 45.8±4.6 10.33±1.05 
 D 344.0±5.0 158.0±2.9 331.0±3.8 60.0±4.9 14.29±0.62 
 M 241.0±4.8 95.5±4.1 274.0±4.0 54.1±3.9 10.67±0.66 
 Total 665.6 264.0 724.0 159.9 35.29 
Agaricus pseudopratensis C 11.6±4.4 48.0±4.1 142.0±3.8 83.8±5.0 5.54±0.13 
 D 67.6±3.0 59.3±4.8 212.0±4.6 105.0±4.4 8.41±0.09 
 M 204.0±1.9 69.3±4.8 162.0±5.0 117.0±3.0 6.26±0.12 
 Total 283.2 176.6 516.0 305.8 20.21 
Agaricus freirei C 147.0±3.4 30.5±4.1 181.0±3.2 106.0±1.8 9.88±0.76 
 D 130.0±4.3 23.0±2.9 280.0±4.6 156.0±2.9 10.97±0.91 
 M 358.0±4.3 61.8±4.8 364.0±3.8 132.0±4.6 7.34±0.10 
 Total 635.0 115.3 825.0 394.0 28.19 
Agaricus devoniensis C 66.3±4.2 27.2±2.9 89.0±4.6 9.9±2.4 4.57±0.17 
 D 54.6±2.0 31.8±2.9 188.0±3.8 36.8±4.7 4.46±0.16 
 M 228.0±3.1 65.5±5.0 329.0±3.3 56.5±1.8 6.14±0.13 
 Total 348.9 124.5 606.0 103.2 15.17 
Agaricus fissuratus C 26.6±4.0 30.5±2.8 113.0±4.0 1.7±1.0 5.26±0.12 
 D 219.0±4.2 24.7±3.8 118.0±3.8 8.0±0.7 7.34±0.29 
 M 229.0±5.0 70.5±5.0 289.0±4.6 27.1±4.7 6.22±0.10 
 Total 474.6 125.7 520.0 36.8 18.82 
Agaricus coniferarum C 152.0±5.0 38.0±4.1 164.0±3.8 54.5±3.2 5.86±0.10 
 D 188.0±4.0 55.5±5.0 263.0±5.2 10.7±2.5 6.97±0.43 
 M 387.0±4.6 155.0±2.9 428.0±5.0 30.7±4.2 8.67±0.13 
 Total 727.0 248.5 828.0 95.9 21.50 
Leucoagaricus litoralis C 71.1±4.4 51.8±4.8 75.0±6.9 51.4±3.5 5.12±0.23 
 D 121.0±4.2 70.5±4.1 45.7±4.6 70.8±4.4 6.40±0.19 
 M 239.0±2.3 73.0±5.0 175.0±6.9 76.3±4.8 6.09±0.44 
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Botanical name Extract  μM TE/g EDW   TPC  
  ABTS+ DPPH
• FRAP ORAC mgGAE/gEDW 
 Total 431.1 195.3 295.7 198.5 17.61 
Leucoagaricus subolivaceus C 29.2±4.2 32.6±2.9 51.0±4.6 32.8±1.3 5.65±0.31 
 D 97.6±2.6 10.5±2.9 109.0±2.3 33.5±3.5 5.97±0.53 
 M 113.0±4.3 28.0±4.8 169.0±4.0 5.6±3.2 4.41±0.19 
 Total 239.8 71.1 329.0 71.9 16.03 
Sericeomyces subvolvatus C 11.1±1.9 29.3±2.5 66.0±2.0 92.5±4.4 5.52±0.24 
 D 109.0±1.0 30.5±4.8 56.0±3.8 86.4±4.3 6.88±0.06 
 M 44.1±1.9 73.0±4.1 175.0±4.6 106.0±3.0 5.01±0.21 
 Total  164.2 132.8 297.0 284.9 17.41 
Gyroporus ammophilus C 14.6±2.6 80.5±5.0 160.0±2.3 109.0±2.4 5.37±0.12 
 D 45.1±2.6 75.5±2.9 130.0±6.1 111.0±1.2 9.64±0.25 
 M 281.0±4.4 137.0±4.8 134.0±4.6 119.0±2.3 8.71±1.12 
 Total 340.7 293.0 424.0 339.0 23.72 
Leccinum (Boletus) lepidus C 49.1±2.5 23.0±5.0 189.0±5.2 102.0±2.2 7.17±0.19 
 D 93.1±4.4 29.3±2.5 148.0±5.0 115.0±2.4 11.28±0.34 
 M 203.0±3.7 96.8±4.8 249.0±4.0 146.0±3.2 7.57±0.34 
 Total 345.2 149.1  586.0
  
363.0 26.02 
Boletus impolitus C 7.6±2.6 33.0±5.0 63.0±3.3 95.4±2.2 6.53±0.27 
 D 279.0±1.6 26.3±2.9 159.0±4.6 118.0±1.0 6.42±0.08 
 M 258.0±3.4 79.3±4.8 382.0±3.3 118.0±1.7 5.49±0.30 
 Total 562.6 138.6 604.0 331.4 18.44 
Boletus luridus C 108.0±4.4 24.7±2.9 270.0±3.8 106.0±2.1 5.20±0.09 
 D 121.0±4.2 24.3±4.8 307.0±4.6 116.0±3.1 5.37±0.01 
 M 247.0±2.3 134.0±2.5 271.0±5.7 124.0±1.2 6.32±0.24 
 Total 476.0 182.92 848.0 346.0 16.89 
Boletus lupines C 23.1±3.0 33.0±2.5 207.0±3.3 204.0±2.1 6.29±0.12 
 D 10.1±4.4 69.3±4.8 188.0±6.0 74.3±3.7 6.20±0.16 
 M 210.0±3.0 178.0±4.1 277.0±4.0 60.2±4.4 8.13±0.19 
 Total 343.2 280.3 672.0 338.5 20.62 
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Botanical name Extract  μM TE/g EDW   TPC  
  ABTS+ DPPH
• FRAP ORAC mgGAE/gEDW 
Xerocomus chrysenteron C 88.5±2.5 5.00±0.5 81.2±1.4 26.5±1.4 6.44±0.31 
 D 35.4±1.7 32.6±0.6 75.2±4.9 16.4±0.1 5.74±0.14 
 M 138.0±4.5 79.5±5.0 36.4±3.5 49.3±3.2 4.96±0.18 
 W 145.0±3.1 98.5±4.2 299.0±4.0 11.9±0.4 6.56±0.12 
 Total 406.9 215.6 491.8 104.1 23.70 
Stropharia halophila C 128.0±2.6 35.5±4.8 186.0±3.8 6.7±1.6 5.01±0.15 
 D 51.3±3.1 30.5±4.1 51.0±4.6 9.0±1.8 6.33±0.20 
 M 258.0±4.8 34.3±4.8 331.0±3.3 20.3±3.1 6.01±0.49 
 Total 432.3 100.3 568.0 36.0 17.35 
Tricholoma focale C 17.1±4.4 40.5±5.0 63.0±4.0 23.3±4.7 5.69±0.24 
 D 36.6±3.7 34.3±4.8 52.3±2.3 58.7±2.2 4.98±0.16 
 M 83.1±4.4 39.3±5.0 71.0±4.0 55.1±4.5 5.42±0.07 
 Total 136.8 114.1 186.3 137.1 16.09 
Tricholoma auratum C 74.1±3.5 25.5±5.0 46.0±3.8 50.5±2.9 7.26±0.25 
 D 207.0±3.5 35.5±4.1 67.0±3.3 61.2±1.2 10.70±0.44 
 M 299.0±4.3 37.4±3.8 254.0±4.6 27.8±2.3 6.07±0.62 
 Total 580.1 100.4 367.0 139.5 24.03 
Tricholoma caligatum C 31.6±1.9 28.0±5.0 287.0±2.3 45.6±4.9 9.60±0.86 
 D 95.6±4.4 36.8±2.5 332.0±4.6 65.3±1.2 11.41±0.81 
 M 91.1±3.4 31.8±4.8 207.0±6.1 41.2±4.4 9.65±0.88 
 W 35.9±1.6 25.8±4.1 173.0±3.8 5.8±1.0 5.89±0.24 
 Total 254.2 122.4 999.0 158.9 36.64 
Tricholoma columbetta C 35.0±0.5 6.9±1.0 120.2±3.5 155.0±1.0 6.25±0.20 
 D 33.1±1.9 15.9±1.3 65.2±6.2 135.0±3.0 4.74±0.06 
 M 47.9±1.1 14.5±3.1 9.1±2.8 64.6±3.6 6.60±3.50 
 W 160.0±1.6 7.1±2.3 10.7±0.2 10.8±0.7 5.18±0.28 
 Total 276.0 44.4 205.2 365.4 22.77 
Melanoleuca cinereifolia C 4.6±1.6 21.3±2.9 23.0±3.3 17.2±2.1 6.04±0.29 
 D 49.1±2.5 20.5±5.0 22.0±3.9 109.0±4.9 5.27±0.16 
 M 74.1±5.0 66.8±4.8 83.0±4.0 100.0±1.4 4.50±0.24 
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Botanical name Extract  μM TE/g EDW   TPC  
  ABTS+ DPPH
• FRAP ORAC mgGAE/gEDW 
 Total 127.8 108.6 128.0 226.2 15.81 
Clitocybe odora C 8.1±1.6 31.8±4.7 172.0±3.8 95.5±2.3 9.46±0.95 
 D 21.1±2.6 28.0±2.8 184.0±2.3 55.3±3.9 9.76±0.43 
 M 251.0±4.4 177.0±4.8 204.0±4.6 41.6±2.1 11.28±0.86 
 Total 280.2 236.8 560.0 192.4 30.50 
Amanita avoidea C 8.5±1.9 36.8±4.8 24.0±2.0 29.0±3.4 7.02±0.20 
 D 23.1±4.8 35.5±4.1 40.0±6.0 21.1±2.1 7.95±0.16 
 M 41.1±2.6 40.5±4.1 93.0±6.9 50.6±3.7 5.21±0.05 
 Total 72.7 112.8 157.0 100.7 20.18 
Cortinarius suberetorum C 25.6±1.9 41.8±4.8 61.0±4.0 73.4±3.3 7.67±0.17 
 D 105.0±2.6 154.3±4.1 160.0±3.3 82.2±4.3 11.51±0.52 
 M 225.0±4.8 45.5±2.3 240.0±3.8 101.0±4.8 6.25±0.17 
 Total  355.6 241.6 461.0 256.6 25.43 
Cortinarius infractus C 63.6±4.43 34.3±4.8 236.0±2.3 114.0±3.6 8.40±0.38 
 D 102.0±3.65 99.3±2.5 304.0±4.6 156.0±1.8 12.06±1.18 
 M 483.0±3.83 354.0±4.8 569.0±4.0 126.0±3.5 17.72±0.90 
 Total 648.6 487.6 905.0 396.0 38.18 
Russula badia C 14.1±1.6 24.3±2.5 13.0±2.3 15.8±2.8 5.80±0.19 
 D 36.6±3.4 21.8±4.7 54.0±5.0 23.2±3.2 4.54±0.18 
 M 82.1±4.3 45.5±4.1 60.3±4.6 23.8±4.4 6.00±0.53 
 Total 132.8 91.6 127.3 62.8 16.34 
Lactarius vinosus C 7.6±1.9 48.0±4.1 108.0±6.0 37.2±2.5 10.16±0.28 
 D 4.1±2.6 99.3±4.7 77.0±2.3 81.1±2.6 9.36±0.33 
 M 17.6±1.9 43.8±2.3 207.0±6.1 38.9±3.2 5.08±0.08 
 Total 29.3 191.1 392.0 157.2 24.6 
Phaeolus schweinitzii C 48.2±1.4 494.0±4.0 11.9±0.7 33.6±1.9 7.07±0.49 
 D 417.0±2.9 176.0±3.6 110.0±2.3 42.7±2.5 9.38±0.41 
 M 1629.0±3.5 1282.0±3.5 874.0±2.0 340.0±3.0 31.88±1.67 
 W 794±3.00 295.0±5.0 970.0±4.2 45.6±2.7 8.20±0.33 
 Total 2888.2 2247.0 1965.9 461.9 56.53 
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7
 
 
Results are expressed as a mean±standard deviation (n=4); C, cyclohexane; D, dichloromethane; M, methanol; W: water. 
 
Botanical name Extract  μM TE/g EDW   TPC  
  ABTS+ DPPH
• FRAP ORAC mgGAE/gEDW 
Inonotus hispidus C 9.9±0.9 118.0±4.2 109.0±4.9 7.5±0.1 4.79±0.36 
 D 587.0±1.4 225.0±3.1 246.0±6.4 18.6±3.2 9.70±0.64 
 
 
 
M 861.0±5.0 1265.0±5.0 883.0±9.1 290.0±1.0 28.91±1.49 
 W 1651.0±2.5 1160.0±5.0 3010.0±4.5 53.1±1.1 41.27±0.86 
 Total 3108.9 2768.0 4248.0 369.2 84.47 
Hydnellum ferrugineum C 16.7±4.1 7.3±2.1 170.0±4.9 38.4±1.9 7.22±0.53 
 D 108.0±5.0 40.2±4.5 180.0±4.2 90.7±1.2 6.92±0.41 
 M 138.0±3.8 79.5±5.0 117.0±9.9 74.0±3.1 8.05±0.23 
 W 1074.0±2.5 215.0±5.0 1230.0±0.7 63.5±3.3 13.31±0.07 
  Total 1336.7 342.0 1697.0 266.6 35.50 
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3.1.2. Antioxidant capacity differences between mushroom species 
The highest antioxidant potential was demonstrated in I. hispidus and P. 
schweinitzii extracts, particularly in SET assays, while the extracts isolated from 
such species as L. vinosus and T. columbetta were the weakest antioxidant sources in 
these assays. For instance, the sum of TEAC of I. hispidus extracts in ABTS•+ 
scavenging assay (3108.9 M TE/g) was more than 100 times higher compared to L. 
vinosus (29.3 M TE/g). These differences were less remarkable in other SET 
assays, while ORAC values varied from 36.0 (S. halophila) to 461.9 M TE/g (P. 
schweinitzii). TPC was from 15.17 (A. devoniensis) to 84.47 mg GAE/g (I. 
hispidus). However, extract yields were dependent both on mushroom species and 
extraction solvent, therefore TPC values obtained for extracts were recalculated for 
1 g of mushroom dry weight (mdw), taking into account how much of TPC is 
extracted with each solvent. The TPC values expressed in this way are presented in 
Fig. 3.2: they were from 0.51 mg GAE/g mdw (S. halophila) to 5.90 mg GAE/g 
mdw (I. hispidus). In general, the TPC values in most cases were in agreement with 
antioxidant capacity values obtained in other assays.  
 
 
Fig. 3.2 Total content of phenolic compounds (TPC) in mushrooms 
Taking into account all measured characteristics, the ASMs of wild 
mushrooms expressed in ciu/g mdw may be grouped in four classes (Fig. 3.3) with 
antioxidant scores 0-100 (8 species), 100-200 (12 species), 200-300 (6 species) and 
more than 300 ciu/g mdw (4 species). Several species (I. hispidus, P. schweinitzii 
and C. infractus) were of superior antioxidant potential compared with the majority 
of studied mushroom species; their integrated antioxidant scores were in the range of 
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481-808 ciu/g mdw; thus, Agaricaceae (109-325 ciu/g mdw) and Boletaceae (140-
253 ciu/g mdw) families had a higher integrated antioxidant score than 
Tricholomataceae (47-206 ciu/g mdw) and the rest of the tested families. 
 
Fig. 3.3 Antioxidant scores of mushrooms species integrating antioxidant activity values 
The RSC of A. devoniensis methanol extract was reported to increase with a 
higher concentration (Al-Fatimi et al., 2005); ethanol and water soluble 
polysaccharide fraction of C. odora was weaker DPPH• and OH• scavenger and 
possessed lower reducing properties compared with the other 4 tested commercial 
mushroom species (Vaz et al., 2011); however, in the mentioned studies antioxidant 
indicators were expressed in percentage of scavenged radicals and therefore are 
difficult to compare with our results. More effective mushrooms species were 
reported to contain higher amounts of secondary metabolites such as phenolics 
exerting multiple biological effects including antioxidant activity (Kim et al., 2008). 
3.1.3. Antioxidant capacity differences between extractants 
Generally polar solvents are more regularly used for the extraction of 
antioxidants from materials containing polyphenolics as the main antioxidative 
active compounds; however, some fungi origin materials may also contain lipophilic 
compounds such as tocopherols, carotenoids and terpenoids, and the use of different 
polarity solvents may provide more comprehensive information on their antioxidant 
potential, particularly in case of less studied mushroom species. Our results clearly 
demonstrate (Table 3.3) that distribution of antioxidative active constituents in the 
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fractions isolated with different solvents is highly dependent on mushroom species. 
The extracts isolated from I. hispidus and P. schweinitzii (the species possessing the 
highest antioxidant potential) with protic solvents methanol and water were 
remarkably stronger antioxidants than cyclohexane and dichloromethane extracts of 
the same species in all assays, while for other species the results are more 
complicated. For instance, cyclohexane extracts of 10 mushrooms species were 10-
30% stronger in antioxidants in SET and/or HAT assays than dichloromethane (A. 
freirei, A. devoniensis, A. fissuratus, B. lupinus, B. Lepidus, S. subvolvatus, G. 
ammophilus, S. halophila, T. focale and C. odora), while another 20 species results 
were similar and activity increased with protic solvent. T. columbetta or X. 
chrysenteron (except DPPH• assay) cyclohexane fractions in all tested assays were 
from 10-40% higher than dichloromethane fractions. However, it should be 
mentioned that these species were characterised as sufficient antioxidant potential. It 
is interesting to note that dichloromethane fractions of species A. menieri, A. 
pseudopratensis, B. luridus and T. caligatum, possessed stronger, sometimes 40% 
higher antioxidant activity than methanol fraction in FRAP, while the TPC values 
were respectively higher for these fractions. A. menieri, A. freirei, L. subolivaceus, 
B. lupinus, T. auratum and L. vinosus values in ORAC assay were 10-50% higher 
than methanol fraction and indicated dichloromethane and cyclohexane as the 
appropriate solvent for extracting phenols. 
Our study shows that methanol and water may be useful solvents for the 
extraction of antioxidants from some mushroom species after applying polar organic 
solvents. Water is a preferable solvent in terms of toxicity and availability; however, 
it is not always sufficiently efficient for the isolation for mushroom bioactive 
compounds. For instance, water extract of I. hispidus was the strongest antioxidant 
in ABTS
•+
, FRAP and TPC assays; however, it was almost 6 times weaker in ORAC 
assays compared to the methanol fraction. It is also important noting that the yield of 
water extract from I. hispidus was remarkably higher than the yields obtained with 
other solvents; water fraction constituted 67% of the total extractives. Water extracts 
of the other 6 tested species were also remarkably less effective in ORAC assays, 
except for H. ferrugineum, when the difference between methanol and water 
fractions constituted only 14%. It should be noted that water extracts were obtained 
by boiling the residues of extractions with organic solvents and in this case some 
hydrolysis and other processes involving chemical changes may occur in extraction 
material. Generally, methanol extracts of most species were strongest in ABTS
•+
, 
DPPH
•
 scavenging, FRAP and the yields were remarkably higher than the yields 
obtained with other solvents; however, cyclohexane and dichloromethane fractions 
were several times weaker radical scavengers than polar methanol extracts, except 
several species described above. Many previously performed studies reported that 
polar solvents extract more antioxidants from botanicals than lower polarity solvents 
(Brahmi et al., 2012), which is not true for some wild mushrooms species. Integrated 
antioxidant potential scores were also calculated for the extracts isolated with 
different solvents for comparative assessment of the effectiveness of each solvent for 
the tested wild mushroom species Figure 3.4, and according to the score levels 
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(ciu/g EDW) the cyclohexane, dichloromethane and methanol extracts were 
classified into the 5 groups and expressed in percentage (Figure 3.5). 
  
Fig 3.4 Antioxidant scores of mushrooms extracts integrating antioxidant activity values 
 
Fig 3.5 Antioxidant scores of extracts (ASE) according to score levels and solvent polarity 
expressed in percentage. 
However, it should be noted that in this case the scores were calculated by 
summing the values measured for 1 g of extracts dw (Fig. 3.4) are not associated 
with the antioxidant scores calculated in ciu/g mdw, which are presented in Fig. 3.3. 
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3.1.4. Antioxidant capacity differences between extraction methods 
Antioxidant activity values obtained by using different evaluation assays are in 
a very wide range, they depend both on mushroom species and extracted fraction. 
Generally, the highest TEAC values were obtained in FRAP assay; their sum from 
all fractions were from 128.0 (M. cinereifolia) to 4248.0 M TE/g (I. hispidus). 
ABTS
•+
 values were from 29.3 (L. vinosus) to 3108.9 M TE/g (I. hispidus); DPPH• 
scavenging assay values were from 44.4 (T. columbetta) to 2768.0 M TE/g (I. 
hispidus), while the lowest values were measured in ORAC, from 36.0 (S. 
halophila) to 461.9 M TE/g (P. schweinitzii). Strong correlation was observed 
between ABTS
•+
 and FRAP (R
2
 = 0.9095) as well as DPPH
•
 and ABTS
•+
 (R
2
 = 
0.9498); Also total phenols had strong correlation with DPPH
•
 (R
2
 = 0.9043), FRAP 
(R
2
 = 0.9230) and ABTS
•+
 (R
2
 = 0.8842), confirming that phenolic compounds are 
important contributors to the antioxidant properties of these extracts. However, the 
correlation between TPC and ORAC was weaker (R
2
 = 0.44). 
Several reasons may be considered to explain the obtained differences between 
the applied assays. Although the principle of the applied radical scavenging or 
reduction assays are based on SET and/or HAT, the peculiarities of reaction 
mechanisms in each assay are different; they may largely depend on reaction media, 
pH, the structure of antioxidative compounds present in the extracts, their 
interactions and other factors. For instance, Agaricaceae, Boletaceae and 
Cortinariaceae families possessed high antioxidant capacities in ABTS•+ and values 
were from 164.2 (S. subvolvatus) to 665.6 (A. menieri) M TE/g, compared to lower 
Tricholomataceae family species (127.8-580.1 M TE/g); the remaining families 
demonstrated weaker activity, except three forest mushroom species H. ferrugineum 
(1336.7 M TE/g), P. schweinitzii (2888.2 M TE/g) and I. hispidus (3108.9 M 
TE/g) with the highest antioxidant capacity. As Zan et al. (2011), reported that in 
ABTS
•+
 scavenging assay, 5 compounds isolated from I. hispidus methanol extract 
exhibited significant activity, from 12.71±3.57 to 59±9.70 M TE/M. These 
findings support our results indicating high ABTS
•+
 scavenging capacity of I. 
hispidus water and methanol fractions. For example, in reported studies five edible 
wild Australian mushrooms, Morchella elata (240±22 M TE/g), Flammulina 
velutipes (221±20 M TE/g), Suillus luteus (154±14 M TE/g), Pleurotus eryngii 
(67.0±0.6 M TE/g) and Cyttaria gunnii (77.0±0.7 M TE/g) were evaluated for 
their antioxidant capacity and methanol fractions were reported as strong ABTS
•+
 
scavengers (Zeng et al., 2012). The values obtained in our study for some species 
were similar, while for other species were two or three times higher than those 
measured for Australian edible mushrooms.  
The sum of values measured in DPPH
•
 scavenging assay of Boletaceae and 
Cortinariaceae families species demonstrated high antioxidant capacity and values 
were 138.6-487.6 M TE/g (B. impolitus and C. infractus respectively), compared to 
slightly lower Agaricaceae (71.1-264.0 M TE/g) and Tricholomataceae (44.4-
236.8 M TE/g) families; remaining families demonstrated similar DPPH• 
scavenging values, except P. schweinitzii (2247.0 M TE/g) and I. hispidus (2768.0 
M TE/g) with the highest antioxidative active components.  In literature 
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antioxidant activity of A. devonienis methanol extract was dependent on 
concentration and varied from 3.3-65.5%; the results were comparable with the 
activity of the reference compound ascorbic acid 48.8-97.2% (Al-Fatimi et al., 
2005), however these results are not applicable for comparison with represented data 
of A. devonienis. DPPH• scavenging capacity was also recently reported for B. 
impolitus and evaluated by measuring their effective methanol value EC50 = 
5.81±0.17 mg/ml (Pereira et al., 2012); thus are difficult to compare with our results 
obtained for B. impolitus methanolic fraction (79.3 μM TE/g). Effective DPPH• 
scavenging concentration of C. odora ethanol and water soluble polysaccharide 
extracts evaluated previously; ethanol fraction was a stronger antioxidant compared 
to water soluble polysaccharide extracts in DPPH
•
 assay, (Vaz et al., 2011, Suay et 
al., 2000). Effective DPPH
•
 scavenging concentration EC50 of X. chrysenteron 
methanol/water extract was 2.06±0.46 mg/ml (Heleno et al., 2012), while methanol 
fraction, depending on extract concentration, inhibited from 27.42±1.23 to 
89.61±0.10% DPPH
•
 (Sarikurkcu et al., 2008). Although we used different 
extraction procedures and antioxidant activity assays, some agreement in the 
obtained results may be observed, particularly in case of DPPH
•
 scavenging assay, 
when in both studies more polar solvent applied stronger antioxidants values in 
DPPH
•
 assays. However, some species have the exception and twice the effective 
antioxidant capacity shown in dichloromethane fractions, such as species A. menieri, 
L. vinosus. 
The third method used to evaluate antioxidant potential of mushroom species 
was FRAP. In the case of this assay the highest total extracts efficiency belongs to 
forest mushrooms H. ferrugineum (1697.0 M TE/g), P. schweinitzii (1965.9 M 
TE/g) and I. hispidus (4248.0 M TE/g); Lower Fe+3 reducing ability had 
Cortinariaceae (461.0-905.0 M TE/g), Tricholomataceae (128.0-999.0 M TE/g), 
Boletaceae (491.8-848.0 M TE/g) and Agaricareae (297.0-828.0 M TE/g) 
families; other species also possessed effective activity and varied from 127.3 (R. 
badia) to 568.0 M TE/g (S. halophila). FRAP was also used in some other studies 
of mushrooms; however, the results are difficult to compare due to different units 
used to express the data. The reducing power of B. impolitus (Pereira et al., 2012) C. 
odora (Vaz et al., 2011, Suay et al., 2000) and X. chrysenteron (Sarikurkcu et al., 
2008) methanol extracts was reported previously as well, however, it was also 
expressed in relative units. However, in FRAP assay as well as in DPPH
•
 scavenging 
assay several mushroom species had more powerful reducing ability in cyclohexane 
or dichloromethane fractions (H. ferrugineum, T. columbetta), than described in 
polar fraction. For example, A. menieri and A. pseudopratensis dichloromethane 
fraction were 20-30% more efficient than methanol fraction, and these mushrooms 
are noticeable as species with a strong phenolic odour. Chelating agents may act as 
secondary antioxidants by reducing redox potential and stabilising the oxidised 
forms of metal ions (Mishra et al., 2013). 
Finally, the antioxidant activity of mushrooms was evaluated using ORAC 
assays; the total values for investigated species with the highest activity were forest 
mushrooms P. schweinitzii (461.9 M TE/g), I. hispidus (369.2 M TE/g) and dune 
families Cortinariaceae (396.0-257.0 μM TE/g) and Gyroporaceae (339.0 μM 
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TE/g); all Boletaceae family species demonstrated strong antioxidant activity and 
ORAC values were 331.4-104.1 μM TE/g; remarkably strong peroxyl radical 
inhibitors showed B. lupinus cyclohexane fraction 204.0 μM TE/g whereas 
dichloromethane and methanol were lower 74.3 and 60.2 μM TE/g respectively. 
Other Boletaceae species possessed similar activity, where methanol extracts were 
dominated in ORAC assays. Some Agaricaceae family species also demonstrated 
high activity, such as A. freirei (394.0 μM TE/g) and A. pseudopratensis (305.8 μM 
TE/g), while other species in the same family had ten to five times lower activity (A. 
fissuratus 36.8 μM TE/g and L. subolivaceus 71.9 μM TE/g). Tricholomataceae 
family species possessed twice the lower activity for tested active species in ORAC 
assays 137.1 (T. focale) to 226.2 (M. cinereifolia) μM TE/g. Amanitaceae, 
Strophariaceae and Russulaceae families were fifty to twenty times lower than most 
active mushroom species in this assay. As far as we know, the ORAC activity of 
tested mushrooms species has been characterised for the first time. 
The values measured with Folin-Ciocalteu reagent and expressed in gallic acid 
or other phenolic compounds are generally accepted as representing the total 
phenolic content (TPC) although it is not fully correct: Folin-Ciocalteu reagent 
reacts not only with phenolics but with other reducing ability possessing compounds 
in the reaction system (Huang et al., 2005). Consequently, the term TPC may be 
used conditionally; however, for convenience we are using this term in our study. 
Thus, the integrated TPC values (their sum in the all extracts) highest phenolic 
content were possessed by P. schweinitzii (56.53 mg GAE/g) and I. hispidus (84.47 
mg GAE/g), following by C. infractus 38.2 mg GAE/g EDW and H. ferrugineum 
35.5 mg GAE/g EDW, the Tricholomataceae family distributed values 15.8-36.5 mg 
GAE/g EDW, it is interesting to note that dichloromethane fractions of T. auratum 
and T. caligatum were approx. 40% and 20% respectively higher than methanol or 
cyclohexane fractions. Agaricaceae family species also demonstrated high TPC 
values 15.2-35.3 mg GAE/g EDW, for instance, A. menieri, possessed the highest 
TPC value of dichloromethane fraction (14.29 GAE/g EDW) in this assay. Other 
species of this family also indicated higher phenolic content in dichloromethane 
fractions, except A. coniferarum and A. devoniensis, where major TPC values 
possessed polar protic solvent methanol. Boletaceae family species TPC sum values 
were similar and varied from 16.9 (B. luridus) to 26.0 GAE/g EDW (B. lepidus). For 
instance, the methanol fraction of B. impolitus (15.50±0.53 GAE/g EDW) (Pereira et 
al., 2012) and water/ethanol (9:1) fraction of C. odora (5.69 GAE/g EDW) (Del 
Signore, Romeo and Giaccio, 1997) extracts are lower than the sum of TPC in all 
extracts obtained from this species in our study (Fig. 3.2), 18.4 and 30.5 GAE/g 
EDW respectively; however, the extracts in previous studies were obtained from the 
whole material, while in our study methanol was used for re-extracting the residue 
after cyclohexane and dichloromethane extraction.  
Antioxidant potential of studied mushrooms was found to be in a rather wide 
range: the differences were observed between the tested species as well as between 
the fractions isolated by different solvents. The assay method was also an important 
factor in determining antioxidant properties of mushroom extracts. The extracts 
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isolated with methanol and water from P. schweinitzii and I. hispidus were the most 
powerful antioxidants in almost all the tested assays.  
3.2. ANTIBACTERIAL AND BIOLOGICAL PROPERTIES OF 
COLLECTED WILD MUSHROOM SPECIES 
Worldwide, bacterial infections have increased dramatically over the past few 
years (Theuretzbacher, 2013). Microorganisms and parasites are becoming 
increasingly resistant. The most common and effective treatment of infectious 
disease until now has been the application of drugs with antimicrobial activity. Drug 
resistance usually occurs after long-term misuse of antibacterial substances and 
bacterial survival is a consequence of the acquisition of mutations in the bacterial 
genome and genes. Nowadays it is impossible to avoid bacterial or parasites 
evolution, it is vital to choose the most appropriate antibiotic and to use them 
appropriately to minimise the growth of resistant microorganisms. There will 
forever be a demand for novel substances or compounds to outstrip bacteria and 
other pathogens (Ren et al., 2014). Many species of fungus produce antibacterial and 
antifungal agents to survive in the natural environment. These metabolites are the 
major sources of pharmacologically active drugs or food preservatives including 
antibiotics, alkaloids, phenols, gallic acids, free fatty acids and their derivatives 
(Lindequist et al., 2005, Gyawali and Ibrahim, 2014).  
3.2.1. Antibacterial properties of mushroom extracts 
Evaluation of antioxidant activity of extracts isolated from the collected 
mushroom species by different solvents revealed remarkable variability in the 
obtained values. It is known that many antioxidative active compounds may also 
possess different effects against microorganisms. 
Antimicrobial activity was considered to be an indicator of the mushroom 
species to produce bioactive secondary metabolites of potential therapeutic interest. 
Therefore, the study was continued for the preliminary screening of antimicrobial 
properties of the extracts against two Gram-positive and two Gram-negative 
bacteria. The results obtained for 80 extracts isolated from 30 mushroom species are 
summarised in Table 3.3, listing the inhibition zones in the agar diffusion assay at 
different applied concentrations. Appendix 1 gives an overview of the sorted 
families and the number of active species against Gram-positive and Gram-negative 
bacteria. It is apparent from Table 3.3 that representatives from the different genera 
marked differences in their ability to show antimicrobial activities. Species of B. 
impolitus, B. luridus, G. ammophilus, S. halophila, T. caligatum and C. infractus 
were especially productive (75-95%), while B. lepidus, B. lupinus, T. focale, T. 
auratum, C. odora, A. avoidea, R. badia, L. vinosus, C. suberetorum, M. cinereifolia 
and Agaricaceae family species gave moderate activity (30-50%). 
 Comparing mushrooms species, the largest inhibition zones of more than 15 
mm was observed for methanol extract of P. schweinitzii and I. hispidus against P. 
aeruginosa and B. cereus respectively; also the extract of B. luridus isolated with 
cyclohexane solvent possessed antibacterial activity against the tested bacteria in the 
agar diffusion assay and showed the largest clear active zones of more than 15 mm, 
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however, the extract was not effective against E. coli. As well a strong effect (>15 
mm) was demonstrated in methanol extract of C. infractus with partial activity 
against P. aeruginosa; It is interesting to note that I. hispidus, P. schweinitzii and C. 
infractus possessed the highest antioxidant potential, compared with other studied 
species. The differences between microbial activity of all of the species might reflect 
the diverse substances of these mushrooms and have a number of effects; it may 
have a strong activity, inhibit all microorganism colony growth or have partially 
inhibition activity around the disc with several colonies. For instance, strong partial 
effect of B. lepidus (D), B. impolitus and S. halophila (M), against S. aureus; G. 
ammophilus (D, M) and T. caligatum (M) against B. cereus; B. luridus and C. 
infractus (M) against P. aeruginosa; A. pseudopratensis against E. coli inhibited 
tested microorganisms in agar diffusion assay of more than 15 mm, but did not fully 
inhibited growth.  Figure 3.6 represents the amount of mushroom extracts with clear 
active zones and partially inhibition zones against tested microorganisms. 
The test mushroom species showed greater antibacterial activity against Gram-
positive than Gram-negative bacteria. For instance, tested bacteria were not inhibited 
by 11% of the tested extracts (Appendix 1). Comparing the solvents, methanol 
extracts in most cases were the strongest antimicrobial agents, whereas Agaricaceae 
family dichloromethane fraction possessed the strongest inhibitory activity except A. 
devoniensis and L. subolivaceus extracts which were not tested. Methanol and 
cyclohexane fraction of the Boletaceae family had very similar activity, except for 
species of B. lupinus methanol extract, which showed stronger activity.  
 
 
Fig. 3.6 Active amounts of mushroom extracts against tested microorganisms 
MIC values, which are evaluated by diluting the extracts and measuring the lowest 
inhibitory concentrations, are important indicators of antimicrobial activity (Table 
3.3). Five mushroom dichloromethane (A. menier, A. pseudopratensis, T. caligatum, 
C. infractus and L. vinosus) and methanol extracts of B. impolitus were determined 
23 mushroom extracts against B. cereus, 15 extracts against E. coli and 25 
mushrooms extracts against P. aeruginosa, as well as S. aureus. The majority of 
other extracts demonstrated MIC of 10 or 20 mg/ml.  
Clear activity 
Partial activity 
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Table 3.3 Antimicrobial activity of mushroom extracts with inhibition zones 
Botanical 
name 
fraction   Staphylococcus aureus Bacillus cereus Pseudomonas aeruginosa          Escherichia coli  
  20  
mg/mL 
10 
 mg/mL 
5  
mg/mL 
20  
mg/mL 
10  
mg/mL 
5  
mg/mL 
20  10 5 
mg/mL   mg/mL  mg/mL 
20  
mg/mL 
10  5 
mg/mL mg/mL 
 
mg/mL 
  
Agaricus  D (++) (+) (+) (++) (+) - ++ ++ + (++) (+) (+) 
menieri M (++) (+) - - - - - - - + - - 
              
Agaricus  C (++) (++) (+) (+) (+) (+) (++) - - - - - 
pseudopratensis D (++) (+) - (++) (+) - ++ + + (++) (+) (+) 
 M + - - + + - + - - (+++) (+) - 
              
Agaricus  C - - - (+) (+) (+) (+) (+) - - - - 
freirei D (+) (+) (+) - - - (++) (++) (+) - - - 
 M (+) (+) - - - - - - - - - - 
              
Agaricus  M + - - - - - + + - - - - 
devoniensis 
 
             
Agaricus  D ++ (++) (++) (++) (+) (+) - - - (++) (++) (+) 
fissuratus M + - - + + - + + - - - - 
              
Agaricus  D (+) (+) - (+) (+) - (+) (+) (+) (+) (+) (+) 
coniferarum M - - - (++) (+) - - - - + - - 
              
Leucoagaricus  D + + - - - - - - - (++) (++) (+) 
litoralis M + + - (++) (+) - - - - + + - 
              
Leucoagaricus  M - - - + - - + + - - - - 
subolivaceus              
              
Sericeomyces  C (++) (+) (+) (+) (+) (+) - - - - - - 
subvolvatus D ++ + + (++) (+) (+) - - - - - - 
 M - - - +(++) +(++) (+) + + - - - - 
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Botanical 
name 
fraction   Staphylococcus aureus Bacillus cereus Pseudomonas aeruginosa          Escherichia coli  
  20  
mg/mL 
10 
 mg/mL 
5  
mg/mL 
20  
mg/mL 
10  
mg/mL 
5  
mg/mL 
20  10 5 
mg/mL   mg/mL  mg/mL 
20  
mg/mL 
10  5 
mg/mL mg/mL 
 
mg/mL 
  
              
Gyroporus  C (++) (+) - (+) (+) - - - - - - - 
ammophilus D (++) (++) - (+++) (++) (+) (++) - - (++) (++) (++) 
 M + + + (+++) (++) (+) (++) (++) (+) - - - 
              
Boletu)  C (++) (++) (+) (++) (+) (+) - - - (+) (+) - 
lepidus D (+++) (++) (++) - - - (++) (++) (+) - - - 
 M - - - + - - - - - ++ + - 
Boletus  C ++ + (+) (++) (+) (+) (++) (+) (+) - - - 
impolitus M ++(+++) +(++) - (++) (+) (+) ++ + + (++) (++) - 
              
Boletus  C +++ ++ ++ (++) (+) (+) (++) (+) - - - - 
luridus M +(++) +(++) - - - - (+++) (+++) (+) + - - 
              
Boletus  C - - - - - - (+) (+) (+) - - - 
lupinus D (++) (++) - (++) (+) (+) - - - (++) (+) (+) 
 M + + + - - - (++) (++) (+) - - - 
              
Xerocomus  C n.t n.t n.t - - n.t + + n.t n.t n.t n.t 
chrysenteron D n.t n.t n.t - - n.t + + n.t n.t n.t n.t 
 M n.t n.t n.t ++ - n.t ++ + n.t n.t n.t n.t 
              
Stropharia  C - - - - - - - - - (+) (+) - 
halophila D (+) (+) (+) - - - - - - - - - 
 M +(+++) +(+++) (+) + - - (++) (+) - - - - 
              
Tricholoma  C ++ + - (+) - - (++) (+) (+) - - - 
focale D (+) - - - - - - - - (++) (+) (+) 
 M (+) (+) (+) (++) (++) (+) (++) (++) (+) - - - 
              
Tricholoma  C - - - - - - - - - (++) (+) (+) 
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Botanical 
name 
fraction   Staphylococcus aureus Bacillus cereus Pseudomonas aeruginosa          Escherichia coli  
  20  
mg/mL 
10 
 mg/mL 
5  
mg/mL 
20  
mg/mL 
10  
mg/mL 
5  
mg/mL 
20  10 5 
mg/mL   mg/mL  mg/mL 
20  
mg/mL 
10  5 
mg/mL mg/mL 
 
mg/mL 
  
auratum D (++) (+) (+) - - - - - - - - - 
 M (++) (+) - (++) (+) (+) + + - ++ + - 
              
Tricholoma C (+) (+) (+) - - - - - - - - - 
caligatum D (++) (++) (+) (++) (++) (++) ++ ++ + (++) (+) (+) 
 M + + + (+++) (++) (++) ++ (++) (+) - - - 
              
Tricholoma  C n.t n.t n.t + - n.t + + n.t n.t n.t n.t 
columbetta D n.t n.t n.t ++ - n.t + + n.t n.t n.t n.t 
 M n.t n.t n.t ++ ++ n.t ++ + n.t n.t n.t n.t 
              
Melanoleuca  C (++) (+) (+) - - - - - - (++) (+) (+) 
cinereifolia M - - - - - - + - - - - - 
              
Clitocyb D (++) (+) (+) - - - (++) (++) (+) - - - 
odora M (+) (+) (+) (++) (+) (+) (++) (+) (+) (++) (+) (+) 
              
Amanita C - - - - - - (++) (+) (+) - - - 
avoidea D - - - - - - ++(++) (+) (+) (++) (+) (+) 
 M ++ + + (++) (+) - (++) (+) (+) - - - 
              
Cortinarius                            C - - - (++) (+) (+) (+) - - - - - 
suberetorum M - - - - - - - - - (++) (+) - 
              
Cortinarius  D ++ (++) (+) (++) (++) (++) ++ +(++) +(++) - - - 
infractus M (+) (+) (+) (++) (++) (++) ++(+++) +(++) (++) (++) (++) (++) 
              
Russula  D - - - - - - - - - - - - 
badia M - - - +(++) +(++) (+) + - - (++) (+) - 
              
Lactarius  D - - - - - - ++ + + - - - 
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Botanical 
name 
fraction   Staphylococcus aureus Bacillus cereus Pseudomonas aeruginosa          Escherichia coli  
  20  
mg/mL 
10 
 mg/mL 
5  
mg/mL 
20  
mg/mL 
10  
mg/mL 
5  
mg/mL 
20  10 5 
mg/mL   mg/mL  mg/mL 
20  
mg/mL 
10  5 
mg/mL mg/mL 
 
mg/mL 
  
vinosus M + + + - - - (++) (+) (+) (++) (++) (+) 
              
Phaeolus  C n.t n.t n.t ++ + n.t + + n.t n.t n.t n.t 
schweinitzii D n.t n.t n.t +++ + n.t + - n.t n.t n.t n.t 
 M n.t n.t n.t +++ +++ n.t +++ +++ n.t n.t n.t n.t 
              
Inonotus  C n.t n.t n.t + + n.t + + n.t n.t n.t n.t 
hispidus D n.t n.t n.t + + n.t + + n.t n.t n.t n.t 
 M n.t n.t n.t ++ + n.t +++ ++ n.t n.t n.t n.t 
 W n.t n.t n.t - - n.t ++ +     
              
Hydnellum  C n.t n.t n.t - - n.t - - n.t n.t n.t n.t 
ferrugineum D n.t n.t n.t + + n.t - - n.t n.t n.t n.t 
 M n.t n.t n.t - - n.t +++ ++ n.t n.t n.t n.t 
              
Control C - - - - - - - - - - - - 
 D - - - - - - - - - - - - 
 M - - - - - - - - - - - - 
 W - - - - - - - - - - - - 
C, cyclohexane; D, dichloromethane; M, methanol; W: water; n.t: not tested; –: No inhibition zone. +: Inhibition zone 7-10 mm. ++: Inhibition 
zone 10-15 mm. +++: Inhibition zone >15 mm. (+): partial active zones 7-10 mm. (++): partial inhibition zone 10-15 mm. (+++): partial 
inhibition zone >15 mm. Fractions which did not form any inhibition zones at all applied concentrations and the tested bacteria:  A. menieri (C), 
A. fissuratus (C), A. coniferarum (C), L. litoralis (C), B. impolitus (D) M. cinereifolia (D), C. infractus (C), R. badia (C),  L. vinosus  (C); 
Fractions which were not tested in this assay: A. devoniensis (C, D), L. subolivaceus (C, D), C. odora (C), B. luridus (D), C. infractus (D) 
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Only a few reports on antimicrobial activity of some species tested in our 
studies are available. Previously reported for A. devoniensis dichloromethane and 
methanol extract were 10 mm and 20 mm inhibition zones against S. aureus; 8 mm 
and 10 mm against P. aeruginosa; 8 mm and 15 mm against  E. coli respectively 
(Suay et al., 2000). In our studies dichloromethane extract of A. devoniensis was not 
tested, although methanol extract demonstrated weaker activity and inhibition zones 
were 7-9 mm against S. aureus as well as E.coli, when P. aeruginosa and B. cereus 
were predominant. In reported studies MIC of B. lupinus methanol extract were 50 
mg/ml against S. aureus, 25 mg/ml against P. aeruginosa, and inactive against E. 
coli (Nikolovska-Nedelkoska et al., 2013), in our methanol extract B. lupinus MIC 
showed 5 mg/ml against the same bacteria, and was inactive against E. coli and P. 
aeruginosa. The reason for the dissimilarities could be the separate extraction 
methods, concentrations of microorganisms or dilutions of extracts, as well as 
cultivar, harvesting time, climatic conditions and other factors. Recorded studies of 
T. auratum dichloromethane and ethanol extracts showed similar antimicrobial 
activity against S. aureus (<10 mm inhibition zones), although methanol used as a 
solvent in these studies (Yamaç and Bilgili, 2006). Earlier studies noted similar 
antimicrobial activity of C. odora against Bacillus brevis with inhibition zones 7-9 
mm of intact extract and 10-15 mm of injured ethyl acetate extracts (Stadler and 
Sterner, 1998). Other records did not demonstrate any antimicrobial activity of 
methanol extract of C. odora (Suay et al., 2000) and essential oil of C. infractus 
(Beattie et al., 2010). 
3.2.2. Agar-overlay (TLC bioautography) technique on mushroom species 
Methanol extracts were fractionated by TLC bioautography assay and active 
substances were shown as clear zones on a violet background. Yellow MTT (3-(4,5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a tetrazole) is reduced to 
purple formazan in the mitochondria of living cells. This reduction takes place only 
when mitochondrial reductase enzymes are active, and therefore conversion can be 
directly related to the number of viable (living) cells. Clear zones and effectiveness 
of the compounds can be deduced as death of cells. The results obtained from 30 
methanolic mushroom species, where 17 extracts demonstrated potential activity are 
summarised in Table 3.4. Seven mushroom extracts were active against B. cereus; 
eleven extracts showed activity against E. coli and twelve mushroom extracts inhibit 
P. aeruginosa. Mushroom extracts that possessed antimicrobial activity of one 
active fraction constitute 54%; whereas extracts indicated two active fractions 
compose 47% of all tested extracts. Species of P. schweinitzii and I. hispidus 
showed considerable active inhibition zones with two fractions against E. coli and P. 
aeruginosa (Fig. 3.7); other tested species have not possessed the evident and bright 
zones with one or two active fractions that lead to moderate antimicrobial activity. 
Differences in tested methanol fractions determined due to low concentration, origin 
and structure of active substance influenced the antimicrobial potential on TLC 
plates. Various secondary metabolites such as alkaloids, flavonoids and phenols of 
the mushrooms may be attributed to the presence of antimicrobial activity in the agar 
overlay technique. However, bioautography is a very convenient and simple way of 
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screening natural sources, especially with significant potential of biological active 
constituents on pathogenic microorganisms. 
 
 
 
Table 3.4 TLC bioautography antibacterial evaluation of mushroom extracts 
Botanical name Microorganisms 
B. cereus E. coli P. aeruginosa 
C. infractus  + + ++  
A. freirei - + ++  
A. menieri - - + 
C. odora - ++  - 
G. ammophilus - - + 
P. schweinitzii +  ++  ++  
I. hispidus - +    ++  
H. ferrugineum - + - 
C. glaucescens + + + 
A. fissuratus +  - ++ 
M. cinereifolia ++ + ++ 
A.coniferarum ++ + - 
T. auratum - - - 
S. halophile ++  - - 
P. schweinitzii               I. hispidus 
 
Fig. 3.7 P. schweinitzii and I. hispidus methanolic extracts inhibition zones against E. coli 
and P. aeruginosa 
P. schweinitzii               I. hispidus 
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Botanical name Microorganisms 
B. cereus E. coli P. aeruginosa 
A. ovoidea - - + 
A. devoniensis - + ++ 
C. suberetorum 
Control (methanol) 
- 
- 
++ 
- 
++ 
- 
+ one active fraction; ++ two active fractions; 
 
Although the separation of natural products can sometimes be a challenge, 
and if the separated amount is very low in many cases, usually it is necessary to 
develop a process that can detect a small amount of substances and measure the 
biological activity at the same time (Dewanjee et al.) Considering these problems the 
bioautographic detection technique combined together with other antimicrobial 
assays is one of the solutions. 
3.2.3. Biological properties of mushroom extracts
1
 
To identify new and potent antileishmanial agents, the mushrooms extracts 
were screened against L. infantum amastigotes. The inhibitory concentration 50% 
(IC50), cytotoxic concentration, which reduced 50% of cell viability, and selectivity 
index (SI) are reported in Table 3.5. Amphotericin B was used as the control drug. 
In the results obtained for 80 extracts isolated from 30 mushroom species, only 43 
extracts from 21 species showed activity. Ten extracts (G. ammophilus (C), B. 
impolitus(C), B. luridus (C, D, M), S. halophila (C, D), C. suberetorum (M) and C. 
infractus (C, D)) displayed IC50 values less than 10 µM and could be considered as 
active as amphotericin B. 
Generally, the most active effect was demonstrated in cyclohexane extract of 
G. ammophilus with an IC50 value 2.04 µg/ml also the cyclohexane and 
dichlorometane extracts of S. halophila with an IC50 value 4.37 µg/ml and 4.46 
µg/ml respectively. Species of B. impolitus (C), B. luridus (C, D, M), C. infractus 
(C, D) and C. suberetorum (M) possessed lower antileishmanial activity against 
amastigotes. Species of A. freirei (C, D), L. litoralis (C, D), G. ammophilus (D), B. 
lepidus (C, M), B. impolitus (D), T. focale (M, D), T. caligatum (C), C. odora (D) 
and C. suberetorum (C) demonstrated only moderate efficacy. Most of the other 
fractions remained weakly active in the range 15.17 µg/ml (L. litoralis (C)) to 60.29 
µg/ml (A. pseudopratensis (D)) or were inactive on amastigotes, such as L. infantum. 
The antileishmanial activity indicated 40% dichloromethane, 37% cyclohexane and 
23% methanol extracts from all tested mushroom species. 
 
Table 3.5 In vitro antileishmanial activities against amastigotes of L. infantum and 
cytotoxicity evaluation 
                                                     
1
Pharma Dev, Université de Toulouse, IRD, UPS 
Botanical name Fraction Amastigote (L. 
infantum) 
IC50 µg/ml 
Macrophage 
(cytotoxicity) 
CC50 µg/ml 
SI 
(selectivity index) 
A. menieri C 21.83 >100 >4.58 
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C, cyclohexane; D, dichloromethane; M, methanol; Amphotericin B: reference drug for 
antileishmanial tests; IC50 values (concentrations inhibiting parasite growth by 50%); CC50 
values (50% cytotoxicity concentration); 
a
IC50 and 
b
CC50 values are represented as average of 
at least duplicate measurements (SD 10%); 
c
SI (selectivity index) = CC50/IC50. 
 
The cytotoxicity influence on mouse macrophage cell line was evaluated for 
tested species in parallel because macrophages are the host cells of amastigotes in 
Botanical name Fraction Amastigote (L. 
infantum) 
IC50 µg/ml 
Macrophage 
(cytotoxicity) 
CC50 µg/ml 
SI 
(selectivity index) 
A. pseudopratensis D 60.29 >100 >1.66 
A. freirei C 11.39 >100 >8.78 
 D 10.89 >100 >9.18 
 M 90.96 >100 >1.10 
A. devoniensis D 58.06 >100 >1.72 
A. coniferarum C 40.46 >100 >2.47 
 D 31.76 >100 >3.15 
L. litoralis C 12.89 >100 >7.76 
 D 15.17 74.25 4.89 
L. subolivaceus C 73.06 >100 >1.37 
 D 43.20 >100 >2.31 
S. subvolvatus M 44.04 >100 >2.27 
G. ammophilus C 2.04 >100 >49.02 
 D 10.18 >100 >9.82 
B. lepidus C 13.03 >100 >7.67 
 M 12.84 >100 >7.79 
B. impolitus C 7.10 >100 >14.08 
 D 10.21 >100 >9.79 
 M 64.85 >100 >1.54 
B. luridus C 8.60 >100 13.21 
 D 6.54 78.81 12.05 
 M 8.58 >100 >11.68 
S. halophila C 4.37 >100 >22.88 
 D 4.46 >100 >22.42 
 M 46.66 >100 >2.14 
T. focale C 29.48 87.04 2.95 
 M 14.00 >100 >7.14 
T. auratum D 14.08 23.12 1.64 
T. caligatum C 14.55 >100 >6.87 
 D 20.22 >100 >4.95 
 M 161.96 >100 >0.62 
C. odora C 17.64 >100 >5.67 
 D 12.74 >100 >7.85 
C. suberetorum C 13.35 >100 >7.49 
 D 16.59 >100 >6.03 
 M 6.72 >100 >14.88 
A. infractus C 8.00 >100 >12.50 
 D 9.81 >100 >10.19 
P. schweinitzii C 22.66 >100 >4.41 
 D 22.72 >100 >4.40 
I. hispidus D 53.17 >100 >1.88 
 M 61.00 >100 >1.64 
Amphotericin B  0.28 30.94 110.5 
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the definitive host organism. In order to identify fractions that were less toxic to 
mouse macrophage cell and at the same time selected as relevant clinical drug 
against L. infantum amastigotes, cytotoxcicity evaluation was necessary. CC50 
values ranged from 23.13 (T. auratum (D)) to more than 100 µg/ml for most of the 
extracts (Table 3.5) which reduced 50% of cell viability. Only the four fractions T. 
auratum (D), L. litoralis (D), B. luridus (D) and T. focale (C) had cytotoxicity less 
than 100 µg/ml (23.12, 74.25, 78.81 and 87.04 µg/ml respectively). The selectivity 
index (SI) was calculated as the ratio of cytotoxicity (CC50 value on mouse cells) to 
activity (IC50 value on amastigotes). This in vitro selectivity index showed that 
fraction G. ammophilus (C)(SI = 49) possessed the better selectivity profile than in 
research on species A. blazei water extract with lower selectivity index (SI = 42) 
against L. chagasi, the use of this mushroom has been associated with folk medicine 
in the treatment of some diseases, such as leukaemia, cancer, and arterial 
hypertension
 
(Valadares et al., 2012). Moderate efficacy selectivity index were 
found in S. halophila (C, D)(SI = 22, SI = 22), in contrast, weaker activity was 
possessed by C. suberetorum (M, SI = 14.88), B. impolitus (C, SI = 14) and B. 
luridus (C, SI = 13), other species obtained a very low selectivity index explaining 
that they were less suitable for parasite L. infantum or active compounds in fractions 
are in micro concentrations. Fractions that exhibited good to moderate 
antileishmanial activity have to be investigated to explain promising activities. 
The results obtained for 90 extracts isolated from 30 mushroom species 
described antibacterial and biological in vitro activity. 89% of mushroom fractions 
possessed antimicrobial activity and expressed a minimal inhibitory concentration 
with listed inhibition zones. The methanol extracts from P. schweinitzii, I. hispidus 
and C. infractus possessed the most powerful antimicrobial activity in disc diffusion 
assays. The tested mushroom species showed greater antibacterial activity against 
Gram-positive than Gram-negative bacteria. Among all the tested mushroom 
extracts only 68% were biologically active as antileishmanial agents. Mushroom 
species G. ammophilus (C) and S. halophila (C, D), exhibited potent selectivity 
index. Based on the obtained data P. schweinitzii was chosen as the research object 
for further detailed analysis. 
3.3. ISOLATION AND IDENTIFICATION OF SECONDARY 
METABOLITES IN METHANOLIC EXTRACT FROM PHAEOLUS 
SCHWEINITZII (FR.) 
In a comprehensive evaluation of wild mushrooms grown in the Midi-
Pyrénées region of France for their antioxidant, antimicrobial and biological 
properties, it was found that the methanol extract of Phaeolus schweinitzii (Fr.) 
distinguished a strong capacity in all tested assays. Previously published data are 
particularly lacking the main components, which are responsible for the superior 
activity. The aim was to identify the major compounds of methanolic extract of 
Phaeolus schweinitzii with the assistance of chromatographic assays. 
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3.3.1. Detection of secondary metabolites by thin layer chromatography 
In analytical practice thin layer chromatography (TLC) is still one of the 
commonly applied methods for fast qualitative and quantitative analysis as well as 
screening of target substances from natural samples (Zarzycki et al., 2011).  
The TLC method gives quick access for localisation, detection and 
categorisation of the compounds in complicated fractions (Kaale, Risha and Layloff, 
2011). A test was carried out on three silica gel 60 F254 TLC plates (10.0 × 2.0 cm) 
in order to locate and select the category of compounds. First, 10 µl of methanol 
extract was developed in the solvent system Chloroform/methanol/water (65:45:10). 
The TLC plates were then carefully dried; absorbing spots were detected at 254 and 
366 nm and covered with three different reagents Fig. 3.8. 
Two coloured zones were detected: their Rf values were found to be 0.5 and 
0.85. On comparing the results with TLC plates acquired in UV (254 and 366 nm) 
and a plate sprayed with Neu reagent (after heating att 110 °C under UV 254 and 
visible light) for the detection of flavonoids (Fig. 3.8, mode 2) and a TLC plate 
observed in vanillin/sulfuric acid vapour (Fig. 3.8, mode 1) under visible light for 
the detection of all organic metabolites such as steroids and terpenoids, it was 
possible to establish the exact position of two active coloured substances.  
 
 
 
 
 
Dragendorff’s reagent has not exposed the activity of alkaloids or substances 
with nitrogen atom (Fig. 3.8, mode 3) and orange-brown spots have not been 
observed. 
1 1 3 2 2 3 
Fig. 3.8 P. schweinitzii methanol extract on TLC plates (visible light): detection mode (1) TLC 
exposed with vanillin/sulfuric acid; (2) TLC exposed with Neu reagent; (3) TLC exposed with 
Dragendorff reagent. 
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3.3.2. Detection of secondary metabolites by TLC-DPPH
• 
bioautography 
The TLC-DPPH
•
 assay belongs to a group of frequently performed methods 
aimed at the detection of compounds with effective direct activity. Thin layer 
chromatography assay plates are developed and sprayed with DPPH
• 
reagent in 
methanol for antioxidant screening. It enables visualisation of separated spots 
exhibiting antioxidant activities and localisation of potential substances (Głód et al., 
2015). This method has several advantages: direct access to separated compounds, 
high throughput, flexibility and the possibility to assess the activity of individual 
compounds found in complex samples, it also allows the rapid dereplication of 
known active compounds and others (Cieśla et al., 2012). In the assay DPPH• 
scavenging activity was observed visually as white yellow spots on a purple 
background. Figure 3.9 (modes 6 and 7) shows a profile of the antioxidant 
components in the methanol extract of P. schweinitzii under visible light. Two main 
spots Rf = 0.5 and Rf = 0.85 in the silica gel plates were observed to have DPPH
• 
scavenging activities, which are identical in spite of their Rf values differing slightly 
between detection modes (Fig. 3.9). The same TLC plate was also inspected under 
visible light after 60 min (Fig. 3.9 mode 7). Note that the same two antioxidant spots 
were observed, with other intangible substances exposed on TLC plate. However, 
these differences were exposed due to the diverse nature and capacity of the 
antioxidative compounds.  
Ueno (Ueno et al., 1964) reported on the separation and isolation of hispidin 
from acetone extract of P. schweinitzii. A paper chromatographical investigation 
was used and hispidin possessed the Rf = 0.4 value. Accordingly, in our research of 
two antioxidative active hispidin derivatives in the methanol extract of P. 
schweinitzii was postulated. 
3.3.3. Isolation of active substances from P. schweinitzii 
Silica gel chromatography has been used for fractionating the methanol extract 
of P. schweinitzii. The extract impregnated with silica gel was subjected to silica gel 
chromatography using dichloromethane/methanol gradient elution (98:2, 95:5, 
90:10, 85:15, 70:30, 60:40, 50:50, 40:60, 30:70. 20:80, 10:90, 0:100, v/v) give 52 
fractions. Each fraction was tested with TLC silica gel chromatography and mainly 
combined to 7 fractions. Fraction 1 was chromatographed over Sephadex LH-20 
eluted with methanol and further purified by preparative HPLC to afford compound 
1 (3.9 mg) and compound 2 (2.7 mg). Fraction 3 was eluted with Sephadex LH-20 to 
obtain compound 3 (25.7 mg) (Fig. 3.10).  
3.3.4.Purification and structure elucidation of active compounds 
For further experiments fraction 1 of P. schweinitzii was used. In order to 
create preparative HPLC method for optimal isolation of active substances from 
methanol fraction, an analytical column XBridge 5 µm (4.6 i.d. × 150 mm) was 
used. A wavelength of 377 nm proved to be the optimal monitoring wavelength. The 
program developed was scaled up successfully to preparative column XBridge 5 µm 
(19 i.d. × 150 mm). 
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Fig. 3.9 P. schweinitzii methanol extract on TLC plate detection mode: (1) TLC under UV light 
366 nm; (2) TLC under UV light 254 nm; (3) TLC exposed with Neu reagent under visible light; (4) 
TLC exposed with Neu reagent under UV light 366 nm; (5) TLC exposed with Neu reagent under UV 
light 254 nm; (6) TLC exposed with DPPH• reagent under visible light, after 1 min; (7) TLC exposed 
with DPPH• reagent under visible light, after 30 min 
 
 
 
  
 
 
 
 
Compound 3 
Compound 1 
Compound 2 
 
 
Fig. 3.10 P. schweinitzii methanol extract on TLC plate under visible light; mode 1: TLC plate 
under UV 366 nm; mode 2: TLC plate under visible light. 
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Two main peaks were detected on the HPLC preparative chromatogram: 3.25 
and 3.93 minute peaks corresponded to the spot Rf = 0.85 and indicated two 
compounds. A 15 minute run flow of 20 ml/min was sufficient for separation of both 
substances. Both compounds were collected and concentrated under reduced 
pressure, after solvent residue was removed with nitrogen flow. Isolates were re-
subjected into UPLC-QTOF MS to check the purity and identify molecular mass in 
positive ion mode (Fig. 3.11 and 3.12). The separated compound 1 had UV 
adsorption maxima at 256 and 370 nm, Rt = 1.1 min and compound 2 adsorption 
maxima at 243 and 377 nm, Rt = 1.3 min. The purity and quantity of isolated 
compounds was sufficient for further NMR and MS experiments.  
MS (ESI in negative ion mode) and several NMR techniques (
1
H, 
13
C, H, H-
COSY, HMBC and HSQC) were used for the structure elucidation of all isolated 
compounds. 
For the first NMR analysis, deuterated methanol was chosen to dilute all 
compounds. It is worth mentioning that improved structure decomposition was 
observed and described for all compounds in deuterated dimethyl sulfoxide 
(DMSO). 
 
 
 
 
 
 
 
 
 
 
 
Compound 2 
Compound 1 
Fig. 3.11 QTOF MS chromatogram of P. schweinitzii purified fraction, compound 2. 
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3.3.5. Structure elucidation of hispidin (compound 3) 
This compound was the major yellow powder from methanol fraction 3 of P. 
schweinitzii. 27.5 mg of pure substance was gained from 2 g methanol fraction and 
purified as described above. Its chemical composition was determined by high 
resolution MS analysis. For ionisation, electrospray (ESI) was used in negative 
mode. As can be seen from Figure 3.13, this high resolution negative ion mode ESI 
spectrum shows a characteristic ion series and compound fragmentation mechanism 
at 35.00 V magnetic field. The ion m/z = 245.05 [M-H]-, with molecular formula 
C13H10O5 derived from ESI-MS/MS spectrum, which indicated fragment ions at m/z 
= 201, 159 and 135 corresponding to the proposed structures drawn in Fig. 3.13.  
The 
1
H NMR spectrum indicated signals attributable to a trisubstituted phenyl 
moiety at  6.78 (1H, d, J = 8.2 Hz, H-13), 6.96 (1H, dd, J = 8.2, 2.1 Hz, H-14), 7.05 
(1H, d, J = 2.1 Hz, H-10), a trans di-hydrogenated double bond at  6.70 (1H, d, J = 
16.0 Hz, H-7) and 7.15 (1H, d, J = 16.0 Hz, H-8) and two constituent protons -
lactone heterocyclic rings at  6.17 (1H, d, J = 2.0 Hz, H-5) and 5.29 (1H, d, J = 2.0 
Hz, H-3). Also three exchangeable hydroxyl phenolic protons at  9.21, 9.53. 11.0. 
13
C NMR data analysis revealed the 13 carbon signals (from which oxygenated 
are C-4 ( 171.0), C-11( 146.1) and C-12 ( 147.9)) and a carboxyl carbon at  
163.5 ppm. The proton signals following respectively with 
13
C data (ppm): H-7 ( 
6.70) with C-6 ( 160.2) and C-5 ( 101.0), H-5 ( 6.17) with C-3 ( 91.0), C-4 ( 
171.0), C-6 ( 160.2) and C-7 ( 118.4), H-3 ( 5.29) with C-2 ( 163.5), C-4 ( 
171.0) and C-5 (101.0) the spectra were identical to literature reports (Singh et al., 
2003) and enabled the identification of 6-(3,4-dihydroxystyryl)-4-hydroxy-2-pyrone, 
also known as hispidin (Fig. 3.14).  
Fig. 3.12 MS + spectra of P. schweinitzii purified fraction, compound 2 
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Fig. 3.13 Negative ESI spectrum and fragmentation pattern of compound 3 isolated from 
P. schweinitzii extract 
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In literature hispidin was first detected in Inonotus hispidus (Polyporus 
hispidus) (Edwards, Lewis and Wilson, 1961) and the structure confirmed by 
Edward and Wilson (Edwards and Wilson, 1961). Afterwards it has been found in 
various related fungal species, such as Inonotus xeranticus, Phellinus linteus (Jung 
et al., 2008) and Gymnopilus spectabilis (Lee et al., 2008b). Hispidin has been 
shown to possess antioxidant activity by inhibiting lipid peroxidation in rat liver 
homogenates (Khushbaktova et al., 1996, Lee and Yun, 2007 and Park et al., 2004), 
to inhibit protein kinase C (PKC) and to possess cytotoxicity against cancer cells 
(Gonindard et al., 1997). Also, hispidin can protect against peroxynitrite-mediated 
cytotoxicity, DNA damage and hydroxyl radical formation (Chen et al., 2012). 
3.3.6. Structure elucidation of hispolon (compound 1) 
The pale yellow pigment can be observed on TLC with Neu reagent, resulting 
in an orange colour under visible light, which indicates the presence of phenolic 
compounds and shows as bright fluorescence under UV 366nm. Compared to 
hispidin, compound 1 shows very similar 
1
H NMR signals of three aromatic and two 
trans-oleofinic protons belonging to the styryl residue. The data of 1H NMR spectra 
are listed as follows (ppm): 2.13 (3H, s, H-1), 5.80 (1H, s, H-4), 6.40 (1H, d, J = 
15.7 Hz, H-5), 7.47 (1H, d, J = 15.7 Hz, H-6), 7.05 (1H, d, J = 2.1, H-8), 6.78 (1H, 
d, J = 7.9Hz, H-11), 6.96 (1H, dd, J = 2.1, 7.9 Hz, H-12) and exchangeable hydroxyl 
phenolic protons at  9.24, 9.56 the spectra were in correlation to literature reports 
(Wang et al., 2014b). 
From the negative ion ESI MS spectrum a characteristic ion series and 
compound 1 fragmentation mechanism can be observed at 35.00 V magnetic field. 
The ion at m/z = 219.1 was interpreted [M-H]-, with the molecular formula C12H12O4 
and the ESI-MS/MS spectrum, of the m/z = 219 ion indicated the characteristic 
fragment ion at m/z =135 base peak (Fig.3.15) 
 
Fig. 3.14 Compound 3 (hispidin (6-(3,4-dihydroxystyryl)-4-hydroxy-2-pyrone)) fragmentation 
mechanism isolated from P. schweinitzii extract 
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At this stage the data obtained for compound 1 were compared to the literature 
and were found to be congruent with the results published by Ali et al., (1996) for a 
compound named hispolon (Fig. 3.16) (6-(3, 4-Dihydroxyphenyl)-4-hydroxyhexa-
3,5-dien-2-one) firstly isolated from the mushroom Inonotus hispidus. However, 
hispolon was first isolated from P. schweinitzii in our research. Also isolated from 
many Phellinus and Inonotus species (Mo et al., 2004, Wang et al., 2014b), hispolon 
was synthesised in several research groups (Venkateswarlu et al., 2002, Ravindran et 
al., 2010). 
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Fig. 3.15 Negative ion ESI spectrum and fragmentation pattern of compound 1 isolated from P. 
schweinitzii extract. 
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Hispolon has antioxidant, anti-inflammatory, analgesic and antiproliferative 
effects and inhibited cell growth or metastasis in various types of tumour cells (Mo 
et al., 2004, Chen et al., 2008, Chen, He and Li, 2006, Lu et al., 2010 and Huang et 
al., 2011a). Further experiments reported that hispolon inhibits foot paw oedema in 
mice (Chang et al., 2010). It protects against acute liver damage in rats by inhibiting 
lipid peroxidation, pro-inflammatory cytokine and oxidative stress (Huang et al., 
2011b). Therefore, scientist suggest that hispolon has the potential to treat hyper-
pigmentation diseases and melanoma skin cancer in the future (Chen et al., 2014) 
3.3.7. Structure elucidation of inonotic acid methyl ester (compound 2) 
The yellow oily compound 2 can be observed on the TLC plate with Neu 
reagent resulting in a strong purple colour. The negative ion ESI MS spectrum 
showed molecular mass ion peak at m/z = 276.97 [M-H]- in good agreement with 
molecular formula C14H14O6 (Fig. 3.18). The ESI-MS/MS fragmentation of 
compound 2 indicated peak fragment ions at m/z = 245 and m/z = 201 similar to 
fragment ions previously described for hispidin. 
 
 
 
 
Fig. 3.16 Structure of hispolon (6-(3, 4-Dihydroxyphenyl)-4-hydroxyhexa-3,5-dien-2-one, compound 1) 
Fig. 3.17 Compound 2 fragmentation pattern isolated from P. schweinitzii extract 
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The high-resolution mass spectrometry in positive ion mode established the 
chemical formula of compound 2 as C14H14O6 with a molecular ion [M+H]
+
 = 
279.0869 and C14H14O6Na [M+Na]
+
 = 301.0688. The ESI-MS/MS fragmentation of 
compound 2 indicated peak fragments ions at m/z = 89.03, 107.05, 117.03, 135.04, 
145.03 and 163.04 (Fig. 3.17, 3.18). 
The 
1
H NMR also showed spectrum attributable to trisubstituted phenyl 
moiety at  6.77 (1H, d, J = 8.0 Hz, H-13), 7.00 (1H, dd, J = 8.0, 1.8 Hz, H-14), 7.07 
(1H, d, J = 1.8 Hz, H-10), a trans di-hydrogenated double bond at  6.51 (1H, d, J = 
15.8 Hz, H-7) and 7.44 (1H, d, J = 15.8 Hz, H-8) as well as protons at  5.91 (1H, s, 
H-5), 3.56 (2H, s, H-3) 3.65 (3H, s, H-1). The 13C NMR spectrum indicated 14 
carbons and following the analysis of the heteronuclear two-dimensional HSQC 
spectrum, it was possible to assign protons with their corresponding carbons and 
their multiplicity. The interpretation of the HMBC spectrum showed long range H-C 
correlations of H-10 ( 7.07) with C-8 ( 141.08), C-11 ( 148.51), C-12 ( 145.67), 
C-14 ( 121.62), the correlation of H-13 ( 6.77) with C-9 ( 126.19), C-11 ( 
148.51), C-12 ( 145.67), C-14 ( 121.62) and the correlation of H-14 ( 7.00) with 
C-8 ( 141.08), C-10 ( 114.73), C-11 ( 148.51), C-13 ( 115.82) revealing an 
ortho substitution of the phenolic hydroxyl protons (Fig. 3.19). Also correlation of 
H-8 ( 7.44) with C-6 ( 177.81), C-10 ( 114. 73), C-14 ( 121.62) and other trans 
di-substituted proton H-7 ( 118.62) correlated with C-6 ( 177.81), C-9 ( 126.19), 
Fig. 3.18 ESI MS and ESI-MS/MS spectra of compound 2 isolated from P. schweinitzii extract 
(from top to bottom: +ESI MS, -ESI MS, -ESI MS
2 
of m/z=277, ESI MS
3
 of m/z 277>243). 
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C-13 (115.82). Proton H-5 ( 5.91) correlation with C-6 ( 177.81) and C-7 ( 
118.62). The spectra were correlated to literature reports (Wangun et al., 2006). 
The other correlations illustrated in Figure 3.19 lead us to assign all atoms, 
particularly methylene H-3 ( 3.56), between the two keto groups C-2 ( 168.01), C-
4 ( 192. 03), C-5 ( 100.56) and the position of the methoxy residue H-1’ ( 3.65) 
with C-2 ( 168.01). 
 
 
 
 
 
Thus compound 2 was assigned as 7-(3,4-dihydroxyphenyl)-5-hydroxy-3-oxo-
hepta-4,6-dienoic acid methyl ester (Fig. 3.20) and differs from hispolon by the 
presence of a carboxymethyl ester group fixed on the terminal Me of hispolon. Only 
one paper describes this compound, named as inonotic acid methyl ester, isolation 
from Inonotus sp. with significant inhibitory activities against key enzymes involved 
in inflammatory processes (Wangun et al., 2006); however, without any information 
about this compound’s biological activity. Inonotic acid methyl ester was first 
isolated from mushroom P. schweinitzii in our research. 
 
 
 
 
 
 
The structures of isolated metabolites share the same biosynthetic origin (Fig. 
3.21). The compounds represent linear or cyclised polyketides derived from 
caffeoyl-CoA (Wangun et al., 2006) and may appear as biodegradation products. 
 
Fig. 3.19 HMBC associated protons to 
13
C-atoms and their multiplicity of inonotic acid 
methyl ester 
Fig. 3.20 Inonotic acid methyl ester (7-(3,4-dihydroxyphenyl)-5-hydroxy-3-oxohepta-4,6-
dienoic acid methyl ester, compound 2) 
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Three main compounds: hispidin, hispolon and inonotic acid methyl ester were 
isolated from methanolic extract of P. schweinitzii. Hispolon and inonotic acid 
methyl ester in mushroom P. schweinitzii are detected for the first time. Isolated 
compounds were used for further analysis in order to evaluated antioxidant and 
cytotoxicity properties.  
3.4. ASSESSMENT OF ANTIOXIDANT, BIOLOGICAL AND 
ANTIPHRASTIC ACTIVITY OF ISOLATED COMPOUNDS FROM P. 
SCHWEINITZII 
The search for novel bioactive molecules will be an ongoing task as long as we 
believe that pharmacologically active molecules are the answers for various humans 
and animals diseases. In the last decade the emergence of the modern 
pharmaceutical industry and the development of the wide range of effective medical 
and veterinary treatments trended to focus on natural resources. For example, the 
molecules derived from natural sources with possible protector agents reducing 
oxidative damage, which also may possess microbial, pharmacological or 
antiphrastic activity. These active compounds with “multi-functional” properties 
may have potential implications in industry. 
The aim was to determine isolated major compounds’ antioxidant and 
biological activities in several assays. Also, to examine the influence of P. 
schweinitzii and I. hispidus extracts collected at different mushroom harvesting 
Fig. 3.21 P. schweinitzii metabolites and their biosynthesis 
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periods and their isolated compounds inhibitory activity properties against 
gastrointestinal nematodes in vitro. 
3.4.1. Compound hispidin antioxidant activity  
The evaluation of the antioxidant activity of the isolated compound hispidin 
was performed on different types of methods and single electron/hydrogen atom 
transfer assays (SET or HAT) were used to obtain the desired results. 
Determination of antioxidant capacity with ORAC-FL assay 
ORAC assay uses a fluorescence-based principle (sometimes abbreviated as 
ORAC-FL) and measures a relative antioxidant index by using a hydrosoluble 
vitamin E derivative Trolox as a reference antioxidant. The exposition of the 
fluorophore, in this case fluorescein (FL), to the peroxyl radical conducts to an 
oxidation process reflected as a decay of fluorescence emission through time. In 
ORAC assay the loss of FL fluorescence generally corresponds to an induction time 
and is reliant on antioxidant capacity of a compound (Bisby, Brooke and 
Navaratnam, 2008) . Indeed, it refers to the time in which the FL is protected against 
the oxidative damage by peroxyl radicals and this behavior is associated to a 
competitive reaction between the radical and the antioxidant. The ORAC value 
encompasses the induction time, the initial rate and the range of total antioxidant 
inhibition. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.22 ORAC-FL decay curves induced by AAPH in the presence of hispidin at a concentration of 
6.25-50 µM/l. Insert: NetAUC vs. hispidin concentration graph 
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The presence of induction time in ORAC-FL profile by the addition of different 
concentrations of hispidin (6.25-50 µM/L) and Trolox is shown in figures: it may be 
observed that the kinetic profiles of hispidin (Fig. 3.22) are quite similar those of 
Trolox (Fig. 3.23). The ORAC values were obtained by plotting Net AUC vs. 
concentrations of hispidin (Fig. 3.22 insert). This is related to the time in which the 
Fig. 3.24 ORAC-FL decay curves induced by AAPH in the presence of Trolox and hispidin 
 
Fig. 3.23 ORAC-FL decay curves induced by AAPH in the presence of Trolox at a concentration of 
6.25-100 µM/l Insert: NetAUC vs. Trolox concentration graph 
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probe molecule of FL is protected against oxidation by peroxyl radicals, in the 
presence of increasing amounts of antioxidant molecule hispidin. Fig. 3.24 shows a 
better hispidin kinetic profile than Trolox and has a stronger oxidation protection 
stability. It was calculated that antioxidant capacity of 1 g of hispidin in ORAC 
assay is equivalent to 2.825 ± 0.7 mM TE/g, which is equal to 0.706 g of Trolox. 
Determination antioxidant capacity with DPPH
•
 assay 
DPPH
•
 assay is widely used as an easy and accurate chemical method for 
measuring the RSC of various substances. This is due to the electronic properties 
shared by DPPH
•
 and peroxyl radicals (the unpaired electron is delocalized through 
the pair of nitrogen or oxygen atoms, respectively), in such way that the reaction rate 
between DPPH
•
 and many antioxidants provides a good approximation for 
scavenging activities (Brand-Williams et al., 1995). Fig. 3.25 shows the percentage 
of DPPH
•
 scavenging activity of the hispidin solutions in comparison with similar 
concentration solutions of Trolox. It may be observed that both compounds 
demonstrated almost similar antioxidant activities at the concentrations applied: the 
percentage DPPH
•
 scavenging depending on the compound concentrations were in 
the ranges of 2.82-83.04% and 3.32-87.53% for trolox and hispidin respectively.  
The value of IC50 for hispidin showing its concentration needed to reduce 50% in the 
reaction present DPPH
•
 radical was measured 3.66 mM. It was calculated that 
antioxidant capacity of 1 g of hispidin in this assay is equivalent to 2.09 ± 0.04 mM 
TE/g, which is equal to 0.52 g of trolox.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.25 Reduction absorbance (%) of DPPH• radical scavenging activity of hispidin and Trolox. 
Insert: Reduction absorbance vs. hispidin concentration graph 
It was previously reported that RSC of hispidin in DPPH
•
 scavenging assay 
varied form 27-75% in the range of concentrations from 25-200 µM/L, which is 
higher than in our study (Han et al., 2013). The reason for these differences might be 
caused by the different DPPH
•
 and hispidin ratio used in the above-mentioned (1:40) 
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and our (1:1) study. Hispidin isolated from the cultured broth of the medicinal fungi 
Inonotus xeranticus and Phellinus linteus (Jung et al., 2008) exhibited strong 
antioxidant activity in DPPH
•
 and ABTS assays with TEAC expressed as IC50 of M 
compound/IC50 of µM Trolox of 1.31 ± 0.81 and 2.27 ± 0.71, respectively. In our 
study recalculated DPPH
•
 scavenging activity of hispidin for all concentrations and 
expressed as IC50 of M compound/IC50 of µM Trolox TEAC was even higher, 
0.99±0.06, which means that RSC of hispidin and trolox are quite similar. Hispidin 
glucoside was isolated from the Sword brake fern (Pteris ensiformis Burm.), the 
most common ingredient of traditional herbal drinks in Taiwan. Hispidin 4-O--D 
glucopyranoside (28.21±1.51 µM for reduction 50 % DPPH
•
 radical) demonstrated 
almost the same DPPH
•
 scavenging activity as reference antioxidants hispidin and 
-tocopherol (IC50 = 29.97±2.84 and  28.08±2.69 µM respectively) (Chen et al., 
2007). In our study used hispidin quantity, needed to reduce 50% in the reaction 
present DPPH
•
 radical, was 20% higher than in research group of Chen et al (2007). 
This potential activity indicates that the structure prerequisite to reinforce DPPH
•
 
scavenging is the catechol moiety, of hispidin. In addition to OH moieties in the 
structural arrangements, and the resonance of electrons between rings may also be 
an important factor for their DPPH
•
 scavenging activities.  
Determination antioxidant capacity with ABTS
•+
 assay 
The method is based on the capacity of a hispidin to inhibit (decolorize) the 
ABTS
•+
 in comparison with a reference antioxidant Trolox. In this
 
assay the decrease 
in absorbance was followed to monitor the consumption of the coloured ABTS˙+. 
Figure 3.26 shows ABTS˙+ RSC of hispidin and Trolox solutions at different 
concentrations, which were in the ranges of 1.57-73.83% and 1.20- 31.88%, 
respectively. Consequently, in this assay RSC of hispidin was significantly higher 
than that of Trolox, particularly at the higher compound concentration. It was 
calculated that antioxidant capacity of 1 g of hispidin in this assay is equivalent to 
7.27 ± 0.03 mM TE/g, which is equal to 1.81 g of trolox. The RSC of  hispidin 
isolated from I. xeranticus, P. linteus and G. spectabilis in ABTS˙+ assay expressed 
as IC50 of M compound/IC50 of µM Trolox was reported 2.72 ± 0.71 (Jung et al., 
2008; Lee et al., 2008); thus in our study, in terms of IC50 the recalculated RSC of 
hispidin in ABTS˙+ was higher (the lower the IC50 the higher RSC) more than three 
times (TEAC = 0.76 ± 0.08 expressed as IC50 of M compound/IC50 of µM Trolox). 
In other study TEAC values for hispidin glucoside isolated from G. spectabilis and 
reference compound hispidin expressed in mL trolox having the antioxidant 
equivalent to 1.0 mM of the tested compound were reported 0.85 ± 0.44 and 0.91 ± 
0.02 mM (Chen et al., 2007).  It is worthy of noting that TEAC of hispidin, which 
has part of caffeoyl moiety were are hydroxyl groups para and ortho substituted on 
an aromatic ring, was similar to the TEAC of caffeic acid. The similarities with 
caffeic acid (3,4-dihydroxycinnamic acid) which are identified as one of the active 
antioxidant explain the potent activity of hispidin (Gülçin, 2006). 
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Fig. 3.26 Reduction absorbance (%) of ABTS˙+ antioxidant capacity of hispidin and Trolox. Insert: 
Reduction absorbance vs. hispidin concentration graph 
 
The RSC of  hispidin isolated from I. xeranticus, P. linteus and G. 
spectabilis in ABTS˙+ assay expressed as IC50 of M compound/IC50 of µM Trolox 
was reported 2.72 ± 0.71 (Jung et al., 2008; Lee et al., 2008); thus in our study, in 
terms of IC50 the recalculated RSC of hispidin in ABTS˙
+ 
was higher (the lower the 
IC50 the higher RSC) more than three times (TEAC = 0.76 ± 0.08 expressed as IC50 
of M compound/IC50 of µM Trolox). In other study TEAC values for hispidin 
glucoside isolated from G. spectabilis and reference compound hispidin expressed in 
mL trolox having the antioxidant equivalent to 1.0 mM of the tested compound were 
reported 0.85 ± 0.44 and 0.91 ± 0.02 mM (Chen et al., 2007).  It is worthy of noting 
that TEAC of hispidin, which has part of caffeoyl moiety were are hydroxyl groups 
para and ortho substituted on an aromatic ring, was similar to the TEAC of caffeic 
acid. The similarities with caffeic acid (3,4-dihydroxycinnamic acid) which are 
identified as one of the active antioxidant explain the potent activity of hispidin 
(Gülçin, 2006). 
Determination antioxidant capacity on FRAP assay 
The ferric reducing antioxidant power (FRAP) assay measures the reduction of 
ferric iron (Fe
3+
) to ferrous iron (Fe
2+
) in the presence of antioxidants, which are 
reductants with half-reaction reduction potentials above Fe
3+
/Fe
2+
 (Gliszczyńska-
Świgło, 2006). In the FRAP assay  hispidin revealed significantly stronger potential 
to reduce Fe
3+
 to Fe
2+
 than trolox at all applied concentrations (Fig. 3.27): whereas 
activity varied between 11.70- 49.71%, and trolox 8.77- 20.18%. The antioxidant 
capacity value of the hispidin expressed as trolox equivalents was 15.54 ± 0.2 mM 
TE/g. The maximal inhibitory concentration needed to reduce 50% of Fe
3
 radicals is 
194.37±3.28 M/l of hispidin.  
y = 0,0731x + 0,5502
R2 = 0,9989
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Fig. 3.27 Reduction absorbance (%) of FRAP reducing antioxidant power of hispidin and Trolox. 
Insert: Reduction absorbance vs. hispidin concentration graph 
The maximal inhibitory concentration needed to reduce 50% of Fe
3
 radicals is 
194.37±3.28 M/l of hispidin. 
By using DPPH
•
, ABTS
•+
, FRAP, ORAC were assessed the free radical 
scavenging efficacy of hispidin. The results were expressed as the maximum 
inhibitory concentration needed to inhibit 50% free radicals. Although the 
antioxidant activity of hispidin is known, its antioxidant single electron and 
hydrogen atom transfer assay is yet to be determined. DPPH
•
 and ABTS
•+ 
scavenging activity data parallel those described with the literature source, FRAP 
and ORAC data were estimated for the first time. The antioxidant efficacy of 
hispidin may originate from the catechol moiety. It has been recommend that a good 
antioxidant must have low O-H bound dissociation enthalpy to simplify the H-
abstraction from the radical and the hydrogen-transfer process must be stable, which 
is generated by the radical (Zhang, Sun and Wang, 2003). Lower bond dissociation 
enthalpy value contributes to the O-H group in the ortho-diphenol moiety also 
stabilising the radical form and has possible changes in the antioxidant capacity 
(Wright et al., 2001). Similarly, antioxidant activity may be affected by the intra-
molecular hydrogen bonds that can exist in the catechol moiety and the inter-
molecular hydrogen bonds between functional groups that involve polar solvents. In 
all tested assays hispidin, with the catechol moiety, exhibited similar or more potent 
activity than Trolox. Results show that hispidin was an effective antioxidant in 
different in vitro antioxidant assays.  
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3.4.2. Isolated compounds and P. schweinitzii and I. hispidus extracts biological 
activity  
3.4.2.1. Determination of antileischmanial and cytotoxicity activity of isolated 
compounds 
2
 
Leishmaniasis is one of the world most fatal diseases, which occurs in 98 
mainly tropical countries. 350 Million people are considered at risk of contracting 
leishmaniasis, and over 2 million new cases occur each year. (Marín et al., 2013). 
Leishmaniasis is caused by kineto-plastid protozoan infection from the Leishmania 
genus parasites that affects both human, other mammal species and is transmitted 
through sand-flies (Elmahallawy et al., 2014). Only a limited number of effective 
antileishmanial agents are available for chemotherapy (sodium stibogluconate, 
pentostam, meglumine antimoniate, glucantime, amphotericin B and pentamidine, 
paromomycin) and many of them are expensive with several side effects or have a 
markedly reduced effectiveness due to the development of drug resistance. Thus, the 
development of novel less toxic antileishmanial drugs is an important goal. In this 
concept, several compounds including synthetic ones, or natural products extracted 
from plants or marine sources, have shown different degrees of efficacy in the 
experimental treatment of leishmaniasis (Machardo et al, 2012; Marín et al., 2013)  
Searching for valuable bioactive substances isolated compounds from P. 
schweinitzii were evaluated the antiproliferative in vitro activity against of L. 
infantum promastigote forms. In parallel the cytotoxicity influence on a mouse line 
was evaluated for hispidin, hispolon and inonotic acid methyl ester. Amphotericin B 
was chosen as the antileishmanial reference-drug, and Doxorubicin used as a 
positive control of cytotoxicity.  All molecules were first screened in vitro on the 
promastigote stage of L. infantum by determining their inhibitory concentrations 
50% (IC50) and comparing them to the one of amphotericin B. In order to assess 
their selectivity of action, the tested molecules were also evaluated in vitro as 
regards their cytotoxicity, measured by the cytotoxic concentrations 50% (CC50) on 
the murine J774A.1 macrophages cell line, giving access to the corresponding 
selectivity indexes (SI = CC50/IC50). The results are presented in Table 3.6. 
Table 3.6 Compounds antileishmanial and cytotoxicity activity 
 L. infantum 
Promastigotes IC50, (µM)
a 
J774A.1 
CC50, (µM)
a 
IS 
(CC50/IC50) 
Hispidin 76.92±13.16 >100 >1.3 
Hispolon 55.03±3.18  18.84±0.28 0.34 
Inonotic acid methyl ester 53.88±4.17 28.48±1.42 0.53 
Amphotericin Bb 0.03±0.01  2.47±0.24  82.33 
Miltefosinb 8.83±2.77 155.63±15.25  17.63 
Pentamidineb 0.51±0.28  0.53±0.57  1.04 
Doxorubicinc - 0.06±0.04  - 
a: Mean of three independent experiments; b: Miltefosine, Pentamidine (Paloque, Hemmert, Valentin & 
Gornitzka, 2015) and Amphotericin B, were used as antileishmanial compounds of reference; c: 
Doxorubicin was used as positive control of cytotoxicity. 
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The tested compounds exhibited moderate antileishmanial activity IC50 in the 
following order: Inonotic acid methyl ester < hispolon < hispidin. Thus compared to 
the cytotoxicity of Amphotericin B (2.47±0.24 µM) or Pentamidine (0.53±0.57 µM) 
compounds were from 7-12 times less toxic than the referenced drug and globally 
slightly toxic. By comparing the selectivity index of referenced drug Pentamidine 
(1.04) the molecules were 33 and 51% less selective for hispolon and inonotic acid 
methyl ester respectively. Meanwhile hispidin (25%) was more selective comparing 
with referenced drug Pentamidine. However, the tested compound had a very low 
selectivity index compared to Amphotericin B or Miltefosin.  
The represented data show that compounds may demonstrate an activity 
against the promastigotes - L. infantum specific target or that it has 
immunomodulatory effects modifying the antiphrastic response of the infected 
macrophages. There have been no reports on antileishmanial activity of isolated 
compounds; however, hispidin and hispolon isolated from ethanolic extract of I. 
hispidus showed considerable antiviral activity against influenza viruses type A and 
B (Awadh Ali et al., 2003). Hispidin isolated from P. linteus inhibit neuraminidases 
which catalyse hydrolysis of terminal neuraminic acid residues from newly formed 
virions and from host cell receptors, and are involved in the release of progeny virus 
from infected cells (Yeom et al., 2012). The neuroprotective efficacy of hispidin 
(10–20 µg/ml) from the same mushroom was found to significantly inhibit 
peroxynitrite-induced DNA damage and cytotoxicity (Chen et al., 2012). 
Furthermore, several reports have demonstrated that hispolon exhibits anticancer 
effects through the inhibition of cell growth or metastasis in various types of tumour 
such as gastric, acute myeloid leukaemia and human hepatoma cancer cells (Chen et 
al., 2008, Hsiao et al., 2013 and Huang et al., 2010). The latest research represent 
dual regulating estrogenic activities of hispolon, which could be used for treating the 
estrogen deficiency-related disease with the benefit of non-toxic to normal cells, 
good antitumor effects and estrogenic activity (Wang et al., 2014b). Overall 
hispidin, hispolon and inonotic acid methyl ester may represent a new lead scaffold 
for various drug developments, and thus its efficacy and side effect deserves further 
evaluation.  
3.4.2.2. Detailed biological activity of mushroom metabolite hispidin
3
 
The present study was to evaluate detail genotoxic activity of the hispidin 
isolated from P. schweinitzii. We used several genotoxicity tests, covering different 
endpoints, namely chromosome aberrations (CAs), micronuclei (MN), sister 
chromatid exchanges (SCEs), and primary DNA damage (detected by Comet assay) 
in human lymphocytes in vitro, and gene mutations in Salmonella/microsome test.   
3.4.2.2.1.Induction of micronuclei in human lymphocytes in vitro  
Micronuclei originate from acentric chromosome fragments (i.e., resulting 
from DNA breakage and lacking a centromere) or whole chromosomes (i.e., 
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resulting from lagging chromosomes unable to migrate to the poles during the 
anaphase), that are not included into the main daughter nuclei during nuclear 
division (OECD 487, 2010).  
Table 3.7 Micronucleus frequency (MN/1000 binucleated cells) and NDI values in 
peripheral blood lymphocytes after treatment with hispidin in vitro 
  Donor F1 Donor M1 
Treatment 
 
Consentration 
(µg/ml) 
MN, 
mean±S.E.M. 
NDI, 
mean±S.E.M. 
MN, 
mean±S.E.M. 
MN, 
mean±S.E.M 
Blank  3±1.73 1.50±0.04 3±1.73 1.57±0.04 
Ethanol 7.5 µl/ml 3±1.73 1.64±0.04 3±1.73 1.72±0.04 
Hispidin 10 – – 4±1.99 1.62±0.04 
 20 – – 5±2.23 1.59±0.04* 
 40 – – 6±2.44 1.55±0.03* 
 50 4±1.99 1.65±0.03* 5±2.23 1.71±0.04 
 100 6±2.44 1.30±0.02* 6±2.44 1.55±0.03* 
 150 8±3.18 0.92±0.01* 5±2.23 1.26±0.02* 
 200 Cytotox. Cytotox. Cytotox. Cytotox. 
* P<0.05 when compared with vehicle (ethanol) controls. 
Thus, the micronuclei assay has potential to detect agents with clastogenic 
(chromosome breaking; DNA as a target) and aneugenic (aneuploidy-inducing; 
mostly a non-DNA target) modes of action. Lymphocytes from two donors (F1 and 
M1) were used for this part of the study and the results are shown in (Table 3.7). 
Hispidin was not genotoxic in the micronucleus test at the dose range of 10–150 
µg/mL. However, hispidin induced a slight, though statistically significant, decrease 
of nuclear division index (NDI) values in lymphocytes of both donors (Table 1).  
The decrease in NDI values may be attributed to the delay of cellular division 
process for repair of damaged DNA, thus modifying the frequency of cells that 
undergo mitosis and changing the frequency of cells with one, two or more nuclei at 
harvest (Kirsch-Volders and Fenech, 2001). The highest tested dose (200 µg/mL) 
was cytotoxic.  
3.4.2.2.2.  Induction of chromosome aberrations and SCEs in human 
lymphocytes in vitro 
We used lymphocytes from donor F2 for the studies of hispidin genotoxicity 
using two additional cytogenetic endpoints, namely chromosome aberrations (CAs) 
and sister chromatid exchanges (SCEs).  
Table 3.8 Effects of hispidin extract on the frequency of CA, and SCE and 
replication index (RI) values in human lymphocyte cultures in vitro 
Treatment Concentr
ation 
(µg/ml) 
Chromosome aberrations a Sister chromatid exchanges 
CA per 100 
cells 
(±S.E.M.) 
ctb cte csb SCE/cell±S.E.M. RI±S.E.M 
Blank 0 3.33±1.89 2 0 1 9.52±0.55 2.67±0.04 
Ethanol 7.5  3.23±3.12 1 0 0 9.94±0.47 2.67±0.04 
Hispidin 10 3.95±1.69 2 1 0 9.82±0.56 2.30±0.05
 b  
 20 3.92±2.72 0 0 2 10.80±0.57 2.06±0.06
 b 
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Treatment Concentr
ation 
(µg/ml) 
Chromosome aberrations a Sister chromatid exchanges 
CA per 100 
cells 
(±S.E.M.) 
ctb cte csb SCE/cell±S.E.M. RI±S.E.M 
 40 6.67±4.56 1 0 1 11.36±0.59 2.07±0.06
 b 
 50 1.85±1.83 1 0 0 12.80±0.68
 b 2.25±0.05 b 
 100 5.89±4.04 1 1 0 14.32±0.53
 b 2.19±0.05 b 
 150 4.76±3.29 1 0 1 18.46±0.86
 b 2.04±0.05 b 
a ctb, chromatid breaks; cte, chromatid exchanges; csb, chromosome breaks; cse, chromosome 
exchanges. b P<0.05 as compared to adequate solvent control. 
 
In vitro chromosome aberration test is commonly used to identify structural 
chromosome aberrations (OECD 473, 1997), and SCEs represent the interchange of 
DNA replication products at apparently homologous loci (OECD 479, 1986).  
Hispidin did not induce significant increase in chromosome aberrations (Table 3.8). 
However, it revealed genotoxic effect in SCE test. Hispidin induced statistically 
significant dose-dependent increase in SCE frequency (y=9.5334+0.05613·x; 
r=0.98593, P0.05) and decrease in replication index (RI) values (y=1.6887–
0.0023·x; r= –0.8329; P0.05).   
3.4.2.2.3.  Induction of primary DNA damage detected by comet assay  
In the present study, Comet assay was used to evaluate the extent of primary 
DNA damage. The alkaline version of the Comet assay developed by Singh et al. 
(1988) and used in our study detects a mixture of lesions including DNA single- and 
double-strand breaks and alkali-labile sites (apurinic/apyrimidinic sites) (Collins et 
al., 2008). The comet assay was performed on isolated peripheral blood lymphocytes 
of two donors (F1 and F3) in order to detect the primary DNA damage induced by 
hispidin in dose range of 25-1, 000 µM. In this study, comet parameters such as tail 
length (TL, µm), % of the DNA in tail (%TDNA), and tail moment (TM, the product 
of relative tail intensity and length) were evaluated, but only the data on the 
%TDNA are presented. %TDNA was a parameter of choice, because it is considered 
to be the most reliable as it covers the widest range of damage and is linearly related 
to DNA break frequency(Collins et al., 2008). Comparable results were obtained 
when tail length was analyzed (data not presented). 
The extent of DNA damage as measured by comet assay is presented in Fig. 6. 
Hispidin did not induce statistically significant increase in the %TDNA in the 
lymphocytes of both donors. Moreover, significant decrease in DNA damage was 
observed in the lymphocytes of donor F1 after treatment with 200 and 500 µM 
hispidin doses. A positive control we used was hydrogen peroxide (H2O2, 20 μM), 
which induced significant increase in the %TDNA in both donors (19.76±1.06 and 
21.36±2.53, in donors F1 and F3 respectively).  
 108 
 
 
Fig. 3.28 Percentage of DNA in a comet tail (%TDNA±S.E.M.) after exposure of human 
lymphocytes in vitro with different concentrations of hispidin 
Hispidin had no influence on cell viability (data not presented), which was 
evaluated using Casy TT Cell Counter and Analyzer (INNOVATIS, Switzerland) 
where quantification of cell viability is based on the dye-free non-invasive electrical 
current exclusion principle.  
3.4.2.2.4.  Salmonella/microsome test  
The Salmonella/microsome (Ames) reverse mutation test is an essential assay 
required for genotoxicity evaluation of exogenous substances (Kirkland et al., 2011). 
This test is commonly employed as an initial assay for the screening of mutagenic 
activity and, in particular, for point mutation-inducing activity (OECD 471, 1997).  
Table 3.9 Mean number of revertants induced by fungal metabolite hispidin, the 
reference mutagen and the negative control in Salmonella/microsome test using 
TA98 and TA100 strains with or without S9 fraction  
In our study the Ames test was carried out using Salmonella typhimurium 
strains TA98 and TA100 with and without S9 metabolic activation.  All hispidin 
Treatment Dose, 
µg/ml 
TA 98 strain 
Revertant colonies/plate, 
mean±S.D. 
TA100 strain 
Revertant colonies/plate, 
mean±S.D. 
Without S9 
fraction 
With S9 
fraction 
Without S9 
fraction 
With S9 
fraction 
Blank control  51.50±13.44 26.50±2.10 80.50±9.19 64.00±7.07 
Vehicle control   50.50±2.12 29.50±0.71 81.50±3.54 72.50±2.12 
Daunomicine  813.00±24.04 – – – 
Sodium Azide  – – 498.50±58.69 – 
2-Amino- 
anthracene 
 – 926.00±265.87 – 1622.50±204.35 
Hispidin 50 42.67±5.03 34.67±3.06 97.33±6,34 82.00±18.19 
 100 39.00±3.61 34.33±6.43 77.67±12.92 102.33±15.50 
 150 40.67±3.06 33.00±3.61 92.33±9.84 83,33±19.86 
 250 39.33±5.51 33.00±4.00 98.00±6.68 72.00±7.94 
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samples showed negative results in the Ames test, indicating that hispidin does not 
produce reverse mutation in bacterial cells (Table 3.9).  
3.4.2.3. Determination of anthelmitic effect on gastrointestinal nematodes 
Parasitic nematodes of the digestive tract are one of the most pathogenic 
parasites of ruminants. Adult worms attached to the digestive system of goats or 
sheep are feed on the blood and have serious consequences in warm humid climates. 
The most important limiting factors of infected ruminants is productivity and health 
problems, which cause anaemia, oedema and death (Joshi et al., 2011, Hoste et al., 
2005). The typical treatment or prevention of infection of gastrointestinal nematodes 
depends on the repeated use of anthelmintics. However, their continued use has led 
to anthelmintics resistance in worm populations and the presence of synthetic 
chemical residues in meat and milk have created markets for organically produced 
animals raised without synthetic anthelmintics (Jackson and Coop, 2000, Acharya, 
Hildreth and Reese, 2014). These aspects have induced scientist to search for 
efficient and alternative “natural” anthelmintics from plant origin that can be used in 
livestock production (Waller and Thamsborg, 2004).  The use of nutraceuticals, 
especially plants rich in tannins or other natural polyphenolic compounds has been 
suggested as a sustainable alternative for the control of gastrointestinal nematodes 
(Manolaraki et al., 2010). It is important to pay attention to mushroom species, 
which are a rich source of bioactive molecules and might have potent activities on 
different gastrointestinal nematodes. For instance, some (Polyporus) Phaeolus 
mushroom species were used in medicine as an effective vermifuge in anthelmintic 
therapy (Lihua et al., 2010).  
 
 
 
 
 
Fig 3.29 Exsheathed L3 larvae of T. colubriformis 
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The isolated compounds of P. schweinitzii were tested as anthelmintic agents 
on predominant hematophagous parasite H. contortus and often co-dominant in 
parasite populations T. colubriformis, although it could be as harmful as 
Heamonchus (Mahieu et al., 2007). The larval exsheathment assay has been 
developed to measure the ability of hispidin, and hispolon to delay or inhibit and 
artificial induce the exsheathment process of infective L3 larvae (Bahuaud et al., 
2006). By preventing the exsheathment (Fig 3.29) process compounds possess 
anthelmintics activity and larvae may not be able to infect the animal; thus 
ensheathed (Fig. 3.30) larvae are excretive from the digestive tract of animals 
(Hertzberg et al., 2002).  
 
   
 
 
 
 
Fig. 3.30 Ensheathed L3 larvae of T. colubriformis 
Fig. 3.31 Hispolon activity on T. columbiformis third-stage larvae on the process of artificial in vitro 
exsheathment. 
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In controls from 97-100% of the H. contortus and T. colubriformis larvae were 
generally exsheathed after 60-minute contact with the solution for exsheathment 
(Fig. 3.31, 3.32 and 3.33.). Hispolon was not tested on H. contortus larvae, but 
provoked a slightly delay only with concentration of 300 µg/ml in the exsheathment 
rate of T. colubriformis (Fig. 3.31). In 3-hour contact hispidin led to a strong 
inhibition of both nematodes species with the highest tested concentration of 300 
µg/ml. The larvae were 3.97±2.88% and 16.52±7.72 exsheathed after 60 minutes for 
T. colubriformis and H. contortus respectively (Fig. 3.32 and 3.33). In contrast, for 
the other concentration of 150 and 75 µg/ml, exsheathment was significantly 
delayed (15-74% and 31-90% respectively) for T. colubriformis. However, smaller 
concentration tested for H. contortus were less effective and the mean percentages 
ranged from 53% to 100% (150 µg/ml) and 84% to 100% (75 µg/ml) after 60 min.  
 
 
 
 
 
The outcome of the larval exsheathment process efficiency depends on 
hispidin and hispolon molecular weight and the compounds structural conformation. 
For instance, the anthelmintic effects of flavan-3-ols showed that the inhibition of 
exsheathment was associated with the total number of hydroxyl groups, the 
molecular weight of the molecules, and the presence of OH group in C ring (Brunet 
and Hoste, 2006). The changes in the exsheathment rate also belong to the 
interaction between bioactive molecules and proteins composition of nematodes 
larvae. The polyphenols possibility have anthelmintic properties and affect the 
biological process proved in vitro and in vivo assays. Several studies in sheep and 
goats describe the short term experimental design that did not permit the 
development and expression of larvae (Paolini et al., 2003a, Paolini et al., 2003b, 
Athanasiadou et al., 2001). Unfortunately, the exact process of action remains 
undefined and could differ depending on the parasite strain, its stage of 
development, possible biochemical characteristics of the forage species and 
bioactive molecules structure (Hoste et al., 2006). 
Fig. 3.32 Different hispidin concentrations activity on T. columbiformis third-stage larvae on the 
process of artificial in vitro exsheathment 
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At the same time methanolic extract of P. schweinitzii was tested against two 
nematodes, together with other methanolic extract of I. hispidus which contain the 
isolated secondary metabolites described above. Both mushrooms were collected in 
the course of two years (2011 and 2012). Exsheathment of H. contortus L3 in the 
control groups was 97-100% obtained after 60 min. Compared to the control values, 
the strong inhibition of the larval exsheathment with I. hispidus (2011) was at 
concentrations of 1200 µg/ml and 600 µg/ml (Fig. 3.34). In contrast, although still 
significant the reduction in the exsheathment process was less pronounced at 300 
µg/ml while, the smolest tested concentrations were ineffective. The inhibition 
process of the larval in a contact with I. hispidus (2012) extract possessed the 
potential activity only with highest tested concentration (Fig.3.36), after the 
concentration reduced twice the exsheathment process was significantly delayed, 
whereas other concentrations were less expressed. 
 
Fig. 3.33 Different hispidin concentrations activity on H. contortus third-stage larvae on the 
process of artificial in vitro exsheathment 
Fig. 3.34 Variations in the inhibition of the artificially induced exsheathment rate measured for H. 
contorus larvae after contact at different concentrations with I. hispidus (2011) extract 
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Compared to the control values, the contact with the extracts of P. schweinitzii 
(2011) induced a highly significant, nearly total inhibition of the exsheathment 
process for the larvae observed at the concentrations of 1,200, 600 and 300 µg/ml 
(Fig. 3.35). Contrary P. schweinitzii (2012) extract was ineffective and 
exsheathment process values were close to control values (Fig.3.37). 
 
After 60 min, the exsheathment of T. columbiformis rates in controls ranged 
from 92 to 100%. Compared to the control values, contact with the I. hispidus 
(2011) extracts induced a highly significant, nearly total inhibition of the larval 
exsheathment process at the concentrations of 600 and 1,200 µg/ml, whereas the 
lower concentration 300 µg/ml was efficient and inhibited 41.40±4.16% larvae after 
60 min (Fig.3.38). Therefore, the inhibition process was less efficient with I. 
hispidus (2012), the highest concentration slightly inhibited larval exsheathment 
67.80±4.49% in 60 min (Fig. 3.40), meanwhile other concentrations were inactive. 
 
 
 
Fig. 3.35 Variations in the inhibition of the artificially induced exsheathment rate measured for H. 
contorus larvae after contact at different concentrations with P. schweinitzii (2011) extract 
 
Fig. 3.36 Variations in the inhibition of the artificially induced exsheathment rate measured for H. 
contorus larvae after contact at different concentrations with I. hispidus (2012) extract 
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With P. schweinitzii (2011) extracts, the inhibition of the larval 
exsheathment, compared to the control rates after 60 min, reached the highly 
efficient values of 2.76±2.64% and 15.43±4.12% at the concentrations of 1,200 and 
600 g/ml (Fig. 3.39). However, the difference between the rates observed after 
contact with the extracts when the concentration reduced four or eight times did not 
significantly differ after 60 min, but inhibition of 300 µg/ml was more efficient until 
40 min with the value 26.19±3.92%. The P. schweinitzii (2012) concentration at 
1,200 µg/ml induced larval exsheathment, 21.04±4.49% in 60 min (Fig.3.41), while 
other concentrations were inactive and showed similar activity as the control.  
 
 
 
Fig. 3.37 Variations in the inhibition of the artificially induced exsheathment rate measured for H. 
contorus larvae after contact at different concentrations with P. schweinitzii (2012) extract 
Fig. 3.38 Variations in the inhibition of the artificially induced exsheathment rate measured for T. 
colubriformis larvae after contact at different concentrations with I. hispidus (2011) extract 
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Fig. 3.39 Variations in the inhibition of the artificially induced exsheathment rate measured for T. 
colubriformis larvae after contact at different concentrations with P. schweinitzii (2011) extract 
Fig. 3.41 Variations in the inhibition of the artificially induced exsheathment rate measured for T. 
colubriformis larvae after contact at different concentrations with P. schweinitzii (2012) extract 
Fig. 3.40 Variations in the inhibition of the artificially induced exsheathment rate measured for T. 
colubriformis larvae after contact at different concentrations with I. hispidus (2012) extract 
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The present results confirmed the anthelmintic properties of both P. 
schweinitzii and I. hispidus. The effects of both mushrooms were year dependent for 
both tested nematodes. Mushrooms collected in 2011 showed better activity, and 
were more effective with lower concentrations. For example, P. schweinitzii (2011) 
had strong inhibition activity (1,200 and 600 µg/ml) and induced less than 20% of 
excheathment during 60 min on H. contorus and T. colubriformis, also similar 
results were produced by I. hispidus. Less efficient results on two nematodes were 
expressed by P. schweinitzii and I. hispidus collected in 2012, a slight delay was 
demonstrated at only the highest concentration and inhibition exsheathment varied 
from 21-68% or smaller concentrations (150 and 300 µg/ml) were inactive. These 
differences may have several factors, such as bioactive component composition and 
concentrations in mushrooms and collection periods or age of the species. For 
instance, salt in the soil modifies flavonoid composition in plants (Tattini and 
Traversi, 2008). 
The contact with P. schweinitzii (2011) extracts at the 3 concentrations tested 
(1,200, 600 and 300 µg/ml), resulted in a nearly total inhibition of exsheathment, 
which was found with H. contorus. The inhibitory effects observed with I. hispidus 
extracts were less efficient and two concentrations showed (1,200 and 600 µg/ml) a 
slight delay. The extracts of I. hispidus (2011) and P. schweinitzii (2011) activity 
were more dependent on the year of collection and showed potent efficiency at two 
tested concentrations (1,200 and 600 µg/ml) with T. colubriformis, thus the highest 
concentrations were slightly delayed for both mushrooms collected in 2012.  
A possible explanation could be that the two nematode parasites occupy 
different locations in the animal, and also the activating conditions for exsheathment 
vary between abomasal and intestinal nematodes. However, from the results it is 
evident that extracts of P. schweinitzii and I. hispidus caused insignificant delays of 
exsheathment in a dose dependent manner for both nematodes especially for the 
2011 collection. The effect of well-known forage legume sainfoin extract was tested 
on H. contortus and T. colubriformis L3 larvae at concentrations of 300, 600 and 
1,200 µg/ml. At the 1,200 µg/ml concentration, nearly total inhibition of 
exsheathment of H. contortus and T. colubriformis was observed (Brunet and Hoste, 
2006). In our study, similar results were observed. Variability of exsheathment 
inhibition between mushroom species could be due to several reasons and may not 
necessarily reflect a true difference between nematode species (Novobilský, 
Mueller-Harvey and Thamsborg, 2011). The extracts probably differed in secondary 
metabolites content and maybe have a synergetic effect in the species between P. 
schweinitzii and I. hispidus. Numerous research gastrointestinal nematodes activity 
explained due to flavonoids and tannins existence, as biologically active components 
in plants (Acharya et al., 2014, Manolaraki et al., 2010, de Oliveira et al., 2011, 
Katiki et al., 2011, Alonso-Díaz et al., 2008). However, besides polyphenols, some 
other classes of biochemical compounds can also participate in the bioactivity and 
inhibit parasites. This was found with chestnut or pine tree extracts when using the 
exsheathment inhibition assay (Azando et al., 2011). Isolation of compounds and 
precise activity identification is one of the factors to understand the biochemical 
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pathways affected by exposure to mushroom extracts. Such isolated bioactive 
molecules (hispidin, hispolon) from P. schweinitzii inhibit exsheathment on 
gastrointestinal nematodes and possessed anthelmintic properties.  
In the last decade drug discovery programs for new anthelmintic compounds 
have been expensive and have produced relatively few new compounds (Csermely et 
al., 2013, Mackenzie and Geary, 2013). Recently, important implications for the 
potential therapies that occur with cocktails of plant extracts combined with existing 
anthelmintic drugs may overcome some of the emerging drug resistance problems 
for some commercially available drugs (Kumarasingha et al., 2014). Therefore, it is 
important to concentrate on natural matter and find novel drugs with anthelmintic 
properties, not only to replace the existing drug, but also to prolong the effective life 
cycle of the existing drugs. 
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4. CONCLUSIONS 
1. Sequential fractionated 30 wild mushroom extract yields increased with 
increasing polarity of extraction solvent. The highest polarity water and methanol 
enabled the highest extract yields to be obtained from 2.94 (H. ferrugineum), 
25.29% (T. caligatum) and from 6.77% (S. halophila) and 41.29% (A. 
pseudopratensis). The yields of cyclohexane and dichloromethane extracts were 
remarkably lower from 0.61 (S. halophila), 5.14% (R. badia), 0.52 (G. ammophilus) 
and 3.42% (T. caligatum). The families possessing significant total yields were 
Agaricaceae, Tricholomataceae and Boletacea. 
 
2. The following factors had effects on the antioxidant capacity of mushroom 
extracts measured by the in vitro ABTS•+, DPPH•, FRAP, ORAC and TPC assays: 
mushroom family and species, solvent type and polarity and evaluation method. The 
highest ‘antioxidant scores’, which were introduced for integrating numerous 
antioxidant evaluation data and expressed in comparative integrated units per g of 
mushroom dry weight, were demonstrated by I. hispidus (808 ciu/g mdw), P. 
schweinitzii (712 ciu/g mdw) and C. infractus (481 ciu/g mdw). In general, the 
species of the Agaricaceae and Boletaceae families possessed superior antioxidant 
potential, which was in the ranges of 109-325 and 140-253 ciu/g mdw respectively. 
The correlation between total phenolic and total antioxidant activity observed in our 
study was not as strong as may be expected, most likely due to the presence of 
various compound classes participating in the applied assays by different 
mechanisms. In general, the extracts isolated with polar solvents were characterised 
as possessing higher antioxidant activity. 
 
3. The majority of mushroom extracts (89% of the total samples tested) 
demonstrated antimicrobial activity, 59% of them characterised as partial 
antimicrobial activity and not fully inhibiting microorganisms. Methanol fractions of 
P. schweinitzii, I. hispidus and C. infractus were the strongest antimicrobial agents 
against tested microorganisms in disc diffusion assay (inhibition zones were from 10 
to >15 mm) and the bioautography method. It should be noted that the same species 
demonstrated the highest antioxidant potential with Gram-positive bacteria; Bacillus 
cereus and Staphylococcus aureus were more sensitive to mushroom extracts than 
Gram-negative, Pseudomonas aeruginosa and Escherichia coli. 
 
4. Cyclohexane extracts of G. ammophilus as well as cyclohexane and 
dichlomethane extracts of S. halophila exhibited good cytotoxic activity against the 
parasite Leishmania infantum amastigotes: the selectivity indexes (SI) indicating the 
ratio between cytotoxicity and activity against parasites for the above-mentioned 
extracts were 49.09, 22.28 and 22.42 respectively. These findings are promising for 
the further development of novel natural antiparasite preparations. 
 
5. P. schweinitzii methanolic extract, as the substance possessing strong 
antioxidant capacity and antimicrobial activity, was fractionated by thin layer 
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chromatography (TLC), column chromatography (CC) and high performance liquid 
chromatography (HPLC): TLC-DPPH
• 
bioautography assay revealed 2 fractions 
exhibiting remarkable radical scavenging capacities which were purified by CC and 
HPLC. 
 
6. Three principal constituents, namely hispidin, hispolon and inonotic acid 
methyl ester were elucidated and identified in P. schweinitzii by using a range of 
spectroscopic techniques - ESI-MS, ESI-MS/MS, 1H NMR, 
13
C NMR, HMBC, 
COSY, HSQC. Hispolon and inonotic acid methyl ester are reported in P. 
schweinitzii for the first time. 
 
7. The activities of the purified principal components were tested for their 
antioxidant capacity and cytotoxicity. Hispidin was an effective antioxidant in 
ABTS
•+
, DPPH
•
, FRAP, ORAC assays; in general, its activity was similar to the 
strong synthetic antioxidant, Trolox. The in vitro assessment of hispidin on human 
lymphocytes in the micronucleus and induction of chromosome aberrations in 
human lymphocytes did not reveal its genotoxicity. Also, hispidin did not induced 
primary DNA damage and mutation in bacterial cell. Hispidin, hispolon and inonotic 
acid methyl ester demonstrated an activity against promastigotes L. infantum and 
had immunomodulatory effects modifying the antiphrastic response of infected 
macrophages.  
 
8. The extracts of P. schweinitzii and I. hispidus were potent inhibitors on larvae 
exsheathment against H. contortus and T. colubriformis gastrointestinal nematodes; 
however, the effects of extracts isolated from the mushrooms collected in different 
years were different, indicating that active components may be present at different 
concentrations. Hispidin led to a strong inhibition with the highest tested 
concentration (300 µg/ ml) against both tested nematodes, while hispolon provoked 
a slightly delay against T. colubriformis. 
 
9. In general, comprehensive and systematic evaluation of antioxidant and 
antimicrobial properties of underinvestigated wild mushroom species provides 
important data for their further valorisation as a source of valuable ingredients. More 
specifically, the extracts isolated from the species possessing the strongest 
antioxidant potential may be promising protecting agents against oxidative damage 
and inhibitors of gastrointestinal nematodes. The principal components of such 
species, hispidin, hispolon and inonotic acid methyl ester may represent a group of 
new natural compounds for developing functional ingredients for nutraceuticals, 
functional foods, pharmaceuticals and other applications. Further research should be 
focused on elucidating the mechanisms of the performance of extracts, fractions and 
purified compounds using wider spectra of the in vitro (e.g. cell cultures) and in vivo 
studies. 
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APPENDIX 1 
Sorted families and the number of active species against tested bacteria 
Family fraction Number  
of 
species 
Number of active 
species against Gram 
positive bacteria 
Number of active 
species against Gram 
negative bacteria 
   S. aureus B. cereus P. aeruginosa E. coli 
Agaricaceae C 7 2 3 2 0 
 D 7 7 5 4 5 
 M 9 6 6 5 4 
Tricholomataceae C 5 3 2 2 2 
 D 5 4 2 3 2 
 M 6 4 5 5 2 
Boletaceae C 5 3 3 4 1 
 D 3 2 1 2 2 
 M 5 3 3 4 3 
Cortinariaceae C 2 0 1 1 1 
 D 1 1 1 1 0 
 M 2 1 1 1 2 
Russulaceae C 2 0 0 0 0 
 D 2 0 0 1 0 
 M 2 2 1 2 2 
Gyroporaceae C 1 1 1 0 0 
 D 1 1 1 1 1 
 M 1 1 1 1 0 
Strophariaceae C 1 0 0 0 1 
 D 1 1 0 0 0 
 M 1 1 1 1 0 
Amanitaceae C 1 0 0. 1 0 
 D 1 0 0 1 1 
 M 1 1 1 1 0 
Polyporaceae C 2 0 2 2 0 
 D 2 0 2 2 0 
 M 2 0 2 2 0 
Bankeraceae D 1 0 1 0 0 
 M 1 0 1 1 0 
Total  80 44 47 50 29 
C, cyclohexane; D, dichloromethane; M, methanol; 
 
